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 Abstract 
The work contained within this thesis concerns the synthesis and characterisation of novel 
[2]-rotaxanes, mediated via H-bonded templation. The template in question is based upon 
the barbiturate receptor as developed by A. D. Hamilton which up until now had not been 
utilised in the synthesis of interlocked structures. 
The initial approaches centred on the use of long appendages of the barbiturate towards a 
threading, and subsequent clipping approach; however a lack of initial threading event 
prevented formation of the pseudorotaxane. In an attempt to overcome these difficulties, 
the synthesis of more rigid, dumbbell-barbiturates, were applied towards a receptor-based 
clipping approach, but the steric bulk acquired from the rigid spacer groups appeared to 
hinder any cyclisation. 
To overcome the problem of threading, shorter appendages were utilised and the threading 
was observed via a crystal structure of the complex. Subsequent stoppering of the azide-
terminated appendages in a CuAAC reaction afforded the first Hamilton Receptor based [2]-
rotaxane. Further studies involving bichromophoric, anthracene-terminated receptors were 
then utilised with these barbiturate guests in the synthesis of a [2]-rotaxane via a novel 
light-induced photodimerisation. 
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1. Introduction 
1.1    Supramolecular chemistry 
Supramolecular chemistry is a field best described by Nobel Laureate J-M Lehn as 
‘chemistry beyond the molecule’.1 This neatly ties in the concept that supramolecular 
chemistry is not concerned with the classical bonds of chemistry, but rather the 
intermolecular forces between the covalent molecules themselves. The concepts of 
supramolecular chemistry, or more specifically the host-guest interaction, were first 
described by Hermann Emil Fischer in 1894. He proposed the enzyme-substrate interaction 
being one of molecular recognition, where the substrate (guest) and enzyme (host) have a 
complementary size match. He coined the phrase ‘lock and key’ to emphasise the specificity 
and complementarity of these interactions, stabilised by intermolecular forces such as 
electrostatics, hydrogen bonding and π-π stacking. Aside from the enzyme-substrate 
interaction, other biological phenomena which exemplify the concepts of supramolecular 
chemistry include protein folding, and DNA helices, displaying the properties of 
preorganisation, recognition and reversibility. 
The natural world has had time on its side to enhance and modify supramolecular 
interactions to provide powerful biological catalysts for numerous functions within the 
metabolic processes of life. Chemists on the other hand, have had to probe and elucidate 
these interactions in order to recreate them in the laboratory. It is not surprising therefore, 
that supramolecular chemistry has had a heavy biological influence in terms of inspiration 
and emulation. With the discovery and description of the hydrogen bond in the early 20th 
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century, chemists were developing the knowledge to be able to understand these 
intermolecular interactions at the molecular level, but it was not until the 1960’s that 
synthetic supramolecular chemistry first emerged. Since then it has seen vast growth in 
terms of the templates, motifs and architectures available, with a growing wealth of real-
world applications. 
In its simplest form, supramolecular chemistry may be regarded as host-guest chemistry, 
a process of molecular recognition, resulting in the formation of a supramolecular complex, 
as demonstrated in Figure 1.1. As observed in enzymes, the guest substrate is bound to the 
cavity via intermolecular bonds in a complementary fashion and chemists have found many 
varied motifs employing this lock (H) and key (G) interaction. The interaction is a reversible 
one, with the thermodynamics of binding determined by the strengths and number of 
interactions present.2 Attachment of various reporter groups to these host species can 
result in supramolecular devices.  
 
Figure 1.1 – Formation of a Host:Guest (H:G) complex from its substituents. 
A fundamental aspect of supramolecular chemistry is that of preorganisation and self-
assembly and these were demonstrated in the first examples of simple supramolecular 
architectures, given by Charles John Pedersen3 (and earning him recognition through the 
award of a Nobel prize in 1987 along with Jean-Marie Lehn and Donald J. Cram). He 
reported the synthesis of cyclic polyethers without the use of high dilution techniques. 
Introduction 
3 
 
These compounds were made by exploiting the host-guest interaction between the cyclic 
polyether and a group 1 metal cation. The metal cation is stabilised within the ring via ion-
dipole interactions between the metal cation and oxygen atoms of the ring and it is this 
interaction that allows the polyether chain to adopt the conformations required for 
cyclisation, as shown in Figure 1.2. This concept gives rise to what is known as known as the 
macrocyclic effect.  
 
Figure 1.2 – Demonstration of the Macrocyclic Effect from a H:G interaction. 
1.1.1 Intermolecular Forces 
Due to the fact that supramolecular chemistry is concerned with intermolecular 
interactions ‘beyond the molecule’, classical covalent and ionic bonds are not necessarily 
observed. What are present between molecules are a series of non-covalent interactions of 
varying strengths, depending on the functional groups and substituents present between 
two or more interacting species. These interactions can be subdivided into five groups, in 
order of their relative strengths; electrostatics, H-Bonding, π-π interactions, van der Waals 
forces and hydrophobic/solvatophobic effects. Bearing in mind that typical covalent bonds 
are of the order of 300-900 kJmol-1, these interactions are somewhat weaker and in some 
cases considerably so. However, when added together over entire arrays, relatively stable 
structures may be formed. 
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Figure 1.3 - Electrostatic interactions of ion-ion (a), ion-dipole (b) and dipole-dipole (c). 
Electrostatic interactions arise due to the close proximity of formal or partial charges 
and are summarised in Figure 1.3. These include ion-ion interactions (a) (an ionic bond), ion-
dipole (50-200 kJmol-1) and dipole-dipole (5-50 kJmol-1) interactions.4 Due to their relative 
strengths, they can be applied towards the design of supramolecular architectures and have 
seen widespread use. Ion-dipole interactions (b) have been utilised in supramolecular 
structures such as the crown ether complexes for the encapsulation of group 1 and 2 metal 
cations as described above. The dipoles present are a direct result of an imbalance of charge 
in a bond due to the relative electronegativities of the atoms present. In such complexes, 
the lone pairs of the oxygen donor atoms are attracted to the positive charge of the metal 
cation. Application of this concept has resulted in the development of a whole host of 
supramolecular sensors, devices and logic gates based on crown ethers. Dipole-dipole 
interactions, such as those between carbonyl compounds (c), despite a degree of 
directionality, are generally weaker than ion-dipole interactions and are easily overcome in 
solution. 
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Hydrogen bonding (4-120 kJmol-1)4 may be considered as a specific type of dipole-
dipole interaction. The nature of an H-bond is determined by electrostatics, repulsive and 
dispersion forces, induced dipoles as well charge transfer and typically involves an 
interaction between a hydrogen atom attached to an electronegative atom (the donor, D) 
and another electronegative atom (the acceptor, A). This arises due to the electronegative 
nature of the donor atom, whereby electron density is withdrawn from the hydrogen atom, 
creating a relatively large positive charge density.2 This is attracted to a lone pair belonging 
to an atom of a nearby molecule, resulting in a relatively strong and highly directional 
interaction, shown in Figure 1.4.a. 
 
Figure 1.4 – An example of H-bonding (a) and complementary base-pairing of C and G bases in DNA (b). 
Due to its high level of directionality and absence of any formal charges, H-bonding 
has seen extensive use in natural and synthetic supramolecular structures, with the most 
widely known being the base pairing of DNA, a G-C base pair is shown in Figure 1.4.b. As 
mentioned previously, the interactions alone are relatively weak; however, they experience 
a cumulative effect when present throughout the whole DNA strand, which results in a 
highly ordered and stable structure. H-bonding also plays a significant role in protein 
folding.  
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When designing H-bonding supramolecular structures, aside from the donor-
acceptor arrays already discussed, it is important to consider the secondary effects of H-
bonding. This concept was developed through computational studies carried out by 
Jorgensen and Pranata5 in their study of triply hydrogen bonded complexes, Figure 1.5.  
 
Figure 1.5 – Examples of secondary effects present in H-bonding structures. 
The two component complexes in question have identical H-bonding motifs in terms 
of their donor and acceptor parts, (two NH--OC and one NH--N H-bonds) but their 
association constants differ considerably. The association constant of complex (a) was found 
to be 104-105 M-1 in CHCl3, whereas complex (b) in CHCl3 was found to be only 170 M-1.6 This 
variation was attributed to the arrangement of the three H-bonds present. In an H-bonding 
array, centres of like charge repel and as such ADA-DAD complexes experience unfavourable 
secondary interactions, and so considering the structures above, (a) contains an extra 
favourable interaction with respect to (b) which results in a stronger binding constant. 
π-π stacking occurs between systems containing aromatic rings, with the two most 
stable forms being either face-to-face (parallel displaced) or edge-to-face, Figure 1.6. The 
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interactions arise due to the inherent quadropole moment present within benzene rings. 
Due to the delocalisation of charge and arrangement of orbitals, there is a negative charge 
above and below the plane of the ring and by adopting a parallel or T-shaped configuration, 
unfavourable interactions are minimised.4  
                                  
Figure 1.6 – Common forms of π-π stacking and a supramolecular host, 1, bearing π-π stacking stabilisations 
encapsulating benzoquinone.7 
These interactions have been employed in the use of receptor 1 towards the 
recognition of benzoquinone by Hunter, in an attempt to mimic the features of quinone 
binding domains in bacterial photosynthetic reaction centres.7 The receptor binds 
benzoquinone via 4 H-bonds, but the binding is enhanced upon by the presence of π-π 
interactions.  
Hydrophobic/solvatophobic effects may not necessarily be considered interactions 
per se, but more of a ‘driving force’ towards the association of apolar components in 
aqueous media or vice-versa. There are entropic and enthalpic components present in this 
association which should be addressed. For example, in the case of calix[n]arenes, a 
hydrophobic pocket is present within the internal walls of the molecular cyclinder. An 
entropic driving force exists whereby small organic molecules will sit within the cavity, 
excluding water molecules and increasing the entropy of the system. The enthalpic term 
1 
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arises from the stabilisation of water molecules originally within the cavity. Once free from 
the relatively poor polar-apolar interactions within the cavity, the water molecules are able 
to re-establish H-bonding with the bulk solvent and as a result, their overall energy and that 
of the system is reduced.4 As well as this, there are also additional van der Waals and π-π 
stacking interactions experienced by the encapsulated molecule, which serve to lower the 
energy. This was first demonstrated by Koga et al.8 with the encapsulation of durene in a 
cyclophane receptor, 2, in acidic aqueous media, shown in Figure 1.7. 
 
Figure 1.7 – Encapsulation of durene within an apolar cavity. 
The final interaction to be considered, although not strictly supramolecular, is the 
coordinate or dative bond, where an electron pair is donated from a ligand to a metal 
centre. Despite this technically being a covalent bond, this concept sees wide use in 
supramolecular chemistry due to its reversibility and its application in the formation of self-
assembled structures. The precise geometries of the metal centre/complex, and the 
reversibility of the assembly processes have given rise to the formation of some elaborate 
molecular topologies. 
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1.1.2 Design of neutral guest binders 
In the design of neutral guest binders there are certain factors to consider including the 
optimal functional groups for binding, the spatial requirements and rigidity vs flexibility of 
the host/guest. As discussed previously, the most critical aspect is one of a size-match 
complementarity. The example shown in Figure 1.8, developed by Hamilton and co-
workers, is a relatively simple motif, 3, displaying H-bond mediated ‘recognition’ of glutaric 
acid.9 Noting the presence of unfavourable secondary interactions, the amidopyridine motif 
was replaced by a urea motif, 4, resulting in a marked increase in the binding constant, with 
the H:G complex stable even in highly competitive solvents.10 
 
Figure 1.8 – Optimisation of binding through functional group changes. 
Highlighting the importance of a size-match fit is the exemplary example shown by 
Julius Rebek.11 Shown below in Figure 1.9 are two highly selective receptors for 
diketopipirazines and barbiturates. In the case of 5, the dilactam receptor forms a complex 
with cyclo(L-leucine)2, which showed a >2.5 kcalmol-1 higher stability than its enantiomer. 
The meso form of the receptor, 6, showed selectivity for barbiturates but the corresponding 
diimide receptors showed no selectivity for either guest species. 
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Figure 1.9 – Structurally similar receptors for diketopipirazines (5) and barbiturates (6). 
  The concept of a preorganisation effect was also highlighted by the same group 
through the synthesis of molecular clefts, Figure 1.10. By incorporating intramolecular H-
bonds, the primary structure of 7 adopted is one suitable for binding, requiring no further 
organisation of the molecule. This is analogous to the secondary structure adopted by 
proteins in positioning their functional groups for optimal substrate binding. 
 
Figure 1.10 – Preorganisation of binding sites used to enhance binding. 
1.2   Interlocked Structures 
1.2.1 History, Nomenclature and Approaches 
Synonymous with the field of supramolecular chemistry is that of interlocked structures. 
By definition, these are structures which consist of two or more independent components 
which are not connected via classical chemical bonds, but instead are bound via a 
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‘mechanical bond’. This means that the components cannot be separated without breaking 
a covalent bond. Classical examples include rotaxanes, catenanes and knots, the former of 
which is the basis of this thesis. The name rotaxane comes from the latin words rota, 
meaning wheel and axis, meaning axle, and was first proposed by Schill and Zollkopf.12 A 
rotaxane consists of at least one threaded macrocycle around an axle, with large stopper 
groups capping the end and preventing dissociation of the macrocycle. The word catenane 
derives from the latin word catena, meaning chain, and are structures consisting of two 
interlocked molecular rings which cannot be separated without breaking either ring, 
analogous to chain links. The simplest structures of both forms of interlocked structures are 
shown below in Figure 1.11. 
 
Figure 1.11 – Simplest topologies of classic catenanes and rotaxanes. 
The nomenclature surrounding interlocked structures is fairly trivial, with the 
schematic diagrams above showing the simplest topologies of two interlocked components. 
The number in square brackets denotes the number of interlocked components present 
within the structure and a selection of other topologies are demonstrated in Figure 1.12. 
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Figure 1.12 – More elaborate topologies of interlocked structures. 
Catenanes were the first interlocked structures to be proposed as far back as 1912, 
but it wasn’t until 1960 that the first catenane was able to be synthesised, as reported by by 
E. Wasserman.13 He highlighted that the limitations of what could be achieved were down 
to the synthetic tools and protocols available. The catenane, 8, shown in Figure 1.13, relied 
on a statistical synthetic approach for its formation, in that the acyclic component was 
observed to thread through the macrocycle and cyclise purely by chance, with the process 
not mediated/preorganised by any intermolecular interaction. 
 
Figure 1.13 – The first characterised catenane produced via a statistical approach. 
Diethyl tetratriacontanedioate was first cyclised and subsequently reduced using 
zinc with deuterated HCl. The cyclisation was again carried out, but this time in the presence 
of the reduced deuterated macrocycle. Once purified, the fraction containing the acyloin 
ring was observed to contain C-D stretches in its I.R. spectrum, indicating the presence of 
the interlocked deuterated macrocycle. A statistical approach essentially relies on the 
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probability of the linear molecule penetrating the macrocycle and then being cyclised itself, 
trapping the catenane. The yields for the catenane were therefore very low, far less than 
1%, so improved strategies were required. The concept of threading using a statistical 
approach was then demonstrated in the synthesis of the first rotaxane, by Harrison and 
Harrison in 1967 using resin bound macrocycles (Figure 1.14).14 
 
Figure 1.14 – Synthesis of a [2]-rotaxane via the use of resin bound macrocycles. 
A directed-strategy was subsequently proposed by G. Schill and A. Luttringhaus.15 
Their method, shown in Figure 1.15, consisted of a ‘directed synthesis’ whereby through a 
careful connection/disconnection strategy, they used the central phenyl group as a scaffold 
on which to construct the catenane, 10, over several synthetic steps. 
Introduction 
14 
 
 
Figure 1.15 – Directed synthesis of a [2]-Catenane. 
Despite improving upon the yields of Wasserman, this strategy involved up to 10 
steps and it was not until the exploitation of supramolecular chemistry and the concept of 
pre-organisation that the synthesis of these interlocked structures could be realised in a few 
simple synthetic steps. 
What followed on from these classical approaches was the application of 
supramolecular chemistry towards the formation of interlocked structures utilising metal 
ions,16 donor-acceptor motifs,17 and hydrophobic interactions.18 This meant that there was 
no longer a need for rather convoluted syntheses or low probabilities of threading; instead 
the strategies employed the use of intermolecular interactions to pre-organise the 
components into the desired conformation for forming interlocked structures.19  
In applying supramolecular approaches to the synthesis of rotaxanes, several 
methods for their synthesis can be found in the literature, as summarised in Figure 1.16.  
Introduction 
15 
 
Figure 1.16 – Approaches towards rotaxane formation, showing stoppering (1), clipping (2) and active 
templation (3). 
The first method shown, known as ‘capping’ or ‘stoppering’,20 involves the formation 
of a pseudo-rotaxane where a linear molecule threads through the macrocycle, a process 
driven by favourable supramolecular interactions. Once the complex is formed, the 
macrocycle is mechanically trapped with appropriately sized stopper groups, preventing it 
from dissociating. The second is a ‘clipping’ approach and involves the use of a pre-
stoppered thread.21 Again utilising supramolecular interactions, the macrocycle precursor is 
assembled around the axle and then either clipped together or capped with a suitable 
reacting group to form the rotaxane. The third example shown is known as an ‘active 
template’ approach, a more recent development, first achieved by Leigh and co-workers,22 
and involves a metal centre that has a dual function. The metal centre is templated within 
the macrocycle via coordination, whereby the active site of catalysis is then located within 
the macrocycle itself. Any subsequent metal-catalysed bond formation between the two 
complementary stoppers then results in the formation of a rotaxane. Due to the nature and 
position of the bond forming process, with the stopper groups in excess, all the macrocycle 
molecules can be converted into the interlocked product, achieving very high yields over 
traditional approaches. 
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1.2.2 H-bond-Templated Interlocked Structures 
Due to the nature of the work contained within this thesis, the primary focus of 
discussion relates to H-bonding and its use in the synthesis of interlocked architectures. As a 
route to pre-organisation, H-bonds offer very attractive attributes towards the synthesis of 
structures with well-defined geometries. Despite being relatively weak, they have enhanced 
directionality and specificity over some other intermolecular forces. Therefore out of the 
various template strategies available for the pre-organisation of host and guest components 
towards the formation of interlocked structures, H-bonding has found its own niche in the 
vast array of template directed synthesis. 
1.2.2.1 Neutral Guests 
The first example of the use of H-bonds in the templation towards interlocked structures 
was demonstrated by Hunter in 1992.23 In attempts towards improving the yields of his 
recent benzoquinone receptor shown previously in Figure 1.6, a modified strategy was 
proposed which involved ‘capping’ towards a macrocycle rather than synthesis via high 
dilution. Due to the nature of the H-bonding groups present, the synthesis of a [2]-catenane 
by-product in 34 % yield was achieved. Later, the concept of H-bonding templation was 
applied towards the synthesis of rotaxanes by Vögtle et al. using these same receptors. 
Rather than capping an internalised unit as in the case shown by Hunter, the approach was 
to stopper a threaded and bound diisophthaloyl chloride component, resulting in a [2]-
rotaxane. Extension of this work within the same group led to improvements of the 
threading moiety through the receptor using olefinic diacid dichloride as the template.24 
What was gained from this study was an understanding of how a dual stoppering event of a 
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threaded component is not necessarily the most facile route towards rotaxanes, and the 
stoppering of mono-stoppered, threaded complexes can be more efficient.  
One of the most efficient  and high yielding H-bond templates to date is the fumaramide 
system developed by the Leigh group,25 which serves to highlight the importance of 
preorganisation (Figure 1.17). When comparing to the already reported peptide based 
binding motif, 11,26 the fumaramide site, 12, has considerably less rotational degrees of 
freedom and as such, locks the binding site in a conformation ideal for macrocycle binding 
and subsequent clipping. Excellent yields of 97% were reported for the rotaxane, compared 
to the good yields of 30-60% obtained with peptide forms. 
Due to the well-known chemistry and H-bonding geometry of benzylic amide 
macrocycles, as used in the examples above, they have been used to template around many 
different H-bond accepting motifs as shown in Figure 1.17. These include squarine 
complexes (13)27, azodicarboxylates (14)28 and phosphinic (15)29 moieties.  
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Figure 1.17 – A selection of H-bonded rotaxanes of benzylic-amide macrocycles bearing different functional 
binding groups. 
1.2.2.2 Cationic Guests 
Cationic H-bond template motifs include the combination of secondary 
dialkylammonium centres and crown ethers, which also utilise ion-dipole interactions, and 
were first used for the synthesis of rotaxane 16 in 1996 by Stoddart, Figure 1.18.30  
 
Figure 1.18 – Stoddart’s dialkylammonium template rotaxane. 
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Interlocked structures bearing this binding unit have been synthesised via stoppering 
reactions,31 pre-rotaxanes32 and clipping,33 and have also been used to achieve higher order, 
[3]-rotaxanes.34  
1.2.2.3 Anionic Guests 
Anion templation, stabilised through the use of H-bond donors has also found use within 
the templation of interlocked structures. The first example of this was displayed by Vögtle 
and co-workers and involved the templation of a phenolate anion using the isophtalamide-
type macrocycles already shown in Figure 1.6 and Figure 1.17. 
 
Scheme 1.1 - Vögtle’s anion template rotaxane. 
As shown in Scheme 1.1, initially the dibromide reacts to form a ‘semi-axle’. This 
then reacts with the bound phenolate-macrocycle complex, acting as a supramolecular 
nucleophile. This method can produce rotaxanes in excellent yields of 95%. This method, 
whilst high yielding, does however involve reaction of the anionic template for the 
formation of a rotaxane, and therefore does not ‘live on’ in the interlocked structure.  In 
order to probe the possible function of anion templation, such as that of sensing, the 
conservation of an anionic template is required. 
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The conservation of an anionic template was first demonstrated by the group of Paul 
Beer.35 Aside from the H-bonding present, the motif in Figure 1.19 also employs 
electrostatics from the pyridinium cation and a degree of π-π stacking to improve the 
efficacy of the template. Once the anion had templated the stoppered thread, the host 
could be cyclised via Grubbs’ metathesis forming the [2]-rotaxane, 17, in 47% yield. Anion 
exchange, followed by comparison studies between the pyridinium•PF6 thread and the 
rotaxane•PF6 showed the rotaxane to have enhanced selectivity towards chloride ions, 
clearly due to the binding site created between the diamide units of the macrocycle and 
thread within the rotaxane. Larger anions must either displace the pyridinium from the 
macrocycle or sit above the plane of the binding site, which in either case would weaken the 
binding interaction. 
 
Figure 1.19 – Beer’s anion template rotaxane. 
1.2.2.4 Molecular Motion and Applications 
With the methods for the synthesis of these topologically interesting structures 
developed, the advancement of their potential applications has also been investigated, 
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primarily focussing on the mimicry of components of machinery from the macroscopic 
world. One of the earliest examples was shown by Stoddart in the synthesis of switchable 
molecular shuttles,36 and whilst not H-bonding in nature, the scope of concepts drawn from 
this example make it worthy of mention. Using their previously developed π-donor-acceptor 
motif of benzidine stations and cyclophane macrocycles, by extending the thread and 
incorporating a second station of biphenol, a two-station thread, 18, was made as shown in 
Figure 1.20. At room temperature, the macrocycle moved between stations at a rate 
comparable to the NMR timescale and as such, only broad, indistinct signals are observed. 
However, upon cooling to 229 K, the macrocycle was observed to be located at either of the 
two distinct stations whereby station exchange was no longer comparable to the NMR 
timescale. 
 
Figure 1.20 – Temperature dependent molecular shuttling based on biaryl stations. 
The concept of shuttling has been extending to the realm of H-bonded interlocked 
structures and was first demonstrated by Leigh and co-workers37 in a similar manner to that 
of Stoddart. By taking their already developed system of peptide-based H-bonding 
templates and applying a further station, they too were able to locate the H-bonding 
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benzylic amide macrocycle at both stations, as observed via variable temperature NMR 
experiments. They were also able to lock the macrocycle at one station through 
functionalisation of the thread to block translation, as shown in Figure 1.21.   
 
Figure 1.21 – Translational motion between stations is restricted by the NTs group. 
Rather than rely on the temperature to control the location at a particular station, it 
is desirable to have an input such as light to drive the motion. As such, an event of 
controlled dynamic motion occurs where a particular station may be occupied following the 
application of a certain input or stimulus. Again, via the use of H-bonding, Leigh and co-
workers were able to show fast and reversible translational motion of a molecular shuttle, 
20, via a photo-induced process, shown in Figure 1.22.38 
Figure 1.22 – Photo-induced molecular shuttling. 
Prior to the 355 nm laser pulse, the shuttle is located at the succinamide station, due 
to the poor H-bonding nature of the napthalimide group. After photo-reduction of this unit 
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by an external donor, D, the napthalimide group becomes an excellent H-bond acceptor and 
the shuttle moves from one station to the other. This reversible shuttling process occurred 
at a rate of 104 times per second. Leigh and co-workers have also extended their H-bonded 
motifs towards pH controlled systems.39  
 The concept of using interlocked structures to perform various functions, employing 
the concept of bottom-up construction, has been shown recently in the transport of 
protons,40 the synthesis of molecular lifts41 and muscles,42 as well as the sequence specific 
synthesis of small peptides43 and applications in potential drug delivery using ‘nano-
valves’.44  
1.3   Barbiturates  
1.3.1 History, background and uses  
The first and simplest of all barbiturates, barbituric acid, was synthesised in 1864 by the 
German chemist Adolf von Baeyer via the condensation of urea with diethyl malonate 
(Scheme 1.2). Being biologically inactive the long historical use of this family of compounds 
as a sedative was not fully realised until the synthesis of its derivative 5,5-diethylbarbituric 
acid, 21, in 1884, and its subsequent discovery as an hypnotic in 1903 by Emil Fischer.45 
What followed was a vast array (more than 2500)46 of substituted barbiturates classified 
according to their biological activity, ranging from short to long lasting effects, and finding 
use as anxiolytics, anticonvulsants, analgesics and hypnotics. A sample of various 
functionalised barbiturates, 22-24, are shown in Figure 1.23, highlighting how various 
substitutions at the 5-5’ position allows control of their activity. Due to their active dose 
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being relatively close to their overdose threshold and coupled with their addictive nature, 
barbiturates were phased out of clinical use in favour of benzodiazepines; however some 
still find use in medicine in the treatment of epilepsy and owing to their lethal properties, in 
lethal injections and euthanasia.  
 
Scheme 1.2 – Classical synthesis of substituted barbiturates. 
 
Figure 1.23 - Highlighting the difference in biological effect based on functionalisation. 
Aside from their interesting biological activity, barbiturates also possess an interesting 
supramolecular property in that the symmetrical imide groups provide a H-bonding motif of 
the order ADA, which forms H-bonds with groups containing the corresponding DAD motif. 
This was first utilised by Feibush in the development of chiral separation protocols towards 
heterocyclic drugs by HPLC,47 and involved the attachment of 2,6-diamino pyridine units to 
the stationary phase. The concept of complementarily binding barbital using artificial 
receptor molecules was then expanded upon by the Hamilton group.48 
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1.3.2 Hamilton receptors  
 
Figure 1.24 – Hamilton’s receptor for barbiturates. 
Shown in Figure 1.24 is the barbiturate receptor, 25, designed by Hamilton. The 
receptor comes in two parts, the main binding site, or ‘bridge’, and the variable lower unit 
linking the two terminal amines. Through the use of an appropriate isophthaloyl spacer, the 
two 2,6-diamino pyridine units form a binding cavity capable of binding barbital, 21, via six 
complementary H-bonds. Binding is enhanced relative to acyclic receptors via cyclisation of 
the receptor due to the macrocyclic effect, shown by a 100 fold difference in binding 
constant. These receptors gave high binding constants to various barbiturate derivatives in 
non-competitive solvents, the highest of which was with barbital, with a value of 1.37 x 106 
M-1 at 25o C in CDCl3. 
1.3.3 Applications 
Since the discovery of these highly successful barbiturate receptors, they have seen a 
number of applications. Known as the Pauling principle, enzyme catalysis depends upon 
substrate complexation and transition state stabilization and Hamilton applied these 
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concepts towards the construction of artificial enzymes. As a result Hamilton was able to 
display rate accelerations of phosphoryl-transfer reactions,49 and was also able to mimic the 
action of protease enzymes.50 An optimal proximity and position of the H-bonded 
barbiturate relative to a functionalised receptor was identified. By placing the nucleophile 
and substrate in the correct proximity and orientation, and thereby mimicking the transition 
state, a large acceleration in the rate of transacylation reactions was achieved. The 
analytical capabilities of these receptors was also demonstrated in the enhanced extraction 
of phenobarbital from a 20 µM phenobarbital solution in human control serum.51 The group 
then went on to develop the receptor further, through the attachment of redox and photo-
active chromophores, as shown in Figure 1.25.52  
 
Figure 1.25 – ET via Barbiturate mediated binding. 
Quenching of fluorescence was observed due to energy transfer to the H-bonded 
barbiturate group. This ‘self-assembly’ strategy was a general one, allowing for many 
choices in the chromophore components used. This family of photoreceptors and 
barbiturates were again used in an attempt to mimic the natural processes of the enzyme 
Cytochrome P450.53 
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Other groups have utilised the specificity of the Hamilton receptor in various ways. 
Building upon the analytical approach demonstrated by Hamilton, Li and co-workers were 
able to demonstrate micro-extractions of barbital and its derivatives using receptor doped 
films.54 Later, the work of San-Qi Zhang demonstrated the use of receptors when bound to 
solid supports for applications of column chromatography.55 The groups of Tucker and 
Bassani have used an anthracene tagged Hamilton receptor to demonstrate photo-switched 
binding.56 The bridge of the receptor was functionalised at the 6-amino position with alkyl 
chains terminated with anthracene units. In the open form, the receptor bound barbital 
with a high binding constant. Upon anthracene dimerization, a head-to-tail photodimer was 
formed and this conformation impacted strongly on the binding site of the receptor. As can 
be seen in Figure 1.26, the ortho-xylene units protrude into the cavity and the 4 N-H bonds 
no longer point towards the centre of the cavity, due to the distortion of the macrocycle. 
The barbital was thus removed from the binding site upon formation of the photo-dimer 
and shows weak binding with the dimerised receptor. It should be noted that the binding is 
not fully inhibited when using longer alkyl chains, an important aspect with regards to this 
thesis. 
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Figure 1.26 - Photo-switched binding of barbital using anthracene tagged Hamilton receptors. 
1.4   Key Reactions  
1.4.1 Grubbs Metathesis 
Metathesis, derived from the greek word meaning ‘change of position’ has, over the 
past few decades, had a profound impact on synthetic organic chemistry. The first 
developments in the field came from the ring-opening metathesis polymerisation (ROMP) of 
norbornene via titanium catalysis57 and was later developed upon, and extended to other 
cycloalkenes through the use of organometallic iridium and ruthenium compounds.58 The 
history then moves through one of development, from multi, to single component catalytic 
systems and despite efforts to improve upon this family of catalysts, they still required 
harsh reaction conditions and showed limited functional group tolerance and sensitivity 
towards oxygen and moisture. The series showing the development of Grubbs’ catalysts is 
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shown in Figure 1.27. With the advent of Grubbs’ initial ruthenium akylidene complex ,27 ,59 
which showed slightly reduced metathesis activity (relative to current ROMP catalysts of the 
time), but with improvements over functional group tolerance, the first synthetically useful 
ruthenium based metathesis catalyst, with regards to ring-opening metathesis 
polymerization of highly strained cyclic olefins was obtained. In order to gain further control 
over the utility of these catalysts with regards to other forms of metathesis, further 
modification of the ruthenium ligands was required. By substitution of the 
triphenylphosphine ligands with better σ-donating alkylphosphines, 28, new and improved 
metathesis activity was accomplished and the first ruthenium complex active towards 
acyclic olefins was achieved.60 The final modification of this complex towards establishing a 
catalyst with high activity came with the replacement of the vinylalkylidene, with a 
benzylidene ligand, 29, to afford Grubbs’ 1st generation catalyst.61 
 
Figure 1.27 – Development of ruthenium catalysts towards Grubbs’ 1st gen. catalyst, 29. 
There are three main types of metathesis reaction, as summarised in Figure 1.28. 
Ring-opening metathesis polymerisation (ROMP) involves the polymerization of monomers 
containing strained, unsaturated rings, with the driving force being one of ring-strain 
release. Ring-closing metathesis (RCM) is the intramolecular metathesis of terminal olefins, 
resulting in a cyclic structure. The major driving force in this process is entropic, due to the 
formation of two molecules from one substrate. One of the two molecules is typically 
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ethene, a gaseous molecule making the reaction essentially irreversible and driving the 
reaction to completion. Cross metathesis (CM) involves the transalkylidenation of two 
terminal alkenes producing a new C-C bond between the two motifs.62  
 
Figure 1.28 – Common forms of Ru catalysed metathesis. 
The mechanism for this metathesis reaction was first proposed by Herisson and 
Chauvin in 1971 and is shown below in Figure 1.29.63 The metal carbene undergoes an 
initiation step with an olefin to form a metallocyclobutane intermediate (a). Collapse of this 
structure to release ethene (b) in a [2+2] cycloaddition occurs to leave the olefin as now 
part of the metal carbene complex. Subsequent addition of the second olefin (c) again forms 
a metallocyclobutane intermediate and collapse of this (d) regenerates the metal carbene 
catalyst and the metathesis product. The difference in stereoisomers occurs as a result of 
the geometry of addition and free rotation prior to forming the metallocyclobutane 
intermediate, shown in square brackets. 
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Figure 1.29 – Chauvin’s mechanism for olefin metathesis. 
Owing to the highly selective and successful nature of olefin metathesis, it is not 
surprising that it has found great use in synthetic chemistry,64 and due to metathesis of 
large ring sizes being possible, this includes the formation of interlocked structures. Only a 
few years after the discovery of these catalysts, the group of Sauvage was able to apply 
their Cu(I) template approach and capture the [2]-catenane, 30, in excellent yields,  via RCM 
between the terminal olefins of the complexed thread, shown in Figure 1.30.65 
 
Figure 1.30 – Sauvage’s Cu(I) template approach coupled with RCM to from catenanes. 
This concept of clipping via RCM has since been expanded upon by numerous groups to 
include multicomponent architectures using various H:G preorganisation motifs.66 
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1.4.2 Cycloaddition Reactions  
Cycloaddition reactions have played an integral role in the synthesis of interlocked 
structures, including those found within this thesis, in part due to their reliability and high 
selectivity for the functional groups involved. The latter part of this thesis concerns the use 
of photo-induced dimerization via a photo-induced cycloaddition, which will be covered in 
greater detail in chapter 4. Although the use of this specific approach has not yet been 
utilised in the capture event of an interlocked structure, there are many other cycloaddition 
reactions present in the literature that have been applied towards their synthesis as 
outlined below.  
The [3+2] cycloaddition between fullerene and an azomethine ylide, as developed by 
Prato et al.67 was later applied towards the synthesis of rotaxanes, employing the fullerene 
moiety as a stopper group as shown in Scheme 1.3.68 However, this was not involved in the 
capture event of the interlocked structure and subsequent clipping of a benzylic amide 
macrocycle around the fumaramide template, as developed by the Leigh group,25 achieved 
the [2]-rotaxane. 
 
 
Scheme 1.3 - Attachment of a fullerene stopper group via a [3+2] cycloaddition. 
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The use of a cycloaddition reaction to capture an interlocked species has been 
shown by the group of Yuliang Li.69 Again through the use of a bis-amide binding motif, a 
pseudo-rotaxane, 31, was formed, and stoppered via a [2+2] cycloaddition between a 
terminal bisaryl alkyne and tetracyanoquinodimethane forming 32, as shown in Scheme 1.4. 
This method of stoppering was chosen over other more widely used cycloadditions in order 
to circumvent the need for any metal catalyst. 
 
Scheme 1.4 – Stoppering event utilising a [2+2] cycloaddition between TCNQ and a bisarylalkyne. 
  Another approach regarding the synthesis of interlocked structures via cycloaddition 
reactions was shown by the Leigh group, Scheme 1.5.70 By employing Zn(II) lewis acids in an 
active-template approach, the metal ion would be coordinated within the macrocycle cavity 
in an ideal geometry for substrate binding. Once the stoppered dieneophile was 
coordinated to the bound metal, the double bond would protrude through the macrocycle 
and be available for subsequent Zn(II) catalysed Diels-Alder cycloaddition with the 
stoppered diene, affording 33. 
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Scheme 1.5 – Synthesis of a [2]-Rotaxane via [4+2] cycloaddition. 
 Interestingly, only the 2-substituted isomer of the diene was found to react to form 
the rotaxane, with 90% of the rotaxane being the 1,4-isomer, whereas all four isomers were 
observed when using an acyclic ligand. In contrast to usual active template methods, which 
involve a ‘passive’ metal ion, in this case the template site was incorporated into the 
rotaxane and the metal-ligand interaction ‘lived on’ in the interlocked structure allowing the 
synthesis of metal-chelated molecular shuttles. 
1.4.2.1 Huisgen 1,3-Dipolar Cycloaddition  
Of these cycloaddition reactions, probably the most prevalent in the literature, and 
now synonymous with the term ‘click chemistry’, is the formation of 1,2,3-triazoles using 
the Huisgen 1,3-dipolar cycloaddition. The term ‘click reaction’ was coined by Sharpless in 
2001, to describe reactions which, amongst other attributes, must be modular, high 
yielding, wide in scope and stereospecific. As well as these features, the reaction must 
possess certain characteristics which include simple reaction conditions and product 
isolation.71 The azide-alkyne Huisgen 1,3-dipolar cycloaddition satisfies many of the 
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required attributes. However, the thermal reaction fails in this respect owing to elevated 
temperatures and a mixture of regioisomers. It was not until this reaction was expanded 
upon by the groups of Meldal72 and Sharpless,73 through the introduction of Cu(I) catalysis, 
that high yielding, regiospecific reactions were achieved at ambient temperatures and in a 
variety of solvents including water. From here on, this reaction will be referred to as a click 
or CuAAC reaction. The proposed mechanism is shown below in Scheme 1.6.74  
 
Scheme 1.6 –  Proposed outline of species involved in the catalytic cycle. 
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The initial step involves formation of the copper(I) acetylide (iii). From DFT 
calculations, it was deduced that the process is not a concerted [2+3] cycloaddition, but a 
stepwise mechanism, with the rate of the catalytic process being second order with respect 
to copper.75 The role of the second copper atom appears to be activation of the azide 
moiety (v). Complexation of the azide activates it towards nucleophilic attack of the 
acetylide to the azide (vi).  This metallocycle positions the bound azide for subsequent ring 
contraction (vii) followed by protonation and dissociation to afford the product.  
Triazole-bearing psuedorotaxane 34 was produced by Mock,79 in their attempts 
towards catalysis using cucurbit[6]uril, CB[6]. This method did not use a Cu(I) catalyst and 
was reliant on the Pauling principle of catalysis, via the encapsulation of the reactants 
within the hydrophobic pocket, holding the reactive groups in close proximity as shown in 
Figure 1.31 (a).80 This work was expanded upon towards interlocked structures in the late 
90’s by Steinke81 towards the formation of catalytically self-threading polyrotaxanes. This 
concept utilised 2 bi-functional monomers, which once cyclised within the cucurbituril, form 
a perfect mainchain polyrotaxane, 35.         
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Figure 1.31 – a) The Pauling principle of catalysis as demonstrated by Mock and b) The repeating unit of the 
polyrotaxane. 
With the advent of the CuAAC reaction, it is not surprising that, owing to the high 
utility and specificity of this reaction, it has seen wide and varied use in a whole host of 
reactions to form interlocked structures. However, not only has it seen use in the synthesis 
of building blocks and the covalent capture of the structures themselves, but due the 
stability towards the functional groups involved, it has found use in the formation of triazole 
rings which can function as ligands in controlling structure dynamics, as well as in post-
synthetic functionalisation. 
The CuAAC reaction was first applied towards the synthesis of interlocked structures 
by the group of Sauvage.20 By using their ‘passive’, Cu(I)-directed approach originally 
developed for targeting catenanes and knots,76 and by combining the preorganisation of a 
phenanthroline macrocycle and an azide-functionalised bypyridine ‘thread’, the formation 
34 
35 
a) 
b) 
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of a pseudo-rotaxane was possible, shown in Scheme 1.7. This was then followed by using 
the CuAAC reaction to cap the complex, affording a [2]-Rotaxane, 36, in 62% yield.  
 
Scheme 1.7 – Stoppering of a pseudo-rotaxane via CuAAC reaction. 
By far the most elegant use of this reaction was to apply a strategy of ‘active’ 
templation. Building upon the template strategy of Sauvage, this was first demonstrated by 
the Leigh group, who were able to produce excellent yields of rotaxane using 
substoichiometric amounts of Cu(I).22 By employing the tetrahedral geometry of a Cu(I) 
atom, and coordinating this at a pyridine site within a macrocycle, this metal centre served 
the dual purpose of locating reacting species within the macrocycle as well as catalysing the 
reaction itself. Once the Cu(I) was bound within the macrocyle, the reacting azide and 
alkyne groups would bind with the Cu(I) catalyst either side of the plane of the macrocycle 
and a subsequent CuAAC reaction would form the rotaxane, 37. Scheme 1.8 shows the key 
step in the catalytic cycle at which both azide and alkyne components bind to the Cu atom 
either side of the macrocycle, due to its inherent tetrahedral geometry. This method has 
since been extensively expanded and adapted upon by others. 
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Scheme 1.8 – Active-template approach employing the CuAAC reaction where R = Bulky stopper. 
As mentioned in Section 1.2, the work of Paul Beer’s group in the field of interlocked 
structures has centred on the use of anion templation.21, 77 Their work was extended to 
incorporate the triazole group in this anion template approach, Scheme 1.9.66b The C(5)-H 
bond of the triazole group is slightly polar. However, no anion binding was observed and 
conversion of the triazole unit, via methylation, to the triazolium cation was shown to 
greatly enhance anion binding. In utilising this anion binding, the triazolium cation was 
employed in their anion-templated RCM synthesis of [2]-rotaxane 38. 
 
Scheme 1.9 – Capture of an interlocked structure via preorganisation of an anion-triazolium complex. 
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This motif exhibited stronger binding with Br- compared to Cl-, with association 
constants of 907 M-1 and 90 M-1, respectively (in CDCl3/MeOD 1:1). This was a different 
result to what was expected since typically, these systems are selective for Cl- in mixed 
solvent systems.77 The rotaxane synthesis was then repeated using Br- as the templating ion 
and an increased yield of rotaxane was observed, which was attributed to the enhanced 
binding affinity and preorganisation of Br-. This highlights a significant improvement in the 
size-shape match for Br- over Cl- in this particular system.      
1.5   Introduction to the project 
1.5.1 Description and aims 
Despite the current and very successful approaches to interlocked structures, there are 
relatively few templates in use, relative to the wide scope of their diverse structures and 
applications. It is the aim of this thesis to build upon the current understanding of 
templating techniques and add to the number of template motifs available towards the 
synthesis of interlocked structures. The concept is to utilise the specific interaction of 
Hamilton receptors and their barbiturate guests to allow a new template towards 
interlocked structures to be realised.  
This receptor binding motif is particularly attractive towards interlocked structure 
formation due to its high level of complementarity with barbiturate guests. One key 
structural aspect of this interaction is that of the sp3 carbon at the 5-position of the 
barbiturate. A crystal structure produced by the Hamilton group78 (Figure 1.32), shows that 
when barbital is bound to a planar, Hamilton macrocycle, this sp3 carbon allows the 
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ethylene groups to protrude above and below the plane of the macrocycle. It can be 
envisaged, that with suitable extension and functionalisation of the groups attached at this 
position, an interlocked structure can be realised.  
 
Figure 1.32 – Crystal structure of a H:G complex consisting of Hamilton’s receptor and barbital and the 
corresponding schematic to highlight the threaded appendages. 
1.5.2 Hosts and Guests 
During this project, a series of different forms of Hamilton receptor have been 
synthesised, along with a range of complementary barbiturates, as summarised in Figure 
1.33 and 1.34. The Hamilton receptors consist of both cyclic and acyclic forms, with the 
methods towards formation and the particular type of interlocked structures that result, 
dependent on the specific combination of host and guest.  
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Figure 1.33 – Acyclic and cyclic Hamilton receptors for various approaches towards interlocked structures. 
 
Figure 1.34 – Barbiturate guests for various approaches towards interlocked structures. 
 Firstly, considering the acyclic receptors, a ‘dumbbell-shaped’ barbiturate with 
stopper groups pre-attached may be bound within the receptor. If the receptor is 
appropriately functionalised with pendant arms and terminated with reactive groups, then 
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an interlocked structure may be formed using a clipping approach. Of the many reactive 
groups available to terminate the receptor two groups were chosen for this project: (I) 
olefin groups for a Grubbs metathesized ring closing reaction and (II) anthracene groups for 
photo-dimerization. This second method was particularly interesting because if successful, it 
would be the first known example of the formation of an interlocked structure using a 
photo-chemical reaction. The clipping approach towards interlocked structures using acyclic 
Hamilton receptors are shown below in Figure 1.35. 
 
Figure 1.35 - Route towards interlocked structures using acyclic Hamilton receptors. 
The second approach involved the use of a Hamilton macrocycle. The barbiturate 
was expected to thread through the macrocycle and once bound in the cavity, the pendant 
arms could be used to form an interlocked structure. Depending on the type of 
functionalisation of the barbiturate pendant arms, either catenane or rotaxane formation 
could be possible. With regards to a clipping reaction, Grubbs metathesis would again be 
used in this approach when the terminal groups of the barbiturate arms were olefins. This 
would build upon the work of a previous PhD student on the project, Mathias Rocher,79 
which was focussed on catenane formation. For a stoppering approach, the terminal groups 
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of the thread and stopper would be an alkyne-azide pair, enabling the use of a copper 
catalysed azide-alkyne 1,3-dipolar cycloaddition. The processes involved using macrocyclic 
Hamilton receptors are summarised in Figure 1.36. 
 
Figure 1.36 – Routes towards interlocked structures using macrocyclic Hamilton receptors. 
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2 Synthesis of the precursor components of non-photoactive 
Interlocked Structures 
As mentioned in the introduction, this thesis focuses on a number of different 
approaches towards H-bonded interlocked structures containing barbiturate components. 
As such, a number of different Hamilton-type receptors and barbiturates have been 
synthesised. Concerning the different types of receptor required, both cyclic and acyclic 
forms have been synthesised as well as a range of barbiturate guest compounds in order to 
fully investigate various strategies i.e. clipping/stoppering. A summary of the compounds 
which were synthesised is shown below in Figure 2.1. 
 
Figure 2.1 – Receptor and guest target compounds contained within Chapter 2, with method of capture 
shown. 
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 Contained within this chapter are some studies carried out by our collaborators in 
Bordeaux. These include a 1H NMR comparison (Figure 2.19), Job plot (Figure 2.16) and 
binding study (Figure 2.18) between host 45 and guest 83 as well as obtaining a crystal 
structure of the pseudo-rotaxane complex (Figure 2.17). A binding study between host 45 
and guest 85 (Figure 2.21) was also carried out in Bordeaux. 
2.1 Synthesis of Hamilton-Receptor Host molecules 
Before any deviation in the synthesis with regards to which type of receptor was to 
be used, the bridge of the receptor first had to be synthesised.1 The first step in the 
synthesis involved the formation of isophthaloyl chloride in quantitative yield from 
isophthalic acid using oxalyl chloride and catalytic DMF in DCM. Upon removal of the 
volatile component of the reaction mixture, the diacid chloride, 39, was then used as 
obtained and reacted with excess 2,6-diamino pyridine using triethylamine as a base to form 
the binding site of the receptor, 40, Scheme 2.1 . The bridging component of the receptor 
was isolated via column chromatography in 75% yield and characterised by 1H NMR 
spectroscopy. 
 
Scheme 2.1 – Synthesis of ‘Bridge’ Receptor 40. 
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2.1.1 Acyclic Receptors: 
Once the bridge of the receptor had been synthesised, the synthetic route could 
then deviate to accommodate the various strategies proposed with the bridge 
functionalised accordingly. The first target was the acyclic receptor with an 8-carbon linker. 
The starting material undecenoyl chloride was commercially available. The formation of the 
acyclic receptors was then carried out by reacting the bridge receptor 40 with the desired 
olefin terminated acid chloride, Scheme 2.2. After work up, the receptor 41 could be 
isolated via column chromatography or addition of hexane to the crude mixture and was 
obtained in fairly good yields. This acyclic receptor could now be applied towards a clipping 
strategy via complexation with stopper-terminated barbiturates (Chapter 3) as well as 
towards the synthesis of macrocyclic precursors, as outlined in the following section. 
 
Scheme 2.2 – Synthesis of acyclic receptor 41. 
2.1.2 Cyclic Receptors 
To obtain the cyclised forms of the receptor, for application towards a 
threading/stoppering strategy, two routes were identified as outlined below; firstly via 
Grubbs metathesis of 41 and secondly via direct cyclisation of bis-amine 40. As already 
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mentioned, there is the possibility to cyclise the acyclic receptors using a Grubbs catalyst, 
followed by subsequent reduction of the double bond.  
2.1.2.1 Via Grubbs Metathesis: 
Following Scheme 2.3, the acyclic receptor 41 was dissolved in DCM and after the 
addition of 10 mol% Grubbs (I) catalyst, the solution was refluxed for 2-3 hours. The reaction 
was monitored via TLC and once the cyclisation was complete, the solvents were removed 
and the crude was purified via column chromatography. Yields for the reaction varied, 
ranging from 85-95%. The double bond could then be reduced using Pd(OH)2 on carbon. The 
ring-closed receptor was dissolved in EtOAc and an excess of palladium catalyst was added. 
A balloon was used to supply the hydrogen over the 16 h period. After several unsuccessful 
attempts varying solvent, temperature and H2 source, the reduction was finally 
accomplished through the addition of a few drops of NEt3 to the reaction mixture. The 
addition of NEt3 results in the formation of a trialkyliminium–palladium hydride complex, 
which acts as the H2 source in this reaction.2 The success of this approach could be due to 
the homogeneity of 42 and the hydrogen source. The work up consisted of filtration through 
a plug of silica and washing with EtOAc, affording the reduced product in near quantitative 
yields.  
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Scheme 2.3 - Synthesis of cyclic receptors via Grubbs catalysis. 
 
 
The 1H NMR spectra in Figure 2.2 show the allyl region of the acyclic receptor 41 
before and after metathesis. The terminal olefin gives two peaks at 4.95 and 4.79 in the 
acyclic form and after metathesis a single peak at 5.33 is observed. Concerns with this 
metathesis method towards a clipping approach were the possible lack of H-bonded 
complexation between host and guest at the reflux temperature required for the reaction 
and also a potential adverse effect on the reaction when carried out in the presence of a 
Figure 2.2 – 1H NMR comparing the allyl regions before and after metathesis. 
 
 
Figure 2.2 – 1H NMR comparing the allyl regions before and after metathesis. 
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barbiturate thread. Therefore, the feasibility of this cyclisation under alternative conditions 
was investigated. All reactions were carried out in DCM with a receptor concentration of 4.5 
mM. 10 mol% Grubbs catalyst was used at room temperature. The progress of each reaction 
was monitored via TLC. 
 Table 2.1 – The yields of various Grubbs catalysed metathesis reactions of 41 at room temperature. 
Catalyst Additive Yield 
Grubbs (I) - 70% 
Grubbs (I) Barbital (1 equiv.) 82% 
Grubbs (II) - 70% 
After periodically monitoring the conversion over 4 hours, there was still starting 
material remaining and so the reactions were left overnight. Each was then worked up in 
identical fashion to the original method and the yields are shown in Table 2.1. It appears 
that the reaction of 41 suffers a slight decrease in yield when conducted at room 
temperature compared to  the yield obtained under reflux (85%) and that there appears to 
be no discernible difference between the Grubbs (I) and (II) catalysts. Interestingly, the 
reaction yield was observed to increase upon the addition of 1 equivalent of barbital. This is 
probably due to some degree of preorganistion, whereby the receptor, when bound to 
barbital, positions the terminal olefin groups in a more favourable position for 
metathesis/cyclisation to occur. An important consequence of this addition was the fact that 
it was not possible to obtain the pure, cyclised receptor from this reaction and only a H:G 
complex was obtained when purifying the reaction mixture via column chromatography, 
and methanol was then used as a competitive solvent to obtain the pure product. This has 
important implications with regards to any detection/purification of interlocked structures 
since the H:G complexes may elute together, regardless of their interlocked nature. Further 
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competition studies would therefore be required to confirm the interlocked nature of a H:G 
complex. 
2.1.2.2 Direct Cyclisation: 
The second method towards cyclic receptors consisted of a cyclisation reaction 
between the bridge receptor and the desired diacid chloride, Scheme 2.4. The diacid 
chloride, 44, was synthesised from the commercially available hexadecanedioic acid using 
(COCl)2 with DMF catalyst in DCM. As before, the diacid chloride was used as obtained and 
reacted with 40 in THF, with NEt3 as a base in a high-dilution, macrocyclisation reaction. This 
method involved the simultaneous and slow addition of receptor and acid chloride to the 
reaction vessel via the use of syringe pumps over a period of two hours. This serves to 
minimise the intermolecular side reactions, and any subsequent polymerisation inherent in 
cyclisation reactions. After stirring overnight, the volatiles were removed and the crude was 
purified via column chromatography giving the pure macrocycle, 45, in 33% yield. The yield 
for this reaction, despite being low, is fairly typical for this type of cyclisation. 
 
Scheme 2.4 – Synthesis of 45, via macrocyclisation. 
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2.2 Synthesis of the Stopper Group 
 The stopper group chosen for these sets of interlocked compounds was the bulky 4-
(tris(4-(tert-butyl)phenyl)methyl)phenol, 48. Following the literature procedure set out by 
Stoddart,3 the synthesis was fairly trivial, with high yielding reaction steps (Scheme 2.5).  
 
Scheme 2.5 – Synthesis of the stopper group, 48. 
The first step was a bromination of tert-butyl benzene, giving the bromobenzene, 46, 
which was then used as obtained to form a Grignard reagent, using magnesium with 
catalytic iodine. The following reaction involved a threefold attack of the Grignard reagent 
on diethyl carbonate, which upon quenching, formed tris(4-(tert-butyl)phenyl)methanol, 47, 
which was purified via recrystallization. The final step was a Friedel Crafts reaction of 47 in 
phenol using HCl as a catalyst. After work up, the crude was again purified via 
recrystallization affording 48 in a good yield. Depending on the functionalization required, 
the free OH of 48 could now be derivatized with any number of reacting groups as outlined 
in the following sections. 
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2.3 Synthesis of Flexible Barbiturate guests 
2.3.1 Concept 
These barbiturates are termed ‘flexible’ due to the type of functionality at the 5-
position. The barbiturates are functionalised with CH2 linkers and as a result, other than the 
minor directionality imposed by the sp3 carbon, have an inherent flexibility about this point. 
The initial target compounds were the synthetically simple, flexible barbiturates to be used 
in a clipping approach in attempts towards both catenanes and rotaxanes (Figure 2.3). The 
formation of rotaxanes via a clipping method, as in (a), involved using a pre-stoppered 
barbiturate and an acyclic receptor and obtaining the interlocked structure via Grubbs-
catalysed metathesis. A second approach, targeting catenanes as in (b), required the 
barbiturate to consist of bis-functionalization at the 5 position with long alkyl chains 
terminating in olefin groups. It was anticipated that these molecules would be able to 
thread through the macrocycle, forming a pseudo-rotaxane, with subsequent clipping via 
Grubbs-catalysed metathesis producing the desired interlocked structure. 
 
Figure 2.3 – Schematic diagram shows the various Grubbs catalysed clipping methods involving bis-olefins. 
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2.3.2 Stopper Terminated Barbiturates 
The first investigation regarding the synthesis of interlocked structures was towards 
rotaxanes via the pre-stoppered barbiturate (Figure 2.3(a)). The synthesis of these flexible 
barbiturate guest molecules followed the classical barbiturate synthesis via di-substitution 
of diethyl malonate. The first step in the synthesis was functionalization of the stopper 
group with a triethylene glycol linker (Scheme 2.6). The bis-iodo compound was used to 
allow further reaction at the terminus of the linker once it has been attached to the stopper. 
Although formation of the unwanted, di-substituted product would compromise the yield of 
product, this side reaction was minimised through the use of a large excess of the bis-iodo 
compound (10 molar equivalents) compared to 48. After the addition of K2CO3, the 
suspension was stirred overnight under reflux. The solvent was then removed and the crude 
product was purified via column chromatography.  A moderate yield was obtained but this 
was considered acceptable given that di-substitution could still occur and that the starting 
materials could be synthesised in large amounts. 
 
Scheme 2.6 – Synthesis of the stopper group with pendant arm, 49. 
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 The next step was to attach the stopper group 49 to diethylmalonate for cyclisation 
(Scheme 2.7). Diethyl malonate was added to a suspension of NaH in THF. After stirring for 
30 minutes, 49 was added and stirred. However, although the reaction was refluxed over a 
period of three days, only starting material was recovered after work up and purification. 
 
Scheme 2.7 – Unsuccessful attempt towards a di-substituted malonate. 
The reason for this reaction being unsuccessful is possibly due to a poor solubility of 
49 and steric factors concerning the attachment of two bulky groups to the alpha carbon of 
the malonate. 49 was recovered from the reaction mixture. Similar reactions have been 
carried out with a structurally similar trityl stopper and these were only achieved in 9% 
yield.4 The trityl group is less bulky than this tris-alkyl analogue and so it may appear that 
the required di-substitution is not possible with these compounds. To overcome this steric 
problem, an increase in chain length is possible. However, long chains might hinder the 
clipping process due to an increase in rotational degrees of freedom, negating the effect of 
the sp3 carbon. Also, when considering the final cyclisation of the disubstituted malonate 
with urea, these reactions have been shown to suffer reduced yields when using bulky 
substituents, when compared to the previous di-substitution step.4 For these reasons, the 
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desired product appeared unattainable and so the synthesis of flexible stoppered 
barbiturates and the approach of clipping these compounds towards a rotaxane was not 
investigated further.  
2.3.3 Olefin Terminated Barbiturates 
The investigation towards interlocked structures then turned towards the clipping 
approach using olefin terminated barbiturates (Figure 2.3(b)). The synthesis followed the 
same procedure for the unsuccessful stoppered-barbiturate synthesis already outlined, but 
a related strategy  had already been shown to be successful in previous projects.4 
 
Scheme 2.8 – Synthesis of olefin terminated flexible barbiturates 52 and 53. 
The allyl bromide of desired chain length was first reacted with diethyl malonate in 
THF with 2.2 equivalents of NaH. The reaction mixture was purified using column 
chromatography to afford the di-substituted malonates 50 and 51. These were then cyclised 
with urea in DMSO and the crude was purified via column chromatography to form the 
5,5,bis-substituted barbiturates 52 and 53 (Scheme 2.8).  
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2.3.4 Binding Study of a Flexible Guest 
The barbiturate guest, 53, was then investigated for its binding properties with the 
Hamilton receptor 45. A solution of 45 was made up to a concentration of 5.08 x 10-3 M (in 
CDCl3) and then a guest solution, at concentration 5.13 x 10-3 M, (in CDCl3) was added to the 
receptor solution. The host:guest interaction is shown below in Figure 2.4. 
 
 
Figure 2.4 – Proposed Host:Guest interaction of 45 with 53. 
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The 1H NMR spectra in Figure 2.5 highlight the downfield region of each spectrum 
and clearly show the downfield shift of the N-H protons of both guest and receptor upon 
complexation indicating an H-bonded structure. The macrocycle HNH protons experience a 
downfield shift of 2.11 ppm for the NH closest to the bridging benzene and 1.9 ppm for the 
second NH proton.  A large shift of 4.87 ppm was observed for the barbiturate HNH signal, 
showing a very strong interaction. Another significant shift noticed was the signal 
corresponding to the proton at position 5. The orientation of this proton places it in the 
binding site of the receptor and so a shift upon guest complexation is not unexpected, 
conversely the protons of the bridge and pyridine units on the exterior of the binding site 
experience very little shifting. This is strong evidence for the formation and orientation of 
the desired H:G complexation for barbiturate-templated interlocked structures.  
45 
53 
45:53 
8 9 3 
HNH 
HNH 
5 
10 
Figure 2.5 - 1H NMR stack showing the aryl region of 45, 53 and 45:53 complex at 289 K in CDCl3 at 5.00 mM. Inset: 
Schematic of H:G interaction 
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The binding constant for the H:G system was measured via monitoring the HNH shift 
of the macrocycle during a 1H NMR titration experiment (Figure 2.6). This method involved 
the stepwise addition of known equivalents of guest into a solution of receptor and the 
addition of guest shifted the signal depending on the concentration and strength of 
interaction. A stack plot of the experiment clearly shows the gradual shift of the HNH proton 
of the macrocycle, which moves relative to the concentration of guest added, up to 3.98 
equivalents. The experiment was carried out using a concentration of 5.00 mM regarding 
the macrocycle, using the solvent system CDCl3-5% DMSO. The DMSO was used to achieve 
full solubility of the macrocycle. However, being a competitive solvent, this will influence 
the binding constant relative to pure CDCl3.  
The experiment was carried out by the stepwise addition of up to 5 equivalents of 
guest molecule, however no increase in HNH shift was observed after 3.98 equivalents and at 
this point the guest was considered fully bound to the macrocycle. It is worth noting the 
initial spectra (bottom) shows a shift in NH peaks relative to the previous example in Figure 
2.5. This is due to the presence of a competitive solvent, DMSO. The peak shifts were used 
to assign the binding constant for this particular system and by treating the data using the 
software WinEQNMR5 a binding curve (Figure 2.7) and subsequent binding constant can be 
extracted. 
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Figure 2.6 - 1H NMR stack showing the aryl region of 45 upon addition of 53 up to and including 3.98 
equivalents at 289 K. 
  
 
 
 
 
 
 
The binding constant was found to be 1.07 x 103 M-1 (± 200), giving a log(K) value of 
3.03 at 298 K. The relatively large error observed in this value probably arose from the 
Figure 2.7 - Binding curve obtained via WinEQNMR, also showing deviation from the best fit. 
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difficulty in peak picking due to the broad nature of the NH peaks. Comparing the binding 
constant with the analogous compound, 52, synthesised by Mathias Rocher, this appears to 
exhibit weaker binding. For the compound containing an 8-CH2 linker, the binding constant 
was obtained using isothermal calorimetry and found to have a log(K) value of 4.62 ± 0.04.4 
This difference can be explained through the use of DMSO in the solvent system, since any 
competitive binding with solvent molecules would reduce the binding constant between 
host and guest. 
2.4 Rigid Barbiturates  
2.4.1 Introduction  
Despite the ability of these guests’ potential to thread and then cyclise, it was found 
previously that they may be too flexible. It can be envisaged that shorter lengths would have 
less degrees of rotation and therefore display more ‘rigid-like’ behaviour. However, any 
shorter lengths than those seen with x=8 would form a ring smaller than is found in any 
known catenane using a clipping approach.6 So it seems that x=9 is the limit at which the 
catenane would readily form when using terminal groups in a cyclisation process. However, 
although sufficient flexibility would be required to ring close around the macrocycle, such 
inherent flexibility in the barbiturate chains would not particularly favour the initial 
threading process, with any cyclisation only occurring in a ‘perched’ conformation. Whilst 
both host and guest molecules are fairly planar in their own right, from the solid state 
crystal structure determined by Hamilton, it can be seen that the bound barbiturate and 
pyridine units, are not co-planar, with the barbiturate sitting out of the plane of the 
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receptor by 27o.1 One can therefore imagine the situation where the arms of the barbiturate 
do not thread but instead form a perched complex as demonstrated in Figure 2.8. 
 
Figure 2.8 – Schematic to show the possible orientation between host and guest giving a ‘perched’ or ‘threaded’ complex. 
Obviously, any clipping in the perched case would only lead to the recovery of two 
independent, non-interlocked macrocycles. One idea to circumvent this possible issue 
would be to synthesise more rigid guest molecules. It was thought that by introducing more 
rigidity at the 5-position, then the sp3 directionality at this position could be emphasised and 
so if the barbiturate were to bind in the binding site, it would have a greater probability of 
threading through the macrocycle. Similarly, this problem encountered with threading can 
be applied to the concept of rotaxane formation. In other words, when clipping around the 
barbiturate dumbbell, if there is not sufficient rigidity or directionality in the spacers 
between the barbiturate and the stoppers, then there would be less chance of a clipping 
event occurring around the axle of the dumbbell. To create this rigidity, a phenyl group 
spacer was proposed (Figure 2.9), although this posed a much greater synthetic challenge 
over the flexible guest molecules. 
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Figure 2.9 -  Schematic showing the chemical analogue of a proposed ‘rigid’ barbiturate. 
Previous synthetic procedures found in the literature for the formation of the bis-
arylated barbiturate 54 consisted of a Friedel Krafts reaction of alloxon monohydrate 
(Scheme 2.9).7 However this is only suitable for simple aryl compounds and is not applicable 
for the longer chains and the types of functionality for an interlocked structure. 
 
Scheme 2.9 – Classical synthesis of diphenyl barbiturates. 
One might propose to simply functionalise the free OH group of the phenol. 
However this is not possible due to the relative acidity of the imide protons of the 
barbiturate and so any substitution would occur at this site rather than at the required OH, 
as shown in 55, Scheme 2.10.  
Synthesis of the precursor components of non-photoactive Interlocked Structures 
 
71 
 
 
Scheme 2.10 – N-functionalisation rather than at the desired phenol substituent. 
It was therefore desirable to find alternative means to achieve the bis-arylation of 
barbituric acid. A method reported by Kopinski et al.8 was found, as discussed in detail in the 
following section.  
2.4.2 Arylation Reactions using Organolead(IV) Compounds 
A reaction which has proved extremely useful throughout this thesis in the synthesis of 
new barbiturates is the arylation reaction of aryl lead tricarboxylate compounds. The 
efficacy of these compounds in the arylation of carbon nucleophiles was first discovered in 
the mid-70’s after the group of Pinhey et al. conducted studies of aryllead(IV) 
tricarboxylates with TFA9 and later applied this chemistry towards the synthesis of a series 
of biaryl compounds.10, 11 The approach was extended to a wide range of soft carbon 
nucleophiles such as β-dicarbonyl compounds, Scheme 2.11, the motif found within 
barbiturates, and led to highly substituted quaternary carbons. Incidentally, these additions 
exhibit higher yields and faster reaction times when R1 ≠ H.12  
 
Scheme 2.11 – Arylation of β-dicarbonyl compounds. 
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The process of generating these aryllead(IV) tricarboxylates can be through either 
direct plumbation or metal-metal exchange, with the latter being the more widely accepted 
method. The first example of metal-metal exchange was shown by Kocheshkov13 in 1952 
generating the target compound using mercury(II) acetate. The use of various 
metal/semimetal centres has since been shown, including the use of mercury, tin and 
silicon. However, the use of mercury catalysed boron-lead exchange, as explored by 
Pinhey,14 displayed a simpler method when compared to mercury or tin exchange, and a 
greater economy in terms of aryl group transfer. Generation of the active species 56, to be 
used in situ, is shown in Scheme 2.12. 
 
Scheme 2.12 – Formation of the in situ organolead species. 
The aryllead(IV) tricarboxylates, generated via transmetalation, behave as aryl cation 
equivalents with their most useful reactions being, but not limited to, those with soft carbon 
nucleophiles, resulting in C-arylation. In general, these reactions proceed with greater yields 
when more acidic substrates are used. This concept was applied by Pinhey towards 
barbituric acid in the synthesis of ibuprofen and phenobarbital and showed that diarylation 
of β-diketones containing two α-hydrogens was possible and that the acyclic precursor 
diethylmalonate was unreactive.15  
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Despite some reported arylations experiencing steric inhibition, the hindered 
compounds which can be obtained with this reaction point towards a ligand coupling 
mechanism as described by Trost and shown below in Figure 2.10.16  
 
Figure 2.10 – Mechanism of arylation. 
The process involves deprotonation of an α-hydrogen, and subsequent attack from this 
nucleophilic centre to form the organolead intermediate. A reductive elimination step forms 
the new C-C bond, and a subsequent addition of a second aryl group will afford the 
diarylated product. Through the use of this lead mediated ligand coupling mechanism, using 
phenylboronic acid precursors, they were able to functionalise barbituric acid with two 
para-methoxyphenyl groups, in essence achieving the compound shown above in Scheme 
2.9 (R=Me), but via what could be a more synthetically useful procedure if tolerant to 
different functionality. Applying this towards rigid guests for interlocked systems, shown in 
Scheme 2.13, the synthesis of these ‘rigid’ compounds requires forming the boronic acid, 
and then utilising a boron–lead exchange to form an aryl-lead intermediate. Despite the 
examples of Pinhey showing the substitution of simple phenyl groups it was hoped to 
extend the synthesis to the more elaborate groups required for an interlocked structure. For 
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the purposes of clipping, X can be either olefin terminated groups towards a catenane, or a 
bulky stopper group for subsequent clipping with a receptor to from a rotaxane. 
 
Scheme 2.13 -  Proposed synthesis of rigid barbiturates utilising boron/lead exchange. 
2.4.3 Synthesis of Rigid Barbiturates - Olefin Terminated Compounds 
The initial strategy investigated toward these rigid barbiturates was in aiding the 
threading process and so the phenyl spacer was appended with an alkyl chain terminated in 
an olefin group. To test the synthetic strategy in the presence of olefin groups, a test 
synthesis was first carried out using allyl bromide (x = 1) (Scheme 2.14). 
 
Scheme 2.14 – Synthesis of allyl functionalised phenylboronic acids. 
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The synthetic strategy began with the funtionalisation of bromo phenol with the 
required bromo alkene. The allyl bromide was attached via nucleophillic substitution at the 
phenol OH using K2CO3 as a base, and compound 57 was obtained in excellent yield. The 
next step, formation of the boronic acid, consisted of a lithiation step at -78o C in THF using 
nBuLi. The reaction was then quenched with triethyl borate and formed the boronic acid, 59, 
which was purified using recrystallization from water and obtained in good yield. 
The following key step was a boron-lead exchange reaction between phenyl boronic 
acid and Pb(OAc)4 (Scheme 2.14). The lead(IV) tetra-acetate was dissolved in dry CHCl3 along 
with a catalytic amount of mercury(II) acetate and heated to 40o C. The boronic acid, 59, was 
then added under argon flow, via spatula, over a period of 15 minutes. Stirring at 40o C was 
maintained for 1 h as the boron-lead exchange occurred. Addition of barbituric acid with 
molar equivalents of pyridine followed and the suspension was then stirred overnight. After 
work up, the crude product was purified via column chromatography to obtain the bis-
arylated product, 61. This ‘proof of concept’ guest molecule highlights the possibilities of 
introducing and employing a more widely varied library of barbiturate substituents for 
interlocked structures.  
Despite this successful and optimistic synthesis where x=1, when extending the chain 
to a longer and more useful tether, a number of problems arose. When x=9, the 
functionalization of bromophenol to form 58 proceeded well and in good yield. However the 
formation of the boronic acid, 60, was hindered due to gel formation, almost certainly due 
to a combination of the low temperature and increased chain length. To overcome this, 
repeated warming and cooling of the reaction, to reform a solution, was needed and this 
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will have contributed towards the reduced yield. The boronic acid, once formed, was only 
able to be purified via column chromatography. However, boronic acids are fairly unstable 
regarding purification via this method and this will have also contributed towards the 
reduced yield. Attempts were made towards recrystallization but no suitable method and/or 
solvent was found. Boronic acid, 60, was then used in the synthesis of 62 and showed 
similar yields to the allyl analogue. The more easily isolatable butandiol bromo-ester was 
synthesised and used in the B-Pb exchange reaction, but despite reports that the boron/lead 
exchange can occur with both the boronic acid and ester analogues,8 this also proved 
unsuccessful and only starting materials were recovered, implying the initial exchange could 
not occur. Despite observing low, but adequate yields in the final boron-lead exchange step, 
the process of forming and purifying the olefin-terminated phenylboronic acid, 60, was 
deemed too problematic and so another synthetic strategy towards these rigid barbiturates 
was required.  
2.5 Rigid Barbiturates – Stopper Terminated Compounds 
Due to the synthetic challenge of olefin terminated rigid barbiturates, and the 
template effect already observed in the cyclisation of receptor 41, the most promising route 
toward an interlocked structure should be clipping the receptor around a dumbbell shaped 
barbiturate, forming a rotaxane. Previous work has shown this to be difficult with the use of 
flexible threads4 and so it would be desirable for the synthesis of dumbbell barbiturates 
with phenyl spacers.  
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2.5.1 Trityl Stoppers 
The initial approach was to follow the procedure mentioned previously, via the 
phenyl boronic acid to arrive at the bis-arylated dumbbell (Scheme 2.14). However, the 
synthesis was even more challenging than with the olefin derivatives due to the solubility of 
63 and no boronic acid was able to be formed and only the starting material was recovered 
(Scheme 2.15). 
 
Scheme 2.15 -  Unsuccessful attempt toward a stopper derivitised phenyl boronic acid. 
2.5.2 Silyl Stoppers 
Due to the issue of the solubility of 63, an alternative silyl group was proposed. The 
common protecting group tert-butyldiphenyl silyl (TBDPS) is a relative bulky group and 
although somewhat labile, it is the most stable in the silyl protecting group series. A crude 
3D model constructed in ChemBio3D Ultra (Figure 2.11), shows the relative sizes of the 
stopper and macrocycle in a space filling display mode showing the stopper is in fact bulky 
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enough and unable to slip over the ring, however further and more in-depth computational 
studies would be required to confirm this. 
 
Figure 2.11 -  ChemBio3D Ultra model depicting 45 with a TBDPS stoppered thread (yellow). 
 The synthesis again started from bromophenol and is shown in Scheme 2.16. 
Addition of a triethylene glycol unit via an iodine substituent was achieved using K2CO3 and 
NaI in DMF. The reaction was heated for 24 hours at 110o C and after work up was purified 
by column chromatography to give 64 in good yield of 70%. The tether was then 
functionalised with TBDPSCl and 65 was formed in 45% yield. Subsequent formation of the 
boronic acid was carried out as previously described to give 66. The compound showed 
enhanced solubility due to the silyl group and conversion was achieved pure and in 
quantitative yields, with no column necessary. Unfortunately, the desired product was not 
formed in the following step and 66 was returned without the boronic acid group. For this 
reason, the silyl-stopper series of compounds was not investigated further. 
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Scheme 2.16 – Synthesis and subsequent failure of the TBDPS stoppered compounds. 
2.5.3 ‘Protect-First’ Strategy 
Due to the clear problems surrounding the current strategy regarding the synthesis 
of these bis-arylated barbiturates it seemed necessary to find an alternate route.  It was for 
this reason that a ‘protect-first’ strategy was proposed. It seems the boron-lead exchange 
reaction is not feasible with large functional groups and when these are present, the 
synthetic route can also be problematic when forming the boronic acid. A method involving 
addition of the aryl groups at as early a stage as possible and then focusing on the 
functionalisation of these phenyl groups could be the most successful strategy. The target 
intermediary of the protection strategy is shown below in Figure 2.12. 
 
Figure 2.12 – Intermediate target towards dumbbell barbiturates. 
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 Attachment of imide protecting groups allows the required functionalization of the 
aryl OH groups. The protecting groups were used in order to circumvent the problem of 
functionalising the imide site over the OH of the aryl group. The protecting group chosen 
was 2,4-dimethoxy benzyl (2,4-DMB). 
2.5.3.1 Synthesis of Benzyl Protected Barbiturates 
Before any protection strategies were attempted, the initial protected barbiturate 
was synthesised. This was achieved in two high yielding steps (Scheme 2.17) starting with 
the formation of a bis protected urea, 67, using a modified literature procedure.17 2-
4,dimethoxybenzylamine was dissolved in DCM and cooled to 0o C. The 2-
4,dimethoxybenzylisocyanate was then added dropwise resulting in the instantaneous 
precipitation of the product which was isolated through filtration in quantitative yield. 67 
was then cyclised with malonic acid, again using a modified literature procedure18 via 
refluxing in acetic anhydride overnight. Subsequent work up afforded a yellow solid of 1,3-
bis(2,4-dimethoxybenzyl)Barbituric acid, 68. 1H NMR analysis showed that the product 
appeared pure. However subsequent dissolving in DCM and refluxing with charcoal 
produced a clean, fluffy-white solid which reduced the yield but resulted in an improvement 
in the yields of subsequent reactions. 
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Scheme 2.17– Synthesis of N-protected barbiturates 
2.5.4 Protect First Strategy and the Feasibility of Key Reactions 
The ‘protect first’ strategy is shown schematically in Scheme 2.19 below and begins 
with the protected barbiturate 68. The first step was a proposed arylation with a simple 
boronic acid. Keeping the boronic acid as simple as possible was key towards the success of 
this route, and allowed a much more feasible addition to the barbiturate compared with the 
low yields and challenging synthesis seen with more complicated systems. The simplest aryl 
motifs for this protection strategy are shown below in Scheme 2.18 where a free OH is 
present allowing subsequent functionalization. The B-Pb exchange reaction was attempted, 
but the presence of free OH groups seemed to interfere with the reaction and both 
attempts were unsuccessful. The starting material 68 was recovered and the boronic acid 
suffered degredation. 
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Scheme 2.18 – Attempts towards arylation of 68 using simple phenylboronic acids. 
This problem introduced an extra protection/deprotection step into the strategy. 
Once arylated with an O-protected phenylboronic acid, the steps follow deprotection of the 
oxygen, then functionalisation to form the thread motif and subsequent N-H deprotection 
giving the rigid “target dumbbell”. 
 
Scheme 2.19 – Modified protection strategy towards rigid barbiturates. 
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In order to test the feasibility of this protection strategy a series of test reactions of 
the key steps were first carried out, in some cases on analogues of the desired motifs. The 
first test was to ensure that the B-Pb exchange reaction will work in the presence of the N-
benzyl protecting groups and when the phenyl boronic acid is appended with a small 
protecting group. Initial investigations were first carried out with bis-paramethoxybenzyl 
barbituric acid, PMB-BA, obtained from our collaborators in Bordeaux. The bis-arylation was 
achieved using the commercially available 3-methoxyphenylboronic acid and 69 was 
obtained (Scheme 2.20). The procedure followed for this step was the same as those 
mentioned for previous ligand coupling reactions. 
 
Scheme 2.20 - Synthesis of N-protected diphenyl barbiturate 
Owing to this promising result it was important to determine that the newly 
attached phenyl groups were stable to any subsequent imide deprotection. This compound 
was then taken through various deprotections in order to determine the best method for 
removal of the benzyl groups. Reactions with Pd(C) or Pd(OH)2 under H2 atmosphere were 
unsuccessful and attempts to form the Boc-protected barbiturate, from 69, followed by 
deprotection on work up were also unsuccessful. In each case only the starting material was 
recovered. Deprotection was found to be successful using ceric(IV) ammonium nitrate 
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(CAN). CAN is a one electron oxidizing agent which enables oxidative cleavage of protecting 
groups via an oxonium ion. The generic reaction pathway is shown in Scheme 2.21.19 
 
Scheme 2.21 - Mechanism of methoxybenzyl deprotection using CAN. 
 The protecting group is oxidized and cleaved in a two-step electron transfer process. 
Cerium is a strong oxidizing agent and two independent Ce(IV) atoms are reduced to Ce(III) 
in the electron transfer steps. The free amide and corresponding aldehyde are formed, both 
usefully diagnostic of the cleavage via 1H NMR spectroscopy. The bis-arylated 2,4-DMB 
protected barbiturate, 69, was then treated with CAN and left to stir overnight in a 1:3 
solvent mix of water/acetonitrile (Scheme 2.22). After workup, and purification via column 
chromatography the product, 70, was isolated affording the required deprotected 
barbiturate. Loss of protecting groups was confirmed by 1H NMR spectroscopy and mass 
spectrometry. 
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Scheme 2.22 – Synthesis of debenzylated diphenyl barbiturate, 70. 
Despite the success in removal of these protecting groups using CAN, it was decided 
to use the 2,4-dimethoxybenzyl analogues, as seen in 68, since these should more labile 
groups compared with the example above due to extra resonance stabilisation. 
2.5.5 Synthesis of Rigid Dumbbell Barbiturates  
The protecting group for the O-phenylboronic acid to be used should have good 
stability during the ligand coupling reaction and be easily removed under conditions which 
do not remove the 2,4-DMB groups. The protecting group selected was TBDMS. Following 
Scheme 2.23, the TBDMS protected boronic acid, 72, was synthesised in two steps from 
bromophenol. The first step involved protection of the OH group, and 71 was isolated in 
quantitative yields after column chromatography. The second step was formation of the 
boronic acid using the same method of lithiation and quenching with triethyl borate as seen 
previously giving 72 in good yield. The purification required the use of column 
chromatography due to any attempts at recrystallization being unsuccessful, and the 
isolated yields therefore suffered due to the purification step. 72 was then used in the 
ligand coupling reaction to form the bis-protected, diarylated barbituric acid, 73. The 
boronic acid is required in excess (2.2 equivalents) and affords the product, after 
purification by column chromatography, in acceptable yields. Subsequent deprotection of 
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the silyl groups of 73 with TBAF in THF gave the deprotected product, 74, in excellent yields 
after purification via column chromatography. As already stressed, 74 is an important 
intermediate in the synthesis of rigid barbiturates, owing to the fact that any number of 
different groups relating towards the synthesis of interlocked structures can be attached at 
a relatively late stage in the synthesis, provided that they are stable to the final CAN 
deprotection. Once the OH group is appropriately functionalised, all that remains is the final 
deprotection of the 2,4-DMB groups to achieve the rigid guests. 
  
Scheme 2.23 – Synthesis of rigid thread precursor, 74. 
The molecule chosen to functionalise the barbiturate was the trityl phenyl appended 
with iodo-terminated triethylene glycol linkers (Scheme 2.24). Starting from the previously 
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synthesised compound, 49, the stopper was attached to 74 by reacting it in excess, in DMF, 
with Cs2CO3 as a base. After work up and purification the stopper-terminated, rigid 
barbiturate, 75, was synthesised in good yields of 75%. The next and final step in the 
synthesis involved deprotection of the 2,4-DMB groups. Due to the inherent issues of 
solubility found when using these stopper groups, the reported conditions for CAN 
deprotection (acetone/water)19 were unacceptable for these series of compounds. A solvent 
mix of DCM/acetone/water was chosen and this was combined with gentle heating to allow 
for maximum solubility of the starting material, whilst still allowing the presence of the 
water required for the reaction. Monitored by TLC, the reaction was complete in only 15 
minutes and after purification via column chromatography afforded the rigid, stoppered 
guest, 76 which was characterised via 1H, 13C and mass spectrometry. A low yield of 22% 
shows scope for optimisation of this reaction, whether through varying time, temperature 
or solvent system, but this fell outside the scope of the current investigation. These rigid, 
dumbbell shaped guest molecules can now be used for a clipping approach with acyclic 
receptor compounds as outlined in the following chapter. 
Synthesis of the precursor components of non-photoactive Interlocked Structures 
 
88 
 
 
Scheme 2.24 – Synthesis of 76, via attachment of stopper groups to 74 and subsequent deprotection. 
The 1H NMR spectrum of 76, with assignment of peaks is shown in Figure 2.13.  
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Figure 2.13 - 1H NMR of 76 in CDCl3 at 298 K. 
2.5.6 Attempts towards reduced reaction steps. 
Despite this successful strategy, due to the number of steps involved, some of which 
were fairly low yielding, a secondary strategy was proposed. This route attempted to attach 
the phenyl groups at the α carbon prior to the cyclisation to the barbiturate. The proposed 
strategy is shown below in Scheme 2.25 and starts from anisole and a triketone.  
 
2, 4, 10 3 
5 9 6 7 
8 
1 
HNH 
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Scheme 2.25 – Attempts towards diphenyl barbiturates 
The bisarylated malonate 77 was formed via a Friedel Crafts reaction with 
ketomalonate and anisole. The reagents were dissolved in acetic acid and a catalytic amount 
of H2SO4 was added. The solution was stirred under reflux for two hours and then stirred at 
room temperature overnight. After work-up and purification, 77 was isolated in 10% yield. 
The ester 77 was then converted to the acid 78 by refluxing for four hours in water/ethanol 
with KOH as a base. The compound was purified via column chromatography and was 
obtained in 80% yield.  
Further cyclisation with a protected urea would form the protected barbiturate with aryl 
groups attached. However, neither 77 or 78 were unable to be cyclised to the barbiturate 
and only starting materials were recovered.    
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2.5.7 Interactions with Receptors 41 and 42 
  
Figure 2.14 – Stacked 1H NMR spectra showing 76 (a), 41:76 (b), 42:76 (c) and 41 (d) in CDCl3 (5 mM) and at 298 K. 
Shown in the spectra of Figure 2.14 are the guest 76 (a) followed by the acyclic 
complex 41:76 (b), the perched complex 42:76 (c) and finally the acyclic receptor 41 (d). 
There is a clear H-bonding interaction present indicated by the downfield shifts of the NH 
protons. The imide NH proton of the guest is shifted significantly from 8.1 – 13.1 ppm. There 
is very little difference between the spectra of the complexes 41:76 and 42:76 indicating 
that interpretation of an interlocked structure from 1H NMR alone may be difficult. 
2.6 Barbiturate Components Towards Click Chemistry – An alternate route to 
Interlocked Structures 
2.6.1 Click Reaction Components - Towards Stoppering 
In order to maximise the scope with which to form interlocked structures from 
Hamilton receptors and barbiturate derivatives, another approach was proposed by our 
collaborators in Bordeaux. The concept involved the use of a Huisgen 1,3-dipolar 
cycloaddition, or ‘click’ reaction, a reaction used extensively in the field of interlocked 
a) 
d) 
c) 
b) 
Shifted to 13.1 ppm 
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structures.20 Click reactions, as discussed in the introduction, typically involve the use of a 
complementary azide/alkyne pair which undergo a copper catalysed cycloaddition to form a 
triazole moiety. The following scheme involves the formation of a [2]-rotaxane via a 
stoppering event. The procedure, shown schematically in Figure 2.15 involved the use of the 
cyclic receptors which will form a H:G complex with a barbiturate which has been appended 
with azide groups. The azide groups are attached at the end of propyl tethers attached at 
the 5 position. The relatively short nature of these linkers should aid with the threading 
process when compared to the longer analogues already discussed. The alkyne component 
is attached to the stopper and once the H:G complex is formed, the rotaxane will be formed 
via the click reaction. 
 
Figure 2.15 – Formation of a [2]-Rotaxane using stoppering via click chemistry 
2.6.1.1 Synthesis of Components 
The start of the synthesis required the production of the azide linkers. The 1-azido-3-
iodopropane, 81, was synthesised in three steps from 3-bromo-1-propanol, via the tosyl 
compound, 80, according to literature procedures and achieved in good yield (Scheme 
2.26).21 In the first step, 3-bromo-1-propanol is added to water followed by NaN3 and the 
mixture is refluxed overnight. After workup, 79 was isolated and the oil can be used as 
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obtained with no further purification required. Addition of the tosyl group was achieved by 
dissolving 79 in DCM and adding 4-toluensulfonyl chloride, with NEt3 added as a base. The 
solution was stirred overnight and after work up, a yellow oil is obtained. Addition of ether 
removed a significant amount of impurity as a white precipitate and the oil obtained from 
the filtrate was then purified via column chromatography to obtain 80 as a clear oil. In the 
final step towards the azide tether, the tosyl group was converted to the iodide by 
dissolving in acetone and adding NaI. The reaction was stirred under reflux overnight and 
the work up merely consists of filtration of the precipitate formed, and removal of the 
solvent from the filtrate to obtain 81 as a clear yellow oil. Care was taken when handling 
these compounds, not only for their volatility due to their relatively low molecular weight, 
but also because low molecular weight azides have been known to be explosive when under 
reduced pressure and/or heat.22  
The iodine terminated azide moiety, 81 was then reacted with diethyl malonate, in 
the same manner as shown previously and shown in Scheme 2.26. The malonate was 
dissolved in THF, and after the addition of NaH to achieve deprotonation of the malonate, 
the azide was added in excess and the reaction was stirred under reflux, overnight. After 
work up and purification via column chromatography the disubstituted product, 82, was 
obtained in good yield. The final step in the synthesis of this target barbiturate was 
cyclisation with urea. The urea was dissolved in DMSO and again NaH was used as a base. 
The malonate was then added and the solution was stirred overnight. After work up, an oil 
was obtained from which the impure product crystalised out under high vacuum. The crude 
solid was separated from the oil and purified via column chromatography to yield the di-
azide substituted barbiturate, 83.  
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Scheme 2.26 – Synthesis of azide terminated barbiturate thread, 83.  
2.6.1.2 Studies of the Pseudo-Rotaxane 45:83 
It was important to establish the nature and strength of binding for these 
barbiturates so a series of binding studies were carried out regarding the formation of the 
pseudo-rotaxane.  
The job plot in Figure 2.16 was used to determine the stoichiometry of the binding 
event between barbiturate 83 and macrocycle 45. By monitoring the changes in absorbance 
whilst varying the molar fraction of the system, the job plot was produced, confirming a 1:1 
H:G complex, as expected for this Hamilton-Barbiturate motif. 
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Formation of this 1:1 complex was confirmed via crystal structure, shown in Figure 
2.17. The crystals of the Host-Guest complex were obtained via slow diffusion of pentane 
into a solution of the complex in dichloromethane. From the crystal structure it can be 
observed that as expected, the barbiturate guest is bound by six complementary H-bonds 
between the imide and bisamidopyridine units along with a central short contact [C−H---
O=C] interaction. The H-bond lengths [N−H---O=C] were found to be 1.9 to 3.2 Å with angles 
of 164° to 170°. In the complex, the median annular plane of the barbiturate guest formed 
an average tilt angle of ca. 26° relative to the median plane of receptor, similar to that 
observed by Hamilton with analogous guest species. Crucially, it is apparent that the two 
alkyl arms of the guest bonded to the sp3 carbon protrude from both sides of the 
Figure 2.16 - Job plot showing binding-induced absorption changes (310 nm) as a function of 
molar fraction of azide barbiturate in the binding between receptor 45 and barbiturate 83. 
([C]tot = 50 µM) in CHCl3. ∆Abs = Amax - Aobs  
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macrocycle cavity forming the desired pseudo-rotaxane, a prerequisite towards the 
formation of an interlocked structure. 
 
 
 
 
 
The binding constant for this interaction was obtained by analysis of the red-shifting 
of the pyridine absorption, induced by guest complexation, at 315 nm, as shown in Figure 
2.18. The value for Kass was found to be 23500 M-1, a logK of 4.37 at 288 K in CHCl3. This 
value shows a relatively strong interaction when compared with the olefin terminated 
barbiturates. This is probably a consequence of the guest’s ability to interpenetrate the 
binding cavity when compared to the longer chained moieties.  
 
 
Figure 2.17 -  X-Ray crystal structure of the  H:G complex formed between 45 and 83. 
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The 1H NMR spectra of Figure 2.19 shows the shifting of signals upon H:G binding. 
The H:G spectrum shows similarities with that of Figure 2.5 where the HNH signals of both 
the host and guest experience a strong downfield shift (HNH83: ∆δ = 3.8 ppm, HNH45: ∆δ = 
1.3 and 1.6 ppm, indicative of the binding interaction). As before, a downfield shift of the 
‘bridge’ proton is also observed. 
        
Figure 2.18 - Changes in electronic absorption spectra of receptor 45 in CHCl3 (C = 25 
µM) on adding aliquots of 83. Inset shows absorption changes at 315 nm upon addition 
of 83 from 0 to 22 equivalents.  
Figure 2.19 – 1H NMR comparison between 83, 45, and a 1:1 mix of 45 and 83 in CDCl3 at 298 K 
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2.6.1.3 Stopper Synthesis 
Both azide and alkyne components are required for the click reaction and the alkyne 
group was chosen for the stopper due to its ease of synthesis and its prevalence in the 
literature.23 The alkyne appended stopper was synthesised in one step from 48, by reacting 
with propargyl bromide in DMF, using K2CO3 as a base (Scheme 2.27). The reaction mixture 
was stirred at 80o C overnight and after work up the crude was purified via column 
chromatography. The product is obtained in an excellent yield of 92%. 
 
Scheme 2.27 – Synthesis of alkyne functionalised stopper, 84. 
Having shown that the formation of the proposed pseudo-rotaxane is indeed 
possible, it can be envisaged that following a successful templation/threading event of the 
barbiturate 83 through a macrocycle, followed by subsequent stoppering with the alkyne 
stoppers in a click reaction, a [2]-rotaxane will be produced which will be outlined in the 
following chapter. The method for the synthesis of a [2]-rotaxane is shown in Figure 2.20, 
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 Figure 2.20 – Proposed synthetic strategy towards click-stoppered [2]-rotaxanes. 
2.6.1.4 Dumb-bell Synthesis and Binding Study 
 In order to test the feasibility of the click reaction, a test reaction was carried out 
between the azide and alkyne substituents in the absence of any form of macrocycle as 
shown in Scheme 2.28. The azide was dissolved in degassed chloroform and the copper 
catalyst Cu(MeCN)4PF6 was added, and the solution stirred for one hour. The alkyne stopper 
was added and the reaction monitored via TLC. After 4 h, the starting materials had been 
consumed and following work up and purification via column chromatography the 
barbiturate dumb-bell 85 was obtained in 90% yield. 
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Scheme 2.28 – Synthesis of triazole barbiturate, 85.  
 The synthesis of a new dumb-bell shaped barbiturate guest, 85, has now been 
accomplished and this can be applied to the synthesis of rotaxanes via a clipping approach 
with acyclic receptors, which will be outlined in Chapter 4. In order to gauge the level of 
binding with Hamilton receptors, a binding study was carried out between 85 and 45.  
 
Figure 2.21 - Changes in electronic absorption spectra of receptor 45 in CHCl3 (C = 25 µM) on adding aliquots of 
85. Inset shows absorption changes at 315 nm upon addition of 85 from 0 to 70 equivalents.  
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 Monitoring the change in absorbance upon addition of 85 gave the binding constant 
and was found to be 4000 M-1, giving a logK of 3.6 at 298 K (Figure 2.21). A decrease in 
binding constant is expected when comparing with the smaller, and threadable guest, 83. 
Considering 85, this is probably because only a perched complex may be formed due to the 
inability of the dumb-bell to thread through the macrocycle resulting in a less favourable 
H:G interaction than observed with 83. This may pose further confirmation towards the 
perched nature of 53, due to its similarity in binding constant with 85. 
2.6.2 Click Reaction  Components - Active Templation Strategy 
 The use of click chemistry and active templation regarding the synthesis of 
interlocked structures has seen many examples over the past decade.24 For this reason, it 
seemed acceptable to apply this process towards our series of compounds. Considering 
Figure 2.22, if the Cu+ catalyst is able to bind in the active site of the receptor, via the 
pyridine groups, then an active template situation would arise, whereby two independent 
azide and alkyne stoppers may click together within the macrocycle.  Formation of a 
rotaxane will then have been achieved without the need for a barbiturate template.  
 
Figure 2.22 - Proposed synthetic strategy towards active template mediated [2]-rotaxanes. 
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2.6.2.1 – Stopper Synthesis 
The synthesis for both the macrocycle, 45, and alkyne funtionalised stopper, 84, has 
already been shown (Section 2.1.2.2 and Section 2.6.1.3). The only component for this 
approach which needed to be synthesised was the azide functionalised stopper (Scheme 
2.29). This was achieved starting from the stopper 48. The azide tosylate, 80, and 48 were 
dissolved in butanone. Heating of the mixture results in dissolution and then K2CO3 was 
added. The solution was stirred overnight at 70o C. Once cool, the suspension was filtered 
and the filtrate was concentrated to give the crude product. Purification via column 
chromatography afforded the pure, white product 86 in 62% yield.  
 
Scheme 2.29 – Synthesis of azide terminated stopper, 86. 
 These components were then taken through towards investigating their application 
towards click chemistry. To test the click reaction itself, in the absence of any receptor 
species, equimolar equivalents of the azide and alkyne stoppers, and the copper catalyst 
Cu(MeCN)4PF6 were dissolved in degassed CHCl3. The reaction was monitored via TLC and all 
the azide had been consumed after 2.5h. Subsequent work up and purification via column 
chromatography gave the ‘clicked’ product in high yield (Scheme 2.30) and was analysed via 
1H, 13C and mass spectrometry. 
Synthesis of the precursor components of non-photoactive Interlocked Structures 
 
103 
 
 
Scheme 2.30 – Synthesis of triazole linked dumbbell. 
 The 1H nmr spectrum in Figure 2.23 shows the pure product. The diagnostic peak at 
7.7 ppm shows the formation of the triazole ring, confirming the formation of the clicked 
product. 
 
 
Figure 2.23 – 1H NMR showing the product, 87, in CDCl3, 298 K. 
  
7 
6
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2.7 Conclusion 
 In conclusion, a number of host and guest molecules have been synthesised 
successfully through various strategies.  
2.7.1 Receptors 
The receptor molecules, both open and closed, have been synthesised with ease and 
allow different routes towards either catenanes or rotaxanes via clipping and/or stoppering 
methods. There is also great scope towards further variation in the chain lengths of these 
compounds to fine tune towards the strongest Host:Guest interaction, as well as reaching a 
‘goldilocks’ point between the ring, guest and stopper size i.e. where the ring size is great 
enough to cyclise around and/or accommodate the guest and yet, be small enough so as not 
to slip over the stopper groups.  
2.7.2 Guests (Flexible) 
Olefin-terminated flexible barbiturates were synthesised in simple steps and as 
expected, these showed binding to receptor 45. Stopper-terminated derivatives of these 
compounds were not synthetically possible via classical methods but triazole analogues 
were accomplished via ‘click’ chemistry. 
2.7.3 Guests (Rigid) 
 With regards to the rigid series of compounds, the olefin terminated form initially 
seemed too problematic and was discontinued due to the low yields and difficult synthesis. 
The stopper terminated compounds were also abandoned for the same reasons, despite 
attempts at optimisation using TBDMS stoppers. A protection strategy was attempted 
regarding the formation of rigid compounds. With the advent of this protection strategy 
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which utilised DMB-protected barbiturates and lead/boron exchange using protected 
boronic acids, the synthesis of stoppered, rigid barbiturates was achieved. One aspect of 
further work would be to reinvestigate the synthesis of previously challenging compounds 
using this new protection strategy. The hindering problems previously shown for the 
functional groups required may now be overcome via addition to the guest molecule at a 
late stage in the synthesis. 
2.7.4 Guests (Click compounds) 
 A series of molecules, including stoppers and guests have been synthesised allowing 
the application of click chemistry. The guest shows binding with the host receptor and the 
availability of crystal structures of the H:G interaction look promising towards the formation 
of an interlocked structure. 
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3 Synthesis of non-Photoactive Interlocked Structures 
3.1 Chapter Aim and Methodology 
This chapter concerns the attempted synthesis of ‘non-photoactive’ interlocked 
structures using an array of receptors and guest molecules whose synthesis was detailed in 
chapter 2. Table 3.1 summarises the various molecules and methods investigated.  
Table 3.1 – Various molecules and methods towards Hamilton-template interlocked structures. 
Entry Methodology Guest/Guest component Locking Method Receptor 
 
 
1 
 
 
Guest 
Threading 
(catenane) 
 
 
 
Guest 
Threading 
(rotaxane) 
 
 
 
 
 
Grubbs 
Metathesis 
 
 
 
 
 
 
 
 
2 
           
 
 
CuAAC 
 
 
 
3 
 
Active 
Template 
(rotaxane) 
 
 
 
CuAAC 
 
 
 
 
 
 
4 
 
 
 
 
Receptor 
Clipping 
(rotaxane) 
 
 
 
 
 
Grubbs 
Metathesis 
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The ‘methodology’ column describes the process used by either the guest or 
receptor to capture the interlocked structure. The next column shows the various guest 
molecules, with their stoppering counterparts included when required. The ‘locking 
method’ column shows the chemical reaction used to attempt the capture of the 
interlocked structure and the final column shows the complementary receptor required for 
the system. The active template strategy, entry 3, requires no barbiturate template and 
instead relies on the complexation of the copper catalyst within the macrocycle.  
Contained within this chapter are some studies carried out by our collaborators in 
Bordeaux. These include a series of stacked 1H NMR spectra of compounds 45, 83, 85 and 
rotaxane 88 and their complexes (Figure 3.10) as well as another stacked 1H NMR spectra 
comparing ‘perched’ vs ‘threaded’ components (Figure 3.11). A stability study of rotaxane 
88 (Figure 3.12) was also carried out in Bordeaux. 
3.2 Approaches Using Grubbs Metathesis 
3.2.1 Using Flexible Barbiturate Guests 
The first method to be investigated was the use of Grubbs metathesis as the locking 
reaction. The first approach was intended to build upon the project of a previous student, 
Mathias Rocher.1 This involved the use of the olefin-terminated flexible barbiturate 53, with 
the Hamilton-type macrocycle, 45, (Scheme 3.1) the syntheses of which have already been 
described in Chapter 2 (Scheme 2.8 and 2.4 respectively). 
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Scheme 3.1 - Scheme showing the proposed H:G interaction of complex 45:53 and subsequent clipping to 
form the desired catenane 45:53’. 
 The utility of guest 53 towards the capture of an interlocked structure requires the 
interpenetration of one pendant arm of 53 through the centre of macrocycle 45 prior to 
establishing the expected binding motif. Following on from this threading event, promoted 
by the complementary H:G interaction, subsequent cyclisation of the guest via Grubbs 
metathesis around 45 would form the desired catenane. Previous unsuccessful attempts 
had been carried out with a barbiturate linker length of 8-CH2 groups. Had this produced a 
catenane, this would have been the smallest ring size for an interlocked structure yet 
known, where the limit is typically 20-21 atoms.2 It was for this reason that this approach 
was reattempted with a longer chain of 9-CH2 groups.  
For the catenation experiment, equimolar amounts of 45 and 53 were dissolved in 
DCM to achieve a 1:1 H:G complex as proven by 1H NMR spectroscopy (Figure 2.5). It was 
thought that any kinetic barrier to threading would be overcome by gentle heating and so 
the flask was heated at 40o C for 2 hours, despite the potential for reduced H:G binding. 10 
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mol% of Grubbs (I) was then added to the solution and reflux continued for a further 2 
hours. Despite not observing complete consumption of the starting guest 53, the reaction 
was stopped due to the appearance of numerous spots when analysed by TLC, and so the 
reaction was cooled and the crude mixture was purified by column chromatography (eluent: 
DCM/MeOH - 0-4%).  
After purification, 28% of the starting barbiturate 53 was recovered. The 
metathesized guest, 53’, was isolated from the column in three subsequent fractions in the 
presence of 45 which could not be isolated as a single fraction. This was evidenced from the 
presence of signals for both 45 and 53’ (and trace amounts of 53) in a 1H NMR spectrum of 
each obtained fraction, which showed strong downfield field shifts of NH signals of both the 
host and guest. No pure 53’ was able to be isolated. At first glance, this would suggest the 
formation of a catenane, since non-interlocked structures would be expected to be 
separated by column chromatography. However, mass spectrometry of this mixture 
revealed no interlocked structure. Subsequent purification of the mixture gave the separate 
components confirming the absence of any interlocked structure. It would seem that 45, 53, 
and 53’ are able to move through a column with some degree of complexation, whether the 
guest is metathesized or not, and possibly in various modes and/or stoichiometries owing to 
the three distinct fractions isolated. Since no catenane was formed (at least not in any 
isolatable yield) we can postulate the formation of a ‘perched’ complex, where 53, despite 
binding to 45, exhibits little or no threading. Despite the sp3 nature of the carbon at the 5-
position of 53, both arms sit above the plane of the receptor, which is likely due to their 
length and inherent and required flexibility. In such a situation, ring closing metathesis 
would then only lead to two non-interlocked macrocycles as shown in Scheme 3.2. 
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Scheme 3.2 – Modified binding event, followed by a perched clipping resulting in two separable macrocycles. 
 The primary issue with this synthetic approach seems to be an inability of 53 to 
interpenetrate 45 prior to cyclisation. Due to this inherent difficulty surrounding the 
threading of such long, yet necessary tethers, this approach was abandoned in favour of a 
more directed approach utilising the previously discussed rigid barbiturates. 
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3.2.2 Rigid Barbiturate Guests 
                           
Figure 3.1- ‘Rigid’ Barbiturate guests 76 and 62. 
As mentioned in the previous chapter, it was anticipated that by introducing greater 
rigidity into the guest molecule at the sp3 carbon through the use of a phenyl spacer, then 
an orientation would be obtained which could be more favourable towards the formation of 
an interlocked structure. Considering the approach outlined in entry 4 of Table 3.1, the 
rotaxane would be achieved via clipping receptor 41 around the rigid, pre-stoppered thread, 
76, the synthesis of which was outlined in Chapter 2 in Scheme 2.23 and 2.24. Owing to the 
challenging synthesis and subsequent low yields of olefin terminated barbiturate 62, these 
were not investigated towards clipping with 41. 
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Figure 3.2 – Proposed binding mode of macrocycle 41 with guest 76, along with schematic representation. 
The proposed binding event and subsequent clipping reaction for the molecules 41 
and 76 is shown in Figure 3.2. To ensure the receptor was fully bound to the guest, an 
excess of three equivalents of 76 was used for the ring-closing reaction. The solution was 
heated to 50o C and then 1 mL of a 2.3 mM solution of Grubbs (I) in DCM was added 
dropwise to the reaction. After 2.5 hours, it was observed via TLC that all of 41 had been 
consumed and the reaction was stopped. 
Interestingly, two extra spots were present which were neither the 
compounds 42 or 76, as shown in the TLC, Figure 3.3. A 1H NMR spectrum of 
F2 showed the presence of a complex between 76 and some unknown form 
of receptor, lacking the CH-CH signals. Due to the pattern and shifting of 
observed peaks it can be postulated that this product results from 
some form of Wacker-Tsuji type oxidation of the double bond, forming 
an aldehyde. A subsequent TLC of this fraction in fact revealed two 
spots, and prepTLC resulted in the isolation of 76 and the oxidized receptor compound. A 1H 
Figure 3.3 – TLC of the 
crude mixture                                     
(eluent: DCM/EtOAc-10 %) 
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NMR spectrum of the other fraction (F1) revealed this to contain some form of complex 
between 42 and 76. This seemed a promising result as a potential candidate for a [2]-
rotaxane. However as observed previously, the components have been known to move 
together on TLC as perched complexes so a series of investigations were carried out, the 
first being analysis of the sample by mass spectrometry, in which no rotaxane product was 
detected. Instead, some thread fragmentation of 76 was detected, and only trace amounts 
of 42 and 76 were observed which meant that the presence of any interlocked structure via 
mass spectrometry was inconclusive. Interestingly, in order to rule out the detection of H-
bonded, perched complexes over their interlocked analogues, a sample was submitted of a 
premixed, 1:1 solution of the complex 42:76 and analysed by ES+. What can only be a 
perched complex was indeed observed and so care should be taken when inferring the 
interlocked nature of these structures from just a mass spectrum. 
 
Figure 3.4 – Diagram of prepTLC of the crude reaction mixture followed by TLC of F1, and addition of Barbital 
to F1 
A subsequent TLC of F1, as shown in Figure 3.4 afforded three further spots 
indicating that the components of F1 were in equilibrium with the complexes/components 
within F2 and F3. In an analogous case to that of these receptors with barbital, it would 
seem that again, there is some form of binding occurring that is not completely disrupted by 
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the purification process, either on a column or TLC plate. To test this, a TLC was prepared 
with two spots. The first consisted of a premixed solution of 42 and 76. The other single 
spot consisted of independent applications of 42 followed by 76. The first spot showed the 
characteristic 3 spots implying a degree of complexation. The second showed only the two 
spots of the respective components, indicating that the complexation must occur in solution 
prior to application to the TLC plate. In an attempt to disrupt this complex formation and in 
turn establish whether any rotaxane had formed, the competitive guest barbital was added 
to a solution of F1 (Figure 3.4). A TLC of this solution showed the disappearance of the 
42:76 complex (F1) found in the previous mixtures and instead only two component spots 
were observed. We can assume the barbital now complexes 42, inhibiting complex 
formation with 76. As described previously in chapter 2, when carrying out ring-closing 
metathesis in the presence of barbital it was observed to form a complex that did not 
dissociate under the purification conditions and the 42:Barbital complex was able to be 
isolated. 
These results suggest that for these conditions, the metathesis reaction involving 
rigid guests is not favourable towards the capture of an interlocked structure. There could 
be a number of factors inhibiting this process, but the major contributing factors are most 
probably due to the excess steric bulk added to the guest when two phenyl groups are 
attached. In the model shown in Figure 3.5, constructed in ChemBio3D Ultra, a simpler, rigid 
guest species has been used to highlight the level of steric interaction in the H:G complex, 
when cyclised.  
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It is evident that there is very little room for the guest molecule in the cyclised 
receptor which does not sit well in the binding cavity. From this it can be inferred that 
cyclisation in the presence of the rigid guest may be hindered, which means that cyclisation 
would only occur in those molecules whose position of equilibrium lies in the dissociated 
form of the complex i.e. when the guest is absent from the binding site. This is shown 
schematically in Scheme 3.3. 
 
Scheme 3.3 - Proposed reaction pathway towards the formation of a perched complex of 42:76. 
Figure 3.5 – Molecular model constructed in ChemBio3D Ultra between 42 and a simple bi-phenyl 
guest. 
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Another issue which was thought to possibly hinder the formation of a rotaxane is 
that of temperature. Initial binding studies between host and guest were carried out at 
room temperature; but binding could be less favoured at the 50o C required for the reaction. 
The series of test reactions at room temperature, discussed in chapter 2, show a diminished, 
but good yield of cyclisation at room temperature. Therefore, to remove any concerns over 
diminished complexation at reaction temperatures, the cyclisation with 41 in the presence 
of 76 was carried out at room temperature. 
Three molar equivalents of 76 were used with respect to 41 and the reaction was 
carried out in DCM at 6.6 mM, using 10 mol% of Grubbs (I) catalyst. Monitoring the reaction 
via TLC, there was no change observed after 2 hours and therefore stirring was continued 
overnight. After 16 hours there was still no change and the reaction was then worked up to 
return only starting materials. From this apparent inhibition of cyclisation at room 
temperature, it seems that complexation may indeed be an issue with regards to cyclisation. 
Despite seeing an increase in the yield of cyclisation when using barbital (a considerably 
smaller guest), the use of bulkier guests required for interlocked structures, hinders 
cyclisation. The ratio of bound and unbound guest will vary with temperature and at lower 
temperatures, the guest is favoured in the bound state and appears to inhibit metathesis. At 
elevated temperatures, there is less binding and so the amount of bound guest decreases, 
resulting in the observed metathesis. These unsuccessful attempts towards interlocked 
structures prompted a rethink in the strategy to be used. Since the inherent problem 
appears to be one of threading, which was not overcome through the use of rigid 
barbiturates due to their steric hindrance, a different strategy was proposed. 
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3.3 Approaches via Azide-Alkyne Cycloaddition 
3.3.1 Using Barbiturate Guests 
Another method for circumventing the problem of threading is to use shorter alkyl 
chains. If the carbon chain is relatively short, then the directionality imposed by the sp3 
carbon of the barbiturate should be more defined and the alkyl chains are able to sit 
through the plane of the macrocycle, threading more easily than their longer counterparts. 
It was thought that if a method could be proposed to stopper these short, threaded 
molecules, then an interlocked structure could be realised. It would therefore be necessary 
to consider alternative ways of locking the structure other than clipping the chains of the 
guest (entry 1, towards a catenane), since the macrocycle formed would be far too small to 
encompass the chain of the receptor.  
Considering entry 2 of Table 3.1, this involved the use of short chain barbiturates, in 
the expectation that threading would occur more easily using shorter appendages. As 
already discussed in chapter 2, the chosen method for stoppering was the Huisgen 1,3-
dipolar cycloaddition (CuAAC, or ‘click’ reaction), which required using the azide-terminated 
barbiturate, 83, as a means towards stoppering, once complexed with 45, via a coupling 
with the alkyne-terminated stopper group, 84. The synthesis of these components (Figure 
3.6) was previously outlined in Schemes 2.26 and 2.27. This method of bond forming has 
already seen extensive use in the field of interlocked structures owing to its high specificity, 
high yielding reactions and tolerance of various functional groups.3 In chapter 2, both the 
ability to from a threaded complex, 83:45, as well as the utility of 83 towards a click reaction 
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with 84 was established. The final step towards an interlocked structure was to combine 
these aspects and stopper the threaded complex, 45:83, as described below 
                                                    
 
3.3.1.1 Synthesis of a Barbiturate Templated [2]-Rotaxane 
 
Scheme 3.4 – CuAAC ‘click’ reaction between 45, 83 and 84 forming the [2]-Rotaxane 88, plus free guest 85. 
The click reaction has a wide scope of reaction conditions which may be used, 
including being carried out at room temperature, in CDCl3. The use of these conditions 
allows a good degree of certainty that the pseudo-rotaxane will be present in solution. A 
schematic for the reaction is shown above in Scheme 3.4. For the click reaction an 
equimolar, 56 mM solution of host and guest in CDCl3 was used. Two equivalents of 84 were 
Figure 3.6 – Molecules 84, 83 and 45 required for the Cu(I)AAC click reaction towards rotaxane formation. 
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added followed by, after a short period of stirring, a catalytic amount of Cu(MeCN)4PF6 and 
TBTA. The reaction was stirred at room temperature for 3 days and after removal of the 
solvent, the crude product was purified via column chromatography to give a 22% yield of 
rotaxane, 88, along with a 26% yield of the dumbbell component 85.  
 The structure of 88 is shown in Figure 3.7, followed by its 1H NMR spectrum with 
assignment of peaks and mass spectrum in Figure 3.8 and 3.9 respectively. Figure 3.8 clearly 
shows the presence of a 1:1, H:G complex and the mass spectrum of Figure 3.9 shows the 
presence of a H:G complex, however care should be taken when inferring its interlocked 
nature from this data. 
 
 
Figure 3.7 – Structure of [2]-Rotaxane, 88. 
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Figure 3.8 – 1H NMR (300 MHz) of [2]-Rotaxane 88 in CDCl3. 
 
Figure 3.9 – HRMS (ESI) of [2]-Rotaxane, 88. 
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3.3.1.2 1H NMR Studies of [2]-Rotaxane 88 
The rotaxane 88 was analysed in detail through a  series of 1H NMR experiments. 
Shown in Figure 3.10, the 1H NMR spectra of 88 and dumb-bell component, 85, have been 
added to the previous 1H NMR stacked plot of Figure 2.19. In comparing the spectra of 
45:83, (b)  and 88, (d), despite minor shifting of the aryl peaks, and a similarity in HN-H shifts 
of the amide protons, there is an observable downfield shift in the HN-H protons of the imide 
protons of 88 when interlocked. This indicates a stronger binding interaction in the 
interlocked structure vs the non-interlocked analogue.  
 
Figure 3.10 - Partial 1H NMR spectra (600 MHz) of barbiturate, 83 (a), pseudo-rotaxane, 45:83 (1:1, 10 mM) 
(b), receptor 45 (c),[2]-rotaxane 88 (d), and corresponding thread by-product, 85 (e) recorded at room 
temperature in CDCl3.4  
a) 
b) 
c) 
d) 
e) 
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Further evidence for the formation of an interlocked structure came from comparing 
the 1H NMR spectra of each individual rotaxane component, 85 and 45, the rotaxane, 88 
and a solution of non-interlocked host and guest, 45:85 (perched complex) as shown in in 
Figure 3.11. When comparing spectra (a) and (b) ([2]-Rotaxane and perched complex, 
respectively), one would expect many of the peaks to be almost identical, since almost all 
protons would be in fairly similar environments, regardless of any interlocked nature. This is 
mostly what is observed, with one exception; the signal for the NH protons of the guest 85 
is significant and shifted downfield by 4.7 ppm (from 8.0 – 12.7 ppm) when present as an 
interlocked motif. 
 
Figure 3.11 - 1H NMR spectra (300 MHz) recorded at room temperature in CDCl3 of the [2]-Rotaxane 88 (10 
mM) (a), mixture of barbiturate 85 and receptor 45 (1:1, 10 mM) (b), barbiturate 85 (c) and receptor 45 (d).4  
To investigate the stability of 88 and to determine whether the rotaxane could be 
synthesised via a slippage approach, a stability study was carried out. The rotaxane was 
a) 
b) 
c) 
d) 
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dissolved in DMSO-d6 (10 mM) and subsequently heated at 392 K over a period of several 
hours to ascertain if any dethreading of 88 from within the macrocycle could occur. The 
study is shown below in Figure 3.12. Due to the nature of the solvent, both 88 and 45 
experience a significant effect on their HNH signals. However, molecule:solvent interactions 
appear somewhat suppressed in the rotaxane, with a distinct upfield shift in the HNH signals. 
This can be considered further evidence for the strong binding interaction between 45 and 
85 when interlocked, due to the removal of the H-bonding solvent from around the vicinity 
of the binding site.  In contrast, the 1H NMR spectrum of the perched complex in DMSO-d6 
shows downfield HNH signals relative to the interlocked analogue, indicating a strong solvent 
interaction and a weak interaction between the two compounds. From the variable 
temperature study there is no evidence of any dethreading and the rotaxane can be 
considered thermally stable. Finally, it is worth noting that the spectrum recorded for the 
rotaxane in DMSO is almost identical to that in CDCl3, revealing that the H-bonding motif 
present in the complex is a relatively strong interaction, of the order of the 
molecule:solvent interactions when using a strong, H-bonding solvent. 
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Figure 3.12 - 1H NMR spectra (600 MHz) recorded at room temperature in DMSO-d6 of 85 (a), 88 (10 mM) 
after heating to 392 K for 0 min (b), 1h (c), 24h (d), 72h (e) and 45 (f).4  
3.3.2 Active –Template Synthesis of Unsymmetrical Rotaxanes [Cu(I)] 
As shown in entry 3 of Table 3.1, the approach of using a click reaction was also 
extended towards the synthesis of interlocked structures through an ‘active-template’ 
approach using the Hamilton motif as a Cu(I) binding site. This method of rotaxane 
formation has no other means of templation other than that of the Cu(I) ion and so this may 
not be considered as a barbiturate-templated rotaxane, but as a secondary route towards 
an interlocked structure using the Hamilton binding motif. Such a method to achieve 
rotaxane synthesis has been carried out previously using various macrocycles.3b, 5 The 
synthesis of these components (Figure 3.13) was outlined previously in Chapter 2, in 
Schemes 2.27 and 2.28. 
 
a) 
b) 
c) 
d) 
e) 
f) 
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The synthesis of 89 is outlined in Scheme 3.5. Receptor 45 was dissolved in 
chloroform and degassed for 10 minutes. Cu(MeCN)4PF6 was then added to the solution, 
forming a suspension which was stirred at room temperature for 1 h, followed by the 
addition of 1.2 equivalents of both stopper groups,  the alkyne, 84, and azide, 86. Upon their 
addition, a solution formed and a colour change to green was observed. After stirring 
overnight, a suspension had reformed and the workup consisted of adding 10 mL of 0.1 M 
KCN solution in methanol. There was an immediate formation of a white precipitate and 
after stirring for 1 h, the solvents were removed and the crude product was purified via 
column chromatography. No isolated starting materials, 84/86, were obtained from the 
column, only the non-interlocked dumb-bell, 87, macrocycle 45 and the [2]-Rotaxane, 89. 
Figure 3.13 - Molecules 84, 45 and 86 required for the Cu(II)AAC ‘click’ reaction towards rotaxane formation. 
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Scheme 3.5 – Reaction scheme for the formation of a Cu(I) templated [2]-Rotaxane 89 using Hamilton-type 
receptor 45. 
Regarding the bond forming reaction itself, the reaction clearly went to completion. 
However, it appears that it did not always occur within 45, leading to the formation of the 
non-interlocked products 45 and 87. One useful advantage of this method over previous 
methods, is the lack of any binding motif between the compounds 87 and 45 and so the 
problem observed with previous examples regarding possible perched complexation was 
not observed since any binding interactions present during the process of rotaxane 
formation do not ‘live on’ in the interlocked species. The rotaxane could therefore be 
isolated without any ambiguity over its interlocked nature.  
The 1H NMR spectrum of 89 is shown in Figure 3.14 along with an assignment of the 
major peaks. This clearly shows the presence of signals for both 45 and 87 in a 1:1 ratio. The 
mass spectrum of 89 is also shown in Figure 3.15 and supports the presence of the [2]-
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rotaxane via the peak at 1786. A TLC comparison of 45, 87 and 89 (eluent: Hexane/EtOAc-
20%) also gave a clear indication of the formation of an interlocked structure. 
 
 
 
 
Figure 3.14 – 1H NMR in CDCl3 of [2]-Rotaxane 89 with assignment of peaks. The receptor binding site is shown 
and labelled for clarity. 
 
 
Figure 3.15 - – HRMS (ESI) of [2]-Rotaxane, 89  
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3.3.2.1 1H NMR Studies of [2]-Rotaxane 89 
 
Figure 3.16 shows a series of stacked 1H NMR spectra showing receptor 45 (a), 
asymmetric rotaxane 89 (b) and the asymmetric dumb-bell 87 (c), respectively. When 
comparing spectrum (a) with (b), there is a clear downfield shift in the signals for both N-H 
protons, as well as for the Hc proton of the bridging phenyl group of 86. There is also a slight 
downfield shift in the triazole proton signal (H14) of interlocked 87 when comparing 
spectrum (c) with (b). Despite no specific H:G binding motif present, these downfield shifts 
are indicative of some level of interaction between the two interlocked components. The 
aryl region corresponding to the stopper groups has clearly become more complex, which is 
possibly due to the two stopper groups now residing in slightly different chemical 
environments. Due to the non-symmetric nature of 89, one might expect a situation where 
HN-H 
HN-H 
H14 
Hc 
a) 
b)  
c) 
Trace amounts of free 
thread 
Figure 3.16 – 1H NMR in CDCl3 of receptor 45 (a), [2]-Rotaxane 89 (b) and assymetric dumb-bell 87 (c). 
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45 does not sit perfectly in the centre of the thread, with respect to the stopper groups. 
From the chemical shifts observed in the 1H NMR spectrum, it appears that 45 is located at 
or around the triazole group (Figure 3.17). This would account for the increase in complexity 
of the signals relating to the stopper groups. 
 
Figure 3.17 – Proposed location of 45, on the thread of 89. 
Despite the adequate solubility of 89 in CDCl3 for spectral analysis, stacked spectra 
for probing any differences in perched/threading motifs was not possible due to the non-
interlocked component being insoluble. However, as mentioned already, despite some 
minor interactions observed due to their close proximity in space, there are no intrinsic H:G 
binding interactions by design, between the thread and macrocycle, as is observed for the 
barbiturate templates. Therefore it is highly unlikely that any perched complex could form. 
3.4 Conclusions and Future Work 
3.4.1 Conclusion 
A number of approaches, with varying successes, have been implemented towards 
the capture of an interlocked structure using Hamilton-type receptors, in most cases 
utilising barbiturate templation. Various methodologies were attempted, including those of 
threading-clipping, clipping, threading-stoppering and active templation. 
Synthesis of non-Photoactive Interlocked Structures 
130 
 
In the case of using flexible, olefin terminated guests, despite an observed H:G 
interaction, no capture of an interlocked structure was possible. This is due to what has 
been described as formation of ‘perched’ complexes, resulting in a clipping event producing 
two independent macrocycles only. Despite the observed H:G binding, it seems that there is 
not a strong enough driving force to favour the desired threading interaction and 
subsequently, this method was abandoned in favour of other approaches.  
So as to improve the likelihood of threading, attempts were made to increase the 
directional nature of the pendant arms using phenyl spacers at the sp3 centre of the 
barbiturate. Synthetic challenges prevented any attempts of a guest-clipping approach with 
the olefin-terminated barbiturate 62 and only an investigation involving guest 76 was 
accomplished. However, once again, despite an observed H:G complex between 76 and 41, 
no interlocked structure was isolated using Grubbs metathesis. This has been attributed to a 
steric effect, introduced by the presence of the phenyl spacers, preventing cyclisation of 41 
when present as a H:G complex. It is possible that an increase in the tether length to try to 
accommodate the increased bulk of the guest would lessen the steric burden. However, 
with an increase in length, the cyclisation yields could diminish. 
Circumventing the problem of threading was a key factor in the synthesis of 
barbiturate-templated rotaxanes. This was achieved by a move away from a metathesis 
approach towards one of click chemistry. By appending relatively short pendant arms to the 
barbiturate, the barrier to threading was overcome and formation of the desired pseudo-
rotaxane was achieved and confirmed via a crystal structure of the complex (Chapter 2, 
Figure 2.17). By employing the high yielding CuAAC reaction, an efficient stoppering event 
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of the threaded 83:45 complex was achieved and the synthesis of the first barbiturate-
templated rotaxane, using Hamilton-type receptors was realised. 
 Hamilton receptors were also employed in the synthesis of assymetrical rotaxanes, 
again employing the CuAAC reaction. The Hamilton receptor was used in an active template 
approach, via the complexation of the Cu(I) catalyst, thus allowing the click reaction to be 
performed within the macrocycle, resulting in the formation of a [2]-rotaxane. This method 
does not require the use of barbiturate templation, but highlights the utility of these 
Hamilton-type receptors as a scaffold for interlocked structures. 
3.4.2 Future Work 
The concept of clipping around a pre-stoppered guest, following a H:G binding event 
(such as the attempts of entry 4 of Table 3.1) may see much more synthetic utility in the 
growing field of interlocked structures than that of a stoppering approach, due to the 
increased array of novel architectures available. In order to expand and improve upon this 
method through the use of acyclic receptors, a different approach towards the required 
rigidity could be investigated. Through the use of different, and less sterically bulky spacer 
groups, it may be possible to overcome the issues already encountered. One candidate for 
this steric enhancement may be through the use of barbiturates with alkyne spacers, Figure 
3.18, which would still provide the desired rigidity and directionality, but are considerably 
smaller than the phenyl groups already used. 
Synthesis of non-Photoactive Interlocked Structures 
132 
 
 
Figure 3.18 – Proposed guest molecule to improve clipping approaches. 
Another aspect of future work to be considered is a different method towards the 
active template approach using a new series of host and guest compounds. This would 
involve a combination of H-Bonding and active templation. This modified approach, as 
shown in Figure 3.19, involves the use of asymmetrical receptor compounds, which have 
pendant arms terminated in both azide and alkyne groups. By combining these with 
barbiturate guests that contain a copper(I) binding site, it may be possible to use the CuAAC 
reaction to afford rotaxanes in improved yields, provided that long enough linkers are used 
to alleviate the issues already seen and accommodate the pyridine groups. 
 
Figure 3.19 – H:G binding event and subsequent ‘Click’ reaction of a potential route to a new [2]-Rotaxane. 
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4 Design and Synthesis of Photoactive Interlocked Structures 
4.1 Introduction and Background 
4.1.1 Fluorescence and Photochemistry 
The following chapter requires a brief outline and general understanding of the 
concepts of fluorescence and photochemistry and in this particular case, that of anthracene. 
Photochemistry is the study of chemical reactions that proceed with the absorption of light 
by atoms or molecules.1 Photochemistry governs a whole array of synthetic and physical 
properties and analytical techniques which are beyond the scope of this introduction, but a 
brief description of the fundamental processes involved is described as follows.  
For every molecule, a series of discrete energy levels exist which may be accessed by 
means of excitation. These energy levels are quantized, and have a specific value for 
different molecules leading to individual frequencies of radiation for absorption and 
emission processes. The Stark-Einstein law states that if a species absorbs radiation, then 
one particle is excited for each quantum of radiation absorbed, which gives us the notion of 
quantum yield, Φ. Quantum yield is defined as the number of molecules of reactant 
consumed per photon of light absorbed. This may be specified for a particular process i.e. 
fluorescence, Φf - the ratio of photons absorbed, to those emitted as fluorescence.2 
Considering the absorption of a single photon by a molecule in the ground state, and per 
the Stark-Einstein law, one molecule is excited for each quantum of radiation absorbed, and 
provided the incident photon is of sufficient energy, an electronic transition occurs, A, as 
shown in Figure 4.1. If it is of sufficient energy, an electron is promoted from its occupied 
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orbital to an unoccupied orbital of higher energy. The system is now at a higher energy and 
is considered an ‘excited state’. From here, any number of pathways may be utilised to 
return to the lower energy ground state through either radiative or non-radiative pathways. 
The Jabłoński diagram of anthracene, Figure 4.1, gives examples of these pathways and 
shows the singlet ground state, S0, singlet excited state, S1 and the triplet excited states, T1 
and T2 in bold, along with the vibrational levels of each discrete energy level. Radiation 
processes are shown in straight lines, non-radiative with waved lines. 
 Figure 4.1 - Jabłoński diagram depicting the various electronic states and processes of relaxation for an 
anthracene molecule. Processes are as follows: A: Absorbance, F: Fluorescence, P: Phosphorescence, IC: 
Internal Conversion, ISC: Intersystem Crossing, R: Vibronic relaxation, Sn: Singlet State, n = energy level, Tn: 
Triplet State, n = energy level. 
 After the initial absorbance of a photon, an electron is excited into a vibrational level 
of a singlet excited state, depending on the initial energy of the incident photon. A 
relaxation then occurs to the lowest vibrational energy level of S1. Every molecule will have 
its own particular lifetimes associated with each of the processes, and these specific 
lifetimes and relative energies of the excited states will lead to the favouring of various 
pathways. If internal conversion, IC, occurs, then the molecule simply relaxes to its original 
ground state, S0, with no radiative emission observed. Relaxation from S1→S0 results in 
emission of a photon producing fluorescence, F. The third pathway involves intersystem 
crossing, ISC, to the triplet excited state, T1, and this is where the spin of the electron is 
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changed. After relaxation to the lowest vibrational energy, a T1→S0 transition will result in 
emission of a photon, known as phosphorescence, P. ISC can also occur from T1, lowering 
the energy of the molecule via relaxation with no emission.2  
 There are other, less common ways in which an excited molecule may reduce its 
energy when in the presence of another molecule. PET, or photo-induced electron transfer 
can result in the transfer of charge via either intra- or intermolecular electron transfer. This 
phenomenon is utilised by plants in photosynthesis as well as in non-biological systems such 
as solar cells. Radiative energy transfer can occur, and involves the emission of a photon, 
which may be reabsorbed by a nearby molecule. Conversely, non-radiative energy transfer 
may occur between molecules through dipole-dipole interactions, or collisions. Finally, 
molecules in the excited state may reach lower energies via chemical reactions, such as 
dissociation leading to fragmentation, isomerization or reaction, the last of which will be the 
process of focus for this chapter. 
4.1.2 Anthracene and its Photochemical Properties  
 
Anthracene, 90, is a small, highly conjugated molecule consisting of three fused 
benzene rings resulting in a planar structure. It is a colourless compound, emitting blue 
fluorescence under UV light and is known to have interesting spectral and photochemical 
properties. The UV-Vis absorption spectrum is shown in Figure 4.2 with the fine structure of 
the S0→S1 band attributed to discrete vibrational transitions between the S0 and S1 states. 
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The energies of the various excited states, relative to S0 are shown on the diagram in Figure 
4.1. The S1→S0 transition has a value of 76 kcal mol-1 and the T1→S0, a value of 42 kcal mol-1. 
The T2 is only fractionally lower in energy than S1, with a value of 74 kcal mol-1 and this has 
significant implications regarding the physical and electronic properties of the molecule. A 
difference of only 2 kcal mol-1 means that ISC from S1 to T2 proceeds readily, with a 
quantum yield of 0.7. The quantum yield of fluorescence has been found to be 0.3 and 
therefore the sum of quantum yields for ISC and F combine to 1.3 Therefore, anthracene 
molecules in S1 are unlikely to relax via IC, indicating that this process is inhibited. 
 
Figure 4.2 - UV-Vis spectrum of anthracene4 in cyclohexane, showing absorption and emission lines, with the 
S0→S1 absorption and S1→S0 emission highlighted.  
In terms of photochemical reactions, a photon of visible light has a similar energy to 
that of some bond dissociation energies and therefore roughly corresponds to activation 
energies for various reactions to take place. In other words, the excited state may adopt a 
conformation and/or electron configuration favourable towards reaction, isomerization, 
etc. There is also the possibility of excited states having marked differences in acid/base or 
electrochemical properties. For instance, when an electron is excited it will be more easily 
removed from the molecule and conversely, the vacancy it leaves behind will be more easily 
S0→S1 
S1→S0 
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filled, so an excited molecule will experience a decrease in ionisation energy and an increase 
in electron affinity. When these excitations are carried out in solution, the close proximity of 
other molecules, including solvents, has a direct influence on the fate of the excited species 
and physical quenching may play a more significant role. If the neighbouring molecule is 
able to react with the excited species, then an intermolecular photochemical reaction can 
take place. There are numerous photochemical reaction pathways that a molecule may 
undergo, including isomerizations/rearrangements, inter- and intra-abstractions and 
photoaddition/cyclisation reactions.2 The latter is the property of focus for anthracene and 
is one of the oldest known photochemical reactions, first discovered by Fritzsche in 1867.5 
 When anthracene is present in solution, excimer formation can occur. An excimer, 
the formation of which was first recognized through the effects of fluorescence on 
increasing concentrations of solute, is a relatively long-lived dimeric interaction between an 
excited species and its ground state molecule. The dimerization of anthracene, A, and 
shown in Scheme 4.1, occurs via a singlet (S1) excimer, which collapses to a photodimer in a 
4π+4π pericyclic cycloaddition. The anthracene excimer shows weak fluorescence, so 
relaxation via emission is supressed and the system therefore reacts efficiently to the dimer, 
91. The process is shown in the following steps, where 1A* is the singlet excited anthracene, 
1(A-A)* is the excimer and A-A is the stable photoproduct.6      
 A + hν → 1A*  (1) 
     1A* + A → 1(A-A)* (2) 
1(A-A)* → A-A  (3) 
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Scheme 4.1 - Dimerization of Anthracene 
 The case shown above is clearly for free anthracene molecules. However, upon 
substitution at the 9 position, photodimerization can lead to two different structural 
isomers, depending upon the orientation of the substituents. The forms can either be head-
to-head (hh) or head-to-tail (ht) and are depicted in Figure 4.3.7 
 
Figure 4.3 – Dimerisation of 9-substituted anthracene forming its two structural isomers, and the reverse 
reaction reforming the starting material. 
In terms of cyclisation reactions, if tethers are implemented between the anthracene 
units, these molecules can now be considered as bichromophoric systems. For 
intramolecular reactions, concentrations <10-3 M are normally required to avoid any 
unwanted intermolecular dimerization.8 Following excitation of one anthracene unit in the 
system, then an excimer is again formed and dimerization will occur. The reaction can be 
considered a photocyclomerisation.9 As shown in Scheme 4.1, the photodimerization of 
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anthracene molecules, whether in a uni- or bimolecular arrangement is by no means a 
permanent arrangement. The photodimer is able to revert back to the parent molecule/s, 
either through the application of heat or by irradiation with shortwave UV light, <270 nm. 
The ease of return depends on the substituents present, and the conformation of the dimer 
(hh vs ht).7 
4.1.3 Applications in Supramolecular chemistry 
4.1.3.1 Non-interlocked Structures 
Owing to their interesting and well-studied optical and electronic properties, 
coupled with a relatively extensive scope towards synthesis and functionalistion, 
anthracene has found a broad use in the field of supramolecular chemistry, most notably in 
the field of chemosensors/devices. Chemosensors typically consist of two regions; a binding 
site is required, which will usually be tailored for a particular substrate/analyte, and a 
reporter group is used to signal the presence of the bound substrate. For a supramolecular 
device to function as such, there must be some variation in the level of observable output of 
the attached reporter group, be it a gradual increase/reduction in signal, or an on/off switch 
of the output. An example of an ON/OFF sensor is shown in Figure 4.4. The binding site will 
be tailored towards the complexation of specific analytes and in this particular case a 
reduction in signal from reporter group R is observed upon the presence of analyte, A, when 
bound in the binding site, B, thus indicating the presence of the analyte of interest.  
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Figure 4.4 – Generic schematic of a signal OFF chemosensor. 
This is considered a SIGNAL OFF sensor but in practice it is more beneficial to use the 
inverse scenario i.e., SIGNAL ON to mitigate ambiguous interpretations. This approach was 
applied towards the detection of biologically important alkali metal ions by A. P. de Silva 
and co-workers.10 The structure and detection process of the ion sensor, 92, is shown in 
Figure 4.5. 
 
Figure 4.5 – Anthracene based receptor as developed by A. P. de Silva. 
In the absence of a metal ion, fluorescence of the anthracene is quenched via photo-
induced electron transfer (PET) from the lone pair on the nitrogen of the monoaza crown 
ether.11 Upon binding, quenching no longer occurs and fluorescence is observed, indicating 
the presence of the metal ion. 
 Another application depicting the use of anthracene in supramolecular chemistry is 
the work carried out by Tucker et al.12 This involved utilising the Hamilton-type receptors 
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towards the photo-switched binding of barbital in chlorinated organic solvents (Figure 4.6), 
(for more detail see Figure 1.26) and although this was covered briefly in the introduction, a 
more thorough discussion of this example follows.  
 
Figure 4.6 – Photodimerization of anthracene terminated Hamilton receptors as demonstrated by Tucker et al. 
The acyclic receptors, appended with anthracene molecules, showed high binding 
constants with barbital. However, after photo-dimerization and formation of the 
macrocycle, the binding site was disrupted and no longer in an optimal geometry for H:G 
binding. For shorter linker lengths (n=3), the guest could therefore be expelled from the 
binding site upon photo-dimerisation. The data obtained regarding the binding constants in 
the cyclic and acyclic forms of these receptors is shown in Table 4.1 and clearly shows the 
differences in binding between the two forms, resulting in the observed photo-switched 
binding. The crystal structure of the dimerized receptors are shown in Figure 4.7 and 
highlights the source of the disturbance towards the binding of barbital where n=3, whereby  
the xylene units of the photodimer protrude into the binding cavity and release the barbital, 
evidenced by a three-fold decrease in binding constant. It should be noted that the longer 
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tether (n=6), despite some distortion in the binding site, experienced reduced changes in 
geometry and as a result, maintained a relatively good binding constant with barbital as a 
photodimer. 
Table 4.112 - Binding constants of bichromophoric hamilton receptors with barbital as determined in iCDCl3 at 
ca. 3.5 x 10-3 M by NMR spectroscopy, iiin CHCl2 at ca. 2 x 10-6 M by fluorescence spectroscopy and iiiin CHCl2 at 
ca. 2.5 x 10-5 M by UV-Vis spectroscopy. 
Tether Length (‘C’ - cyclised) Binding Constant 
3ii 38000 
3Ci 38 
6iii 71000 
6Ciii 26000 
This concept of photo-release of guest molecules upon irradiation offers a new and 
reversible binding motif, and mode of guest release, into the collection of photo-induced 
molecular processes.  
 
Figure 4.712 X-Ray crystal structures of dimerised receptors of varying tether lengths.  
4.1.3.2 Interlocked Structures 
 In the field of interlocked structures, the physical, electronic and chemical 
properties of anthracene have been used. The steric bulk of anthracene has been combined 
 
 n=3 n=6 
Design and Synthesis of Photoactive Interlocked Structures 
144 
 
with its electronic properties and utilised to great effect by the Leigh group.13 Here, the 
anthracene molecule was used as a stopper group for an isophthalamide macrocycle as 
shown in Figure 4.8. Originally intended as an ‘inactive’ model towards studies concerning 
electron and energy transfer, rotaxane 93 was found to exhibit photo-induced shuttling on a 
subnanosecond timescale, brought about by a rearrangement in the pattern of hydrogen 
bonds between thread and macrocycle leading to a shift of the latter from the peptide site 
toward the anthracene-9-carboxamide stopper which has a greatly enhanced hydrogen 
bonding affinity in the excited state. In H-bonding solvents, essentially identical absorbance 
spectra were obtained for the rotaxane and thread components, since the macrocycle is 
located on the alkyl spacer. However, in non-competitive solvents, the fluorescence of the 
rotaxane is considerably broader and more intense. This is thought to be due to 
conformational changes, as proposed by Werner and Rogers in their studies of the 
fluorescent properties of meso-substituted amidoanthracenes.14 They explained their 
observation by assuming that in the excited singlet state, the conformation changes from 
one in which the planes of the amide group and the anthracene ring are essentially 
perpendicular to a planar configuration, in which a considerable transfer of charge onto the 
carbonyl oxygen atom occurs, leading to enhanced hydrogen bonding. The photoinduced 
motion presented is of particular significance since light is considered an extremely 
convenient stimulus, when compared to other such photoinduced shuttling phenomena 
which require the use of external chemical reagents such as photo/redox-active 
components.15 
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Figure 4.8 – Proposed structures for photo-induced molecular shuttling 
 Further novel and interesting applications of anthracene related to interlocked 
structures were achieved through the inclusion of anthracene within the interlocked ring 
(rather than acting as a stopper group) in the synthesis of the squaraine rotaxane 94 (Figure 
4.9). When solutions of the rotaxane were irradiated in the presence of oxygen, quantitative 
formation of the corresponding endoperoxide was observed. These could be stored 
indefinitely at cool temperatures and upon warming would revert to the parent molecule 
via chemiluminescent endoperoxide cycloreversion. This process displays possible imaging 
applications in living subjects due to the molecule’s property of near-IR fluorescence.16 
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Figure 4.9 – Functional, squaraine rotaxane incorporating the use of anthracene.  
4.1.4 Chapter Aim and methodology 
Despite the wide ranging use of anthracene in interlocked structures found in the 
literature, up until now, its dimerization properties have not yet been attempted to be used 
in the ‘structure forming event’ towards the synthesis of such compounds. A 
photodimerization event of a bis-apended, bichromophoric molecule, as seen in the work of 
Tucker and others, produces a macrocycle. By utilising the photoactive Hamilton-type 
receptors and combining with appropriately functionalised barbiturate dumb-bells as shown 
in Scheme 4.2, these compounds are left open to exploitation regarding a clipping event 
towards an interlocked structure. 
   
Scheme 4.2 - Proposed scheme towards the clipping of barbiturate dumb-bell molecules via photodimerization 
of anthracene appended Hamilton receptors. 
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 As already discussed, care should be taken when selecting the appropriate tether 
length with reference to the ultimate ring size due to variations in binding constants and 
distortions of the binding site. From crystal structures already produced12, it was thought 
that a tether of 3 carbons alone could be too small to incorporate the guest as well as 
undergo photodimerization, since the guests used would be considerably bulkier than the 
barbital molecule already investigated. For this reason it was decided to synthesise a series 
of receptor compounds, containing tethers of length 3, 6 and 9 carbons for a full 
investigation towards photoactive interlocked structures. Since this method would involve 
the use of Hamilton-type chromophores, it was clear that only a clipping approach around a 
barbiturate would be applicable, so the barbiturates chosen to be investigated were the 
previously synthesised dumbbell shaped guest molecules, 76 and 85. 
                 
 Despite the problems already experienced with compound 76, regarding the failure 
to cyclise olefin-terminated Hamilton-type receptors via Grubbs Metathesis, it was hoped 
that this would be overcome in the case of photocyclomerisation since no bulky catalyst 
would be involved in the cyclisation event, only a single photon. 
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Contained within this chapter are some studies carried out by our collaborators in 
Bordeaux. A series of Job plots (Figure 3.17) and binding studies (Figure 3.18 to Figure 3.20) 
were conducted between receptor compounds 107, 108, and 109 with guest 85. A fatigue 
and stability study of rotaxane 113 were carried out (Figure 3.28 and 3.29), as well as a 1H 
NMR comparison between [2]-rotaxane 113 and the non-interlocked complexes of 
macrocycles 110, 111, and 112 with guest 85 (Figure 3.38). 
4.2 Synthesis and Spectral Analysis of Anthracene-Terminated Receptors and 
their Complexes 
4.2.1 Synthesis 
The synthesis of the barbiturate guests, 76 and 85, has been covered in Chapter 2. The 
synthesis contained within this section concerns the bi-chromophoric Hamilton-type 
receptors. Due to insolubility of the precursors, direct functionalization of the binding site 
motif was not possible and the anthracene terminated receptors were not able to be 
synthesised using the same approach as shown previously for the acyclic, olefin-terminated 
receptors. Conversely, for this series of receptors, the synthesis involved formation from the 
‘appended unit’ via functionalization of anthrone with the required tether, followed by 
construction of the binding site of the receptor. The synthesis was achieved in a total of 5 
steps, shown in Schemes 4.3 and 4.4. All reactions were conducted in the dark in order to 
prevent photo-oxidative cleavage of anthracene. Three different chain length receptors, of 
spacer length 3, 6 and 9 carbons between the receptor amide and terminal anthracene 
were synthesised as per literature procedures.12 
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Scheme 4.3 – Synthesis of anthracene terminated receptors up to NHS Ester derivatives. 
The first step in the synthesis is the functionalization of anthrone with the desired 
chain length of bromo-ester. The reagents were dissolved in acetone, K2CO3 was added and 
the mixture refluxed overnight. Purification via column chromatography afforded the ester 
compounds, 95-97, in varying yields. Formation of the acid followed via hydrolysis of the 
ester. This was accomplished using NaOH and refluxing overnight. The product was 
precipitated out of the reaction mixture using the slow addition of conc. HCl and once 
filtered, the product was used as obtained. Although 98 and 99 were obtained in good 
yields, this work up became problematic when isolating 100, since the increased chain 
length meant that a precipitate was more difficult to obtain. Instead, an extraction was used 
to isolate 100 from the crude mixture, which was pure enough to be used as obtained. The 
NHS-activated ester was then formed in excellent yields using dicyclohexyl carbodiimide 
(DCC) as the coupling reagent. The reaction was refluxed for 3 days and monitored for 
completion by TLC. Once full conversion of the starting material was observed, the solution 
obtained after work up was cooled for 4 h on ice to precipitate the products 101-103 that 
required no further purification. 
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 The synthesis was continued as shown in Scheme 4.4. The series of NHS-activated 
compounds were reacted with 2,6-diaminopyridine in DCM and after refluxing for 5 days, 
the receptor precursors, 104-106, were isolated via column chromatography and obtained 
in varying yields. The final step was a reaction between tert-butyl isophthaloyl chloride, 39, 
with 2.2 equivalents of the chosen 2,6-diaminopyridine anthracene compound. Each 
reaction was carried out in THF under reflux conditions, using NEt3 as a base. Initially a 
reflux of 1-2 days was employed and monitored for completion by TLC via the consumption 
of starting materials. Once complete, and after the subsequent work up, the pure products 
were isolated via column chromatography to obtain 107 and 108 in acceptable yields to give 
a series of photo-active, acyclic Hamilton-type receptors. However, in initial attempts to 
generate the receptor 109, only a 6% yield was observed after refluxing for three days. No 
degradation occurred and the starting materials could be recovered. However, the yield 
greatly improved to 53% by the addition of catalytic DMAP and refluxing for three days. This 
observation opens up the possibility of increased reaction yields for the other compounds. 
Throughout the synthesis, the yields varied substantially between the different length 
chains and, with the exception of the initial step (and the final optimised step forming 109), 
a decrease in yield was observed with an increase in chain length. 
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Scheme 4.4 - Synthesis of anthracene terminated receptors, 107-109. 
4.2.2 UV-Vis Absorption 
The series of receptor compounds, 107, 108 and 109 were analysed by UV-Vis 
spectroscopy (DCM at 2.6 x 10-5 M). The band between 340-400 nm is the characteristic 
anthracene band, and the large peak at 270-330 nm is an absorbance of the pyridine rings 
of the receptor (Figure 4.10). The gap in signal at 298-304 nm is instrument error due to the 
switchover of scanners and the variations in intensity are probably due to operator error, 
arising from making up solutions and should be repeated before anything is inferred from 
the relatively large difference observed with 108. As would be expected, each trace is 
essentially identical, since the only difference between the three compounds is one of 
carbon chain length.  
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Figure 4.10 – UV-Vis absorption spectrum  of 107, 108 and 109 in DCM at 2.6 x 10-5 M and 298 K. 
4.2.3 Photo-dimerisation 
With the acyclic anthracene-terminated receptors characterised, attempts were 
then made to cyclise them via photo-dimerisation, Scheme 4.5. A solution of each receptor 
was made up to a concentration of 0.5 mM in DCM. It is imperative to exclude air from 
these reactions due to an unwanted side reaction of photo-oxidation, which causes 
cleavage of the anthracene groups, converting them to anthraquinone. The receptor 
solutions were then subjected to UV radiation using a water-cooled mercury lamp with a 
bandpass filter at 365 nm.  
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Scheme 4.5 - Cyclisation of acyclic anthracene terminated receptors via photodimerisation. 
The dimerization was followed using UV-Vis absorption spectroscopy via the 
disappearance of the characteristic 3-fingered anthracene absorption band. Shown in 
Figures 4.11-4.13 are the UV-Vis traces for the dimerization process of compounds 107-109. 
In all three cases it was not possible to totally exclude oxygen and so degradation of the 
receptor would increase with time. Therefore, the irradiation was stopped once the signal 
had been sufficiently reduced to minimise any further degradation which left trace amounts 
of acyclic receptor still present. The solvent was then removed and in each case, the residue 
purified via column chromatography to give excellent yields of dimerised receptor. By 1H 
NMR, only one product was isolated which was thought to be the ht isomer12 due to the 
much lower thermal stability of hh photodimers induced by the additional steric and oxygen 
lone-pair repulsions (absent in a case of ht dimers).  
One noticeable difference between traces is the time taken for the dimerization 
process. Despite the trend being one of decreasing dimerization time with increasing chain 
length, this is probably not due to any steric or kinetic components of the molecules 
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themselves, but a physical aspect of the experimental procedure and is due to variations in 
UV flux from the apparatus between different experiments. This could be confirmed 
through repetitions of the experiments. 
 
Figure 4.11 - Change in electronic absorption spectra of solution of 107 in DCM over 2 days upon irradiation at 
365 nm at 298 K. 
 
Figure 4.12 - Change in electronic absorption spectra of a solution of 108 in DCM over 11.5 hours upon 
irradiation at 365 nm at 298 K. 
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Figure 4.13 - Change in electronic absorption spectra of solution of 109 in DCM over 2 hours upon irradiation 
at 365 nm at 298 K. 
By comparing the 1H NMR spectra of the starting material and product (Figure 4.14), 
the dimerization is clearly observed. The distinctive anthracene signals at 7.41 ppm are 
completely absent in the product and have been replaced by the xylene signals at 6.69 and 
6.92 ppm. Also present in the product is the characteristic bridgehead proton at 4.55 ppm. 
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Figure 4.14 – 1H NMR spectra comparing 109 and 112 regarding the signals present before and 
after photodimerisation. 
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4.3 Interactions with Guest Molecules 
4.3.1 Guest 76 
To determine the ability of the macrocycles to act as hosts, a series of 1H NMR 
spectrometry experiments were conducted to create a stacked spectrum of the receptor, 
108, the rigid barbiturate 76 and a 1:1 mixture of the two components, 108:76 . The 
interaction is shown in Scheme 4.6 and the stacked 1H NMR spectra are shown in Figure 
4.15. From the observed shifting of the NH peaks of 108, it is clear that an H-bonding 
interaction is occurring and the complex 108:76 is present in solution. 
 
Scheme 4.6 - Host:Guest interaction of receptor 108 with guest 76. 
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Figure 4.15 – A series of 1H NMR spectra showing the complex 108:76 (a), 76 (b) and 108 (c) in CDCl3 at 5 mM 
and 298 K. 
4.3.2 Guest 85 
 
Figure 4.16 – Host:Guest interaction of receptor 108 with guest 85. 
A series of binding studies were carried out to characterise the strength and modes 
of binding between these receptors and the previously synthesised guest molecule 85. 
a 
b 
c 
108:76 
108 
76 
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4.3.2.1 Job Plot 
The first study consisted of a series of Job plots as shown in Figure 4.17, plotting the 
binding induced absorption changes of the pyridine band at 310 nm. 
 
 
 
 
 
 
 
As can be seen from the binding curves, a maximum absorbance change occurs at a molar 
fraction of 0.5, confirming a 1:1 H:G interaction for each of the receptors, as would be 
expected for this motif. 
4.3.2.2 Binding Studies 
 In order to establish the strength of interaction, titrations with the guest molecule 
were carried out and monitored via UV-Vis absorption spectroscopy. Shown in Figures 4.18 - 
4.20 are the UV-vis spectra for the titrations for receptors 107, 108 and 109  with guest 85. 
0
0.1
0.2
0.3
0.4
0 0.5 1
[1]/([1]+[62])
0 0.5 1
[1]/([1]+[64])
0 0.5 1
[1]/([1]+[63])
c) a) b) 
Figure 4.17 - Job plot showing binding induced absorption changes (310 nm) as a function of molar fraction of 
receptor compounds 107 (a), 108 (b), and 109 (c) in their binding with 85 ([C]tot = 50 uM) in CH2Cl2. 
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Figure 4.18 – Changes in electronic absorbance of 107 upon addition of 85 up to 40 equivalents in CH2CL2 (C = 
34 µM), at room temperature. Inset shows the increase in molar absorption coefficient at 315 nm upon 
addition of 85. 
 
 
 
 
 
Figure 4.19 - Changes in electronic absorbance of 108 upon addition of 85 up to 20 equivalents in CH2CL2 (C = 
37 µM), at room temperature. Inset shows the increase in molar absorption coefficient at 315 nm upon 
addition of 85. 
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Figure 4.20 - Changes in electronic absorption spectra of receptor 109 in CH2Cl2 (concentration = 24 μM) on 
adding aliquots of barbiturate 85. Inset shows the increase in the observed molar absorption coefficient at 315 
nm upon addition of 85. 
Analysis of the complex-induced red-shifting of the pyridine absorption band of the 
receptors at 315 nm allowed determination of the binding constants. Summarised in Table 
4.2 are the results of these titrations, and for comparison purposes, the binding constants 
with barbital have been included.  
Table 4.2 – Table displaying the obtained binding constants of receptors 107, 108 and 109 with guest molecule 
85 in DCM, and for comparison purposes, those of barbital (in chlorinated organic solvents) obtained 
previously. 
Receptor Binding Constant [log(K)] with 
Barbital 
Binding Constant [log(K)] (+/-5 %) 
with 85  
107 4.57 4.47 
108 4.85 4.74 
109 - 4.81 
 Comparing the binding constants of the receptors with 85, and although these 
values are close to the limit of experimental error, a slight trend appears, where the binding 
constant is seen to increase with increasing tether length. This is what was observed in the 
previous studies with barbital12 and can be explained in terms of sterics. When decreasing 
the tether length, then the bulky anthracenes are located closer to the binding site and as a 
result, will have an increased steric effect on the H:G binding interaction. When comparing 
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between the two guests, a decreased binding constant is observed for guest 85. This again 
can be explained in terms of sterics, since despite having the same central binding structure, 
85 is considerably more bulky, which would make binding less favourable. 
4.4 Attempts Towards Rotaxanes using Receptor 108 
4.4.1 Size Constraints 
Building upon previous work carried out by the Tucker group,12 compound 108 was 
chosen to be investigated first in attempts to form a photo-rotaxane. This length of tether 
was chosen because of the nature of photo-switched binding and subsequent binding 
constants exhibited after photodimerization. A linker of 6 carbons as found in 108, once 
cyclised, was shown to have the least decrease in binding with respect to a three carbon 
linker (Table 4.1). If the binding with the barbital moiety was still relatively strong in the 
dimerized form, then one would expect there to be minimal disruption to the binding site 
upon dimerization, which would provide a cavity of sufficient size to facilitate cyclisation in 
the presence of the guest. However, it is important not to make the ring too large, 
otherwise it would be impossible to form an interlocked structure due to slippage of the 
dumbbell through the macrocycle. The photoproduct of the n=6 linker, compound 111, 
gives a ring size of 33 atoms for the hh dimer and a ring size of 36 atoms for the more stable 
ht dimer which is thought to form. In fact, 33 atoms is of the order of what is observed with 
other interlocked systems utilising stopper 48,17 and attemps to isolate rotaxanes with 
higher ring sizes of 41 atoms (i.e. of a similar size to 112) could not be isolated,18 even with 
bulkier biphenyl stopper derivatives. In addition, for longer linker lengths, there would be 
less of a driving force towards dimerization and the process of polymerisation may be 
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favoured, or the clipping event may not occur around the axle of the dumbbell, clipping in 
only a perched conformation due to increased flexibility. For these reasons receptor 108, 
was used in the initial investigation. 
4.4.2 Dimerization in the Presence of 76 
The initial attempt towards rotaxane formation used the bulky guest, 76. This guest 
was used since it was hoped that, for the same reasons as applied to the metathesis ring 
closure (Chapter 3), that the directionality imposed by the phenyl groups would aid the 
clipping process around the thread and not under it. It was anticipated that the triethylene 
glycol units would place the stopper groups away from the site of dimerization, so as not to 
sterically hinder the process. 
 
Scheme 4.7 – Proposed process of photodimerization of 108 in the presence of 76 
The planned H:G interaction and subsequent photo-induced clipping event is shown 
in Scheme 4.7. For the dimerization experiment, a receptor solution of 0.5 mM in degassed 
DCM was made up, followed by the addition of three molar equivalents of the rigid 
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barbiturate, 76. The flask was purged with argon and then the solution was irradiated at 365 
nm as described before (Section 4.2.3). Dimerization was followed via UV-Vis spectroscopy, 
by monitoring the decrease of the anthracene band over time. The UV-Vis spectrum is 
shown below in Figure 4.21. For the UV-Vis analysis, a 50 µL aliquot of the reaction solution 
was taken and diluted up to 1 mL to give a concentration 2.53 x 10-5 M. 
 Initially, UV-Vis measurements were taken periodically over a series of hours. 
However, no substantial reduction in anthracene signal was observed until the reaction had 
been irradiated overnight. Irradiation was therefore continued over a period of days along 
with regular monitoring of the system, and eventually the anthracene bands were observed 
to eventually decrease, as would be expected for a dimerization event.  
 
Figure 4.21 – Change in electronic absorbance of 108 in the presence of 3 equivalents of 76 in DCM, upon 
irradiation at 365 nm over several days 
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After more than 3 days of continuous irradiation, it appeared that the dimerization 
was complete. The solvents were removed and the crude mixture analysed by 1H NMR. 
However, from the spectrum obtained, it was discovered that this decrease in signal was 
found to be due to degradation of the anthracene, forming anthraquinone, rather than 
dimerization.  
The reason for this lack of photo-dimerization is probably similar to the ring closing 
metathesis experiment already discussed. Under these conditions the guest is clearly bound 
at the receptor site; however complexation must inhibit dimerization since it occurs readily 
in the absence of this guest, over a period of a few hours (Figure 4.12). When the 
macrocycle is dimerised it forms a ring size of 36 atoms (for the ht dimer) and the 
metathesized receptors form a similar ring size of 35 atoms. So despite the optimism 
regarding the lack of a bulky catalyst which may have possibly been hindering the cyclisation 
event, it seems that the ring size may simply be too small to accommodate the bulkier rigid 
dumbbell barbiturate, 76. The steric bulk of the guest might prevent the formation of an 
excimer, which is essential prior to dimerization as shown in Scheme 4.8. A secondary 
consideration is that for the favoured ht dimer, the xylene units protrude into the cavity, 
which would disfavour cyclisation due to the steric bulk of 76.  Therefore it may be the case 
that the initial hh dimer is formed, whose conformation may accommodate the guest, but 
due to its low thermal stability, it reverts to the open form in situ and is unable to be 
isolated and the following prolonged and continuous photoexcitation of the anthracene 
then eventually leads to its degredation. A larger macrocycle would be needed to 
accommodate the guest, however this increases the probability of slipping and therefore, it 
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appears that the rigid guest, 76, is too sterically hindered to function as an appropriate 
template towards the formation of an interlocked structure.  
 
 
Scheme 4.8 - Process of degradation of 108 when in the presence of 76. 
4.4.3 Attempts toward an Interlocked Structure with Guest 85 
Since it has been shown that, at least in terms of its size and inclusion within the 
binding site, that rotaxane formation is indeed possible with the short-chained triazole 
linked barbiturate, 85, (Chapter 3) rotaxane formation through photodimerisation was now 
attempted with this guest. 
4.4.3.1 Dimerization in the presence of 85 
The dimerization was carried out at the usual concentration of 0.5 mM for the 
receptor, in degassed DCM. The anticipated process is shown in Scheme 4.9. The 
dimerization was attempted using receptor 108 and irradiation was carried out at room 
temperature in the presence of 85. Three molar equivalents of 85 were used to ensure 
complete complexation of the guest, to maximise the yield of potential rotaxane. As before, 
a wavelength of 365 nm was used to achieve the dimerization and the progression of the 
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reaction was monitored via UV-Vis absorption using diluted aliquots of reaction mixture at a 
concentration of 2.50 x 10-5 M.  
 
Scheme 4.9 – Proposed complexation and subsequent dimerization event, between 108 and 85, towards a 
photo-clipped [2]-Rotaxane. 
The UV-Vis spectrum that illustrates the dimerization process is shown in Figure 
4.22. The dimerization was monitored periodically and after an irradiation time of 5.5 h, 
there was no further reduction in the anthracene signals and the dimerization was 
considered complete. Due to the time of completion, it is clear that the photoreaction is 
considerably more efficient compared to guest 76 and in fact is faster than for 108 alone. 
Considering that the guest should be completely bound, it is clear that dimerization is by no 
means hindered with these triazole linked guests and this was a promising result, so long as 
the guest wasn’t so flexible that dimerization could occur in a perched conformation. 
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A TLC of the white solid obtained showed the presence of a small amount of 
unreacted receptor (Rf = 0.48, eluent: DCM/EtOAc-15%) as well as a new spot at a higher Rf 
(Rf = 0.66, eluent: DCM/EtOAc-15%). This fraction was isolated by column chromatography 
(eluent: DCM/EtOAc-5%) and then purified further by prep TLC to afford the reaction 
product. 1H NMR analysis of the solid revealed the presence of both host and guest 
compounds, occurring in a 1:1 ratio from their integrations, as would be expected for the 
formation of a [2]-Rotaxane. This fraction was isolated in 66% yield and the proposed 
structure of [2]-Rotaxane, 113, is shown in Figure 4.23. It should be noted that no free 
dimerized receptor, 111, was isolated from the reaction mixture which is a good indication 
of the level of binding occurring between the host and guest. It also shows how with 
sufficient exclusion of air from the reaction mixture, potentially all of macrocycle 108 may 
be converted to rotaxane 113. 
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Figure 4.22 - Change in electronic absorbance of 108 in the presence of 3 equivalents of 85 in DCM, upon 
irradiation at 365 nm over 5.5 hours 
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Figure 4.23 – Proposed structure of a photo-clipped [2]-Rotaxane, 113 
 
 
Figure 4.24 - 1H NMR (300 MHz) of 113 in Acetone-d6 at room temperature 
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Shown in Figure 4.24, is the 1H NMR spectrum in acetone-d6 of the isolated fraction 
along with the assignment of peaks. The N-H peaks are shifted downfield, to 9.4 and 9.6 
ppm, (the NH of the guest was not observed in acetone-d6) indicating H-bonding in the 
complex and are not included in the figure. 
As had been observed in some previous attempts, it was possible for the H/G 
components to move as non-interlocked H:G complexes during purification by column 
chromatography. To remove any concern over this possibility, a TLC was carried out 
between the isolated fraction 113 and a premixed solution of components, 111 and 85. As 
shown in Figure 4.25, when compared to a premixed solution of dimerized host and guest 
(perched complex) it is clear that the complex 113 is a single, interlocked component 
whereas the perched complex dissociates.  
Further evidence supporting the isolation 
of an interlocked structure came from the mass 
spectrum, Figure 4.26. Only trace amounts of the 
molecular ion peak at 2392.3 were observed. 
However, peaks at 1197.2 and 1197.7 clearly show 
the presence of a +2 molecular ion peak, with the 
same analogous pattern of peaks at 798.4 and 798.8 showing the +3 molecular ion peak. 
Obviously, differences of 0.5 and 0.3/0.4 mass units cannot occur due to singularly charged 
molecules and must be due to a +2 and +3 molecular ion of the rotaxane, respectively. 
Figure 4.25 – TLC comparing a premixed solution 
of 111and 85 against isolated fraction 113 
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Figure 4.26 – ES+ Mass Spectrum of isolated product, 113. 
 It can be seen from the mass spectrum that there are also small amounts of 
receptor and dumb-bell present at 1378.0 and 1013.5. It can be assumed that these are due 
to fragmentation of the rotaxane. 
4.4.3.2 Analysis of 113 by 1H NMR Studies 
 Despite the strong evidence for an interlocked structure from the 1H NMR 
spectrum, TLC comparisons and mass spectrum, to alleviate any uncertainty over the 
presence of a perched vs an interlocked compound, a series of 1H NMR spectra were carried 
out as shown in Figure 4.27. Three separate solutions were made up in DCM-d2; the first 
solution (a) consisted of a 1:1 mixture of the acyclic host, 108, and the independent guest, 
85, to allow a comparison of changes before and after dimerization. The second (b) 
consisted of the proposed photo-clipped rotaxane, 113 (b). The third solution, (c) was a 1:1 
mixture of dimerised host, 111, plus the independent dumb-bell, 85, which can only form a 
perched complex. Despite a better resolution of peaks for the rotaxane in acetone-d6, DCM-
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d2 was used for the comparison due to solubility issues for the non-interlocked 85 in CDCl3 
and acetone-d6.  
 
Figure 4.27 – 1H NMR (300 MHz) comparison between the H:G complexes 108:85, 113 and 111:85 at a 
concentration of 5 mM in DCM-d2 at 298 K, including schematics of the proposed structures present. 
 The analysis reveals that there is some very minor variation between each spectrum 
in the alkyl region, with a slight shifting of most peaks observed, but nothing indicative of 
any specific interaction. Similarly, within the range of 6.5 - 8.3ppm, there are also generally 
minor changes observed for both the receptor (e.g. the pyridine protons) and the dumbbell. 
However, the bridgehead proton, Hbridge, (q in Figure 4.23) formed upon photo-dimerization 
and present in the spectra b) and c), experiences a small but significant shift of ∆δ = 0.3 
ppm. This implies a slightly different environment for the binding sites of the perched and 
threaded forms. Also, it seems as if the symmetry of the structure is maintained, since no 
extra peaks are observed, which would be expected if the complex became unsymmetrical.  
Hbridge 
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The most prominent change in the comparison of each spectrum concerns the imide 
NH protons of the receptor (the HNH signal for 85 has been excluded due to its significant 
shift to ~12 ppm). In all spectra there is a degree of H-bonding present, which is apparent 
due to the shifts of the HNH peaks relative to the free receptors (cf Figure 4.14), but each 
signal is shifted by a different amount depending on the specific H:G interaction. In 
comparing the shifts of spectra a) and c), the interactions with the acyclic hosts appear 
significantly stronger, due to the increased downfield shifts of the signals. This fits with what 
would be expected, since stronger binding should be observed with the acyclic form due to 
the ability of the guest to be fully inserted into the binding cavity. In contrast with the 
perched complex, 111:85, formed with cyclised receptors, the barbiturate guest can only sit 
above the plane of the receptor. 
An even greater HNH downfield shift is observed for 113 (Figure 4.27b), relative to 
both 108:85 and 111:85. This can be rationalised in the same way in that the guest is 
internalised into the cavity as part of the rotaxane, with should result in a stronger 
interaction. This data shows that when in the interlocked form, the macrocycle is still bound 
through H-bonding to the guest, even with the probable intrusion of the xylene units into 
the cavity. This is backed up by the downfield shift of the bridgehead proton, which resides 
close to the binding site and is clearly considerably affected by the structural constraints 
imposed by the interlocked structure. 
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Figure 4.28 – 1H NMR spectra (300 MHz) recorded at room temperature in DMSO of 85 (a),  [2]-Rotaxane 113 
after heating to 353 K for 0 min (b), 15h (c), 39h (d), 63h (e) and receptor 111 (f). 
 Shown above in Figure 4.28 is a temperature study, regarding the [2]-Rotaxane 113 
(b)-(e). The molecular components: free guest 85 (a) and free macrocycle 111 (f) are 
included for comparison purposes. The study was conducted in DMSO and hence a strong 
downfield shift is observed initially for the NH resonances. Although the NH shift of the 
guest experiences no difference in shift in DMSO when either free or interlocked, 
interestingly, the NH peaks of the receptor are shifted further downfield when interlocked 
as part of the rotaxane, showing a significantly strong interaction when in this 
conformation. The rotaxane was monitored over a period of 63 h at a temperature of 353 K. 
The rotaxane shows fairly good stability at this temperature. However, after 38 h, secondary 
NH peaks appear, which may be the product of either degredation, or cycloreversion. From 
a) 
b) 
c) 
d) 
e) 
f) 
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the emergence of the multiplet at 7.5 ppm, it can be concluded that the rotaxane is indeed 
opening up into its constituent acyclic receptor, releasing the guest. 
To elaborate upon this thermal opening to the acyclic complex, a fatigue study was 
conducted. A solution was made up in degassed DCM, consisting of the acyclic receptor 108 
and the dumb-bell guest 85 in a ratio of 1:40. The solution was irradiated at 365 nm for 1 h 
to achieve photodimerization of 108. The solution was then be heated to 110o C for 14 h to 
cause the thermal return of the cyclic complex. The results are shown in Figure 4.29 and 
indicate that despite a significant amount of degredation the system is able to withstand 
several cycles. 
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Figure 4.29 – Fatigue study of complex 108:85 (40:1) in degassed CH2Cl2 (25 x 10-6 M 
monitored by UV-Vis absorption. Each cycle corresponds to an irradiation at 365 nm 
(1 h) resulting in photodimerization followed by thermal return (110o C, 14 h). 
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4.5 DOSY NMR 
4.5.1 Background 
Diffusion-ordered NMR spectroscopy (DOSY) is based on a pulse-field gradient spin-
echo (PGSE) NMR experiment and was first developed by Tanner and Stejskal in 1965.19 The 
PGSE sequence is shown in Figure 4.30. 
 
Figure 4.30 - Pulse-gradient spin-echo experiment used for DOSY NMR 
The initial net magnetization is orientated along the z-axis. What follows is a 90o 
radio frequency (RF) pulse which rotates the magnetization into the x-y plane. A pulse 
gradient of duration 𝛿 and magnitude G is then applied at a time point t1 and each spin 
experiences a phase shift. A subsequent 180o RF pulse reverses the sign of processing and 
phase angle, and a second gradient is applied at t1+∆ which is of equal duration and 
magnitude to the original pulse. If diffusion has occurred, then the phase shift experienced 
after the initial τ, will be different to that experienced after the second τ. This is due to each 
species being located in a different spatial position along the z-axis between times t1 and 
time t1+∆ and as a result, each species will experience a different magnetic field, dependent 
on its relative positions. The phase angle will therefore fan out, refocussing will be poor and 
a reduced echo signal will be recorded as a direct result of diffusion. Note: if no diffusion 
occurs, then the spins are refocused after the 180o RF pulse (and subsequent G) and there 
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will be no attenuation of the signal. In essence a gradient pulse is used to encode the spatial 
positions of nuclear spins, and a second matched gradient pulse decodes positions.20 
Relating this to a specific sample, for a given mixture containing different 
components, each component will have a different translational diffusion coefficient, 
related to its hydrodynamic radius and molecular weight, a product of Brownian motion. 
This value relies on any number of factors such as size, shape, mass and charge, as well as 
external factors such as solvent, temperature, aggregation etc. Essentially, field gradients 
are used to make the sample experience a different field in different parts of the NMR tube 
and as molecules diffuse during the acquisition process, they experience a different field 
depending on their relative motion. The more a molecule moves, the more different the 
field it experiences and this will decrease the intensity of the signals.20 Attenuation of the 
spin-echo and a Fourier transformation of the half echo permits diffusion rates to be 
associated with individual lines in the NMR spectrum.20 In terms of mixtures, the signal of 
each component will decay over time and this rate of decay will vary depending on the 
factors listed above. 
 A DOSY spectrum, obtained from the PGSE experiment provides a means for ‘virtual 
separation’ of mixtures and displays this diffusion data in a 2D matrix and a two-
dimensional spectra is produced, with one dimension being the standard chemical shift and 
the other displaying that specific molecules diffusion behaviour. In general, it is assumed 
that the larger the molecule, the slower the diffusion coefficient. For well resolved spectra, 
the diffusion coefficient is obtained, after suitable experimental and processing methods, 
with good accuracies of 0.2%. 
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4.5.2 Applications 
 One of the more widely used applications of DOSY NMR is the identification of 
individual species in multi-component solutions, which involves ‘separating’ spectra with 
similar or overlapping chemical shifts based on their individual diffusion properties and has 
been used by Jayawickrama et al. in the identification of polymer additives.21 This concept 
of in situ, spectroscopic separation has earned it the nickname ‘NMR chromatography’.20 
DOSY has seen many applications including the characterization of reactive intermediates,22 
as well as extensive use in determining accurate molecular weights from mixtures in 
polymer chemistry,23 the petrochemical industry24 and of nanoparticles25. The technique 
can also be used for signal suppression, such as that of water signals in aqueous solutions26, 
of course, as long as the molecule in question has a different value of diffusion compared 
with water. 
 As well as its use in medicinal,27 polymer and material science, DOSY NMR has a 
particular appeal towards supramolecular chemists, and specifically in the field of 
interlocked structures28, 28b where a proof of their interlocked nature is required. Molecular 
interactions, the essence of supramolecular chemistry, may be probed by any number of 
spectroscopic techniques and of these; DOSY NMR can prove a powerful tool providing 
information unavailable by other means. Diffusion coefficients not only give an idea of the 
presence of H:G systems and interlocked structures, but also their physical properties and 
interactions, since their diffusion coefficient will also vary due to their shape, size and 
intermolecular interactions. DOSY also enables chemists, given the right binding modes and 
conditions, to deduce binding and association constants from diffusion data. 
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4.5.3 DOSY NMR of [2]-Rotaxane, 113, and its components 
In order to gain further insight regarding the interlocked nature of 113, as well as its 
physical behaviour in solution, a series of 1H DOSY NMR spectra were recorded for the 
various components. These consisted of the photo-clipped rotaxane, 113, the dumb-bell + 
cyclic receptor (perched) solution, 111:85, as well as solutions of free dumb-bell, 85, and 
free cyclic receptor, 111. The spectra are shown in Figures 4.31-4.34. The value obtained for 
each solution gives the linear diffusion coefficient and gives some idea of how the molecules 
and/or complexes diffuse in solution, with lower values meaning a slower rate of diffusion. 
It should be noted that solutions of equivalent concentrations are essential, since the 
diffusion is affected not just by molecular mass, but also by external factors i.e. viscosity.  
Using solution concentrations of 27 mM and the solvent DCM-d2 throughout, the first 
coefficients to be calculated are that of the individual components, 85 and 111. Shown in 
the figures below are the DOSY spectra of 85 (Figure 4.31) and 111 (Figure 4.32). The 
diffusion coefficients were found to be 0.31 x10-9 m2s-1 and 0.65 x10-9 m2s-1 for the dumb-
bell, 85, and macrocycle, 111, respectively. The diffusion coefficients of the solvent, DCM-
d2, in each case were found to be 3.1 x10-9 m2s-1 and 3.3 x10-9 m2s-1 respectively.   
Design and Synthesis of Photoactive Interlocked Structures 
179 
 
 
 
                                    
Figure 4.31 - 1H DOSY NMR of 85 at a concentration of 27 mM in DCM-d2  Figure 4.32 - 1H DOSY NMR of 111 at a concentration of 27 mM in DCM-d2  
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Figure 4.33 - 1H DOSY NMR of 113 at a concentration of 27 mM in DCM-d2           Figure 4.34 - 1H DOSY NMR of 85:111 at a concentration of 27 mM in DCM-d2
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The rotaxane, 113, was then analysed. The spectrum obtained is shown in Figure 
4.33 and the coefficient was found to be 0.38 x10-9 m2s-1 with a consistent solvent value 
found to be 3.2 x10-9 m2s-1. The most important aspect of this result was the fact that a 
single diffusion coefficient was found for the complex, giving further evidence to support its 
interlocked nature. The final comparison to be made was a mixture of the guest, 85, and 
macrocycle, 111, to try to distinguish the two molecules based on their independent 
diffusion rates. This comparison was important due to the fact that two separate diffusion 
coefficients should be obtained since any complex formed will not be interlocked, and be in 
a state of equilibrium. The spectrum obtained is shown in Figure 4.34. As expected, two 
separate values were obtained for each component. 85 was found to have a value of 0.35 
x10-9 m2s-1 and 112, 0.43 x10-9 m2s-1. Again, a consistent solvent value of 3.1 x10-9 m2s-1 was 
found. The summary of results is shown in Table 4.3, below. 
Table 4.3 - Various results of diffusion coefficients, obtained via 1H DOSY NMR, of 85, 111, 113 and 85:111  
 Linear Diffusion Coefficient (x10-9 m2s-1) 
Entry 
 
Concentration, mM Dumb-bell  
Mr = 1379.9 
85 
Macrocycle  
Mr = 1011.3 
111 
Rotaxane  
Mr = 2391.2 
113 
Solvent 
   (DCM-d2) 
 
1 
 
27 
 
0.31 
 
0.65 
 
0.38 
85 – 3.1 
111 – 3.3 
113 – 3.2 
2 27 0.35 0.43 - 111:85 – 3.1 
3 50 - 0.62 - 111 - 3.2 
4 96 0.20 - - 85 - 2.6 
5 50 - 0.43 - 111 - 2.5 (CDCl3) 
 
Using the table for comparison, it is now clear to see that the variations in molecular 
weight and shape alter the diffusion coefficient. When comparing 85 with 111 at 27 mM 
(entry 1), the larger and considerably more bulky dumbbell diffuses slower than the 
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macrocycle. At constant concentrations, a consistent diffusion coefficient was found for the 
solvent.   
 Highlighting the importance of a consistent concentration, when the concentration 
of solution was altered, so too did the diffusion coefficient. This is highlighted by entry 4, 
where a solution of 85 was used at a concentration of 96 mM in DCM-d2. Comparing with a 
concentration of 27 mM (entry 1) there is a reduction in diffusion coefficient for both the 
molecule under consideration and solvent. This is an expected result, since in a more 
viscous solution, both solute and the solvent will be diffusing slower relative to one another, 
resulting in a lower diffusion coefficient. A similar argument can be made for varying 
solvent. When comparing entries 3 and 5, which consist of 50 mM solutions of 111 in DCM-
d2 and CDCl3 respectively, the diffusion coefficient for both solute and solvent are observed 
to decrease in the case of CDCl3. This can be explained via the known viscosities of the 
solvents. DCM has a viscosity of 0.41 cP with chloroform having a higher value of 0.54 cP.29 
An inherently more viscous solution will show decreased diffusion coefficients when 
compared to less viscous samples and this is what was observed.  
When comparing the independent diffusion rates of macrocycle, dumb-bell and 
rotaxane, one would expect a step-wise decrease with increasing molecular weight. 
However, despite the trend holding when comparing 111 and 113, in fact a higher value 
than expected for the rotaxane was found, which diffuses faster than 85. However, at this 
point it is important to state that there are many factors, both intrinsic and external, which 
affect the diffusion coefficient, besides molecular weight. It could be possible that any 
solvent-solute interactions, due to the polar regions present in the components of the 
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rotaxane, are reduced and/or occupied in the interlocked form due to the presence of H-
bonding, folding of the complex, etc. This concept is supported by the notable presence of 
H-bonding in the complex, observable via 1H NMR, see Figure 4.27. This may be analogous 
to the situation observed under TLC comparison, Figure 4.25, where the rotaxane and non-
interlocked H:G complexes would diffuse up the TLC plate faster than the free components. 
Size may also be a contributing factor, not just the lack of interacting groups and it is 
feasible that the rotaxane is folded into a smaller shape and conformation when interlocked 
and therefore diffuses faster than its free components. 
Another important comparison to be made is between the free and mixed 
components, perched complex 85:111 (entry 2). As expected, when a mixed solution was 
analysed, two independent diffusion coefficients were observed, clearly visible on the DOSY 
NMR in Figure 4.34. The values for 85 and 111, were found to be 0.35 and 0.43 respectively, 
which differ from the values obtained as independent solutions, despite identical conditions 
of temperature, solvent and concentration. This can be rationalised due to the occurrence 
of complexation between the host and guest molecules. This is also evident from the NH 
shifts of the amide protons in the ‘perched’ spectra in Figure 4.27. The only variable 
between each sample was the presence of each molecules corresponding H-bonding 
component. If we consider that some degree of complexation is occurring, it appears as if 
the faster diffusing 111 is ‘held back’ by the slower 85 and inversely the slower diffusing 85 
is ‘sped up’ through solution by 111, due to their H-bonding behaviour. Despite this 
interesting result, the most important aspect concerning this experiment was the presence 
of two values for the diffusion of the two independent components. Comparing this DOSY 
2D-spectrum to the one obtained for the rotaxane, where a single diffusion coefficient was 
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obtained and therefore, a single compound is present, it can be concluded that the 
molecule, 113, is in fact interlocked and not moving as a complex.  
4.6 Attempts Towards Dimerization with Different Length Tethers 
In an attempt to expand upon the utility of this photo-clipping method, the n=3 and 
n=9 linker receptors, 107 and 109, were investigated to establish their abilities to form 
photo-rotaxanes. Only guest 85 was used in these attempts, owing to the fact that it has 
already shown its ability towards the synthesis of interlocked structures. 
4.6.1 Attempts with Anthracene Receptor 107 (n=3) 
The first receptor investigated was 107 and as before, it was dissolved in degassed 
DCM to form a 0.5 mM solution. As done previously 3 equivalents of 85 were added and the 
flask was then irradiated at 365 nm. The dimerization was monitored periodically using UV-
Vis spectroscopy. The UV-Vis spectrum is shown in Figure 4.35.  
 
Figure 4.35 - Variation in electronic absorption spectra of 107 in the presence of 85 in DCM upon irradiation at 
365 nm. 
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Based on previous observations, concerning the issues observed during the 
dimerization of 108 with the rigid barbiturate 76, for the time taken to obtain such a 
meagre reduction in signal, it was clear that the dimerization was unable to occur. Further 
evidence for this lack of dimerization was found from periodic analysis by TLC of the 
reaction solution. An anthraquinone spot was observed to increase over time, showing 
increasing degradation of the receptor, and so irradiation was stopped and the solvents 
were removed. The crude 1H NMR spectrum confirmed the lack of any dimerization 
whatsoever, and only 107, 85 and the products of oxidation (accounting for the reduction in 
signal) were observed. These were separated via column chromatography. Over the period 
of irradiation, there is very little decrease in anthracene signal and this appears to show a 
similar trend to that observed with the rigid dumbbell, 76, Figure 4.21. This highlights the 
relationship between the tether length, which affects the capability of cyclisation. Despite 
guest 85 showing the capability of forming interlocked structures when dimerizing with a 
receptor of sufficient tether length (n=6, compound 108), upon reduction of the length, the 
guest is now too big for the receptor to cyclise around it  as shown in Scheme 4.10. 
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Scheme 4.10 - Proposed scheme for the failed clipping attempt of 107 with 85. 
This result is not unexpected and it has been previously shown by Tucker,12 that the 
n=3 linker receptors show photo-switched binding of barbital (a much smaller guest), with 
the guest released upon cyclisation. Therefore in this case, the guest prevents the 
anthracene from coming into close enough proximity to cyclise and so the formation of an 
interlocked structure is not possible with this combination of components. This could 
however, be considered as guest-mediated, on/off photo-dimerization. 
4.6.2 Attempts with Anthracene Receptor 109 (n=9) 
It was anticipated that increasing the tether length between amide and anthracene 
groups to nine carbons would allow a more facile route towards the rotaxane due to 
minimization of any steric hindrance from the guest. It was also thought that this could 
promote the situation where the macrocycle would be large enough to no longer favour 
strong H-bonding with the clipped guest and so move away from the binding site upon 
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dimerization under certain conditions. This would be advantageous towards applications 
regarding shuttling or the synthesis of [n]-Rotaxanes, provided the dumb-bell linker groups 
could accommodate this.  
The photo-clipping process was therefore attempted with the n=9 linker, 109.  A 0.5 
mM solution of 109, in degassed DCM was used and after the addition of three molar 
equivalents of 85 the solution was irradiated at 365 nm and the dimerization monitored via 
UV-Vis spectroscopy as before. The UV-Vis spectrum obtained for the dimerization is shown 
in Figure 4.36. It is clear that the dimerization is extremely efficient, and faster than 
observed for the free receptor (Figure 4.13), with no further dimerization occurring after 1.5 
h. 
 
Figure 4.36 - Variation in electronic absorption spectra of 109 in the presence of 85 in DCM upon irradiation at 
365 nm. 
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After 2.5 hours of irradiation, the solvents were removed and a TLC 
of the reaction mixture (eluent: DCM/EtOAc-10%) revealed two major 
components (Figure 4.37). Subsequent column chromatography and 1H 
NMR revealed these to be the dimerised receptor, 112 and the non-
interlocked dumb-bell, 85. Trace amounts of 109 were 
isolated and interestingly, this was the only dimerised 
compound which could be separated from its acyclic isomer due to a different Rf. Despite a 
successful and highly efficient dimerization, the components were returned, clearly in a 
non-interlocked fashion. It seems that when using n=9 tethers, an interlocked structure is 
not possible, at least not with this particular guest and clipping method. In this case, the 
dimerization was clearly not hindered, so steric factors regarding the guest can be ruled out, 
and as far as irradiation time was concerned, an increase in efficiency of the system appears 
to have been achieved, albeit lacking the target rotaxane.  
  
Scheme 4.11 - Proposed scheme for the failed clipping attempt of 109 with 85. 
85 
112 
109 
Figure 4.37 - TLC of the reaction 
mixture 
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The simplest explanation for this data is that the macrocycle is too large for the 
capture of an interlocked structure and may be due to one of two proposed reasons as 
outlined in Scheme 4.11. The first, route a, is the possibility of conformations available 
which are not favourable for the capture of an interlocked structure. Due to the increased 
length of tether, it is feasible that the anthracenes may orientate themselves away from the 
guest and essentially clip together in a perched conformation, resulting in the isolation of 
separable components. The second potential route, b, is the possibility of slippage of the 
dumbbell over the macrocycle, a consequence of the increased ring size. The ring size 
obtained upon cyclisation is approaching the limit regarding this size of stopper group, so 
the dimerization may occur around the axle of the dumb-bell, but is unable to stay 
interlocked. If this process is occurring in situ, then it may be worthy of further 
investigations with these 9-C tethers centred around larger stopper groups since 
dimerization is clearly not disfavoured by complexation of 85. 
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4.6.3 Summary of Perched complexes 
 
Figure 4.38 – 1H NMR spectra (300 MHz) at room temperature in CD2Cl2 of 113 (a) and 1:1 complexes of 
111:85 (b), 112:85 (c) and 110:85 (d) at concentrations of 5 mM. 
Expanding upon this notion of a slippage event the series of perched complexes 
were investigated. From the summary of spectra in Figure 4.38, comparing rotaxane 113 
(n=6) and the formation of perched products, between the three various cyclised receptors 
and guest 85, it is clear from the apparent shifts of the receptor NH signals that spectra of 
111:85 (Figure 4.38.b) and 110:85 (Figure 4.38.d) do indeed show the formation of perched 
complexes due to their relative differences in spectra, when compared to [2]-Rotaxane 113. 
Considering the spectrum of 112:85 (Figure 4.38.c), however, two independent sets of 
signals are present for the NH protons (12.49 and 10.05 for the imide NH protons of the 
guest and 9.70, 8.75 and 9.25, 8.32 for the two NH protons of the receptor) and this 
denotes the presence of two separate complexes which are forming in situ. One of the sets 
a) 
b) 
c) 
d) 
113 
111:85 
112:85 
110:85 
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of signals correlates to what can be considered a strong interaction analogous to that of a 
threaded complex. This is potentially the formation of a pseudorotaxane via a slippage 
event which appears to be unable to be isolated, due to the increase in ring size. 
4.7 Conclusion and Future Work 
4.7.1 Conclusion 
In conclusion, what may be considered the first reported capture of an interlocked 
structure, via a light-triggered photo-dimerization, has been demonstrated through the use 
of bichromophoric Hamilton-type receptors and appropriately functionalised barbiturate 
guest molecules. Proof of the molecules interlocked nature has been shown using 1H NMR 
spectral analysis, 1H DOSY NMR and mass spectrometry. Minor attempts towards the 
optimisation of rotaxane formation through variations in ring-size have been attempted; 
however, these seem to have been hindered via either steric constraints or increased 
flexibility and it seems that the ideal ring size was found originally, (n=6). 
Aside from unsuccessful attempts regarding different receptors, other failed attempts 
included the use of guest 76, probably due to increased steric hindrance near the binding 
site for this guest. 
Future work to be carried out on compound 113 should initially consist of fine tuning 
the ring-size through variation in the tether length, for example, 4, 5 or 7-C linkers and 
optimisation of the size of the stopper moiety, which may provide higher yielding and more 
stable products. Possible capture of the proposed slippage product of 112:85 could also be 
considered, however, this would be unstable at room temperature. 
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Greater understanding of why the other attempts failed may be garnered through 
further investigations of guests of various sizes and geometries and through the analysis of 
the specific photochemistry of the molecules and complexes. The determination of the 
presence of the excimer required for dimerization would also be beneficial. 
4.7.2 Future Work 
A further concept of exploration would be the synthesis of [n]-Rotaxanes via a multi-
dimerization event in order to create interesting topologies of these motifs and provide a 
route towards multiply functionalised rotaxanes. As shown in Scheme 4.12, if the 
barbiturate dumb-bell is created with a sufficiently long linker between the stopper groups 
and barbiturate, then there should be space on the axle to accommodate more than one 
ring. This will depend on many factors, especially whether or not the binding site is occupied 
more strongly by the first macrocycle than subsequent acyclic receptors. Despite rotaxane 
113 showing some degree of H:G binding, there is evidence that this should not necessarily 
localise at the binding site in the presence of acyclic receptor compounds, since dimerised 
receptors have been shown to have weaker binding with barbiturate guests when in their 
cyclised form. In the presence of another guest, or under different solvent conditions, the 
receptor could slip down onto the axle, leaving a binding site free for a subsequent 
dimerization event. There is also the mode of addition to consider; this process could 
feasibly be a one-pot reaction, using a large excess of receptor, or a multi-step process 
requiring subsequent addition of successive rings after purification of each [n]-rotaxane. 
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Scheme 4.12 – A potential multidimerisation event producing [n]-rotaxanes 
 Further, and more in-depth studies may be applied towards these systems using new 
functionalised guests to impart some functionality into the rotaxane, as well as the 
possibility of designing new and different receptors and/or guests to create an array of 
interesting structures. i.e. attachment to a surface, or multi guest and/or receptor 
compounds as illustrated in Figure 4.39.  
 
Figure 4.39 – Potential multicomponent systems towards alternate interlocked structures and possible surface 
applications 
Efforts could also be made to use this photo-clipping strategy towards current H:G 
motifs. Employing the use of considerably more studied systems, such as Beer’s anion 
templates,30 or Leigh’s fumarimide systems,31 could allow further advancements and 
functionalizations of these motifs, or towards new topologies of structures not yet 
obtained. 
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5. Experimental 
5.1  General 
All starting materials were purchased from Aldrich or Lancaster and solvents from 
Fischer and VWR. Commercially available solvents and reagents were used without further 
purification, except for Et2O, MeOH, THF, MeCN and DCM, which were dried in Pure SolvTM 
Solvent Purification Systems, and DMSO, which was dried using CaH2 and stored under 
argon and in the presence of molecular sieves. Unless otherwise stated, all reactions were 
carried out under argon atmosphere with the exclusion of moisture, and for reactions 
containing the anthracene molecules, the reactions were conducted in the absence of light, 
using tin foil, in degassed solvents. Thin layer chromatography plates were visualised under 
UV light, or by the stains potassium permanganate or ceric ammonium molydbate (CAM) 
and flash chromatography was carried out using silica gel (Merck, grade 60) using the eluent 
stated. 1H NMR spectra were recorded at 300 MHz on a Bruker AVIII300 spectrometer and 
13C NMR spectra at 101 MHz on a Bruker AVIII400 NMR spectrometer, at room 
temperature, unless otherwise stated. Chemical shifts (δ) are in ppm and coupling constants 
(J) are in Hz. Mass spectra were recorded with a Waters/Micromass spectrometer using the 
method stated. IR spectra were recorded neat on a PerkinElmer Spectrum 100 FT-IR 
spectrometer. 
[WARNING] - When conducting any azide chemistry, as a precaution, a blast shield was 
used during solvent removal due to the potentially explosive nature of low molecular weight 
azides.  
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Photochemistry of the anthracene moieties were conducted by making up solutions of 
the desired compound to a concentration of 0.5 mM in degassed DCM. The solutions were 
then irradiated using a Photochemical Reactors Ltd. 125W mercury arc lamp, which was 
enclosed within a housing with an outlet containing a 365 nm bandpass filter (Edmund 
Optics 65-615, 12.5 mm diameter, 10 nm bandwidth). The dimerization was monitored at 
set intervals through UV spectroscopy measuring the decrease in absorbance of the 
anthracene band at 320-400 nm. UV-Vis spectra were recorded using a Shimadzu 1800 
spectrometer using samples at 2.6 x 10-5 M. 
5.2 Experimental Procedures and Characterisation 
(5-tert-butyl Isophthaloyl Dichloride), 39  
Oxalyl Chloride (5.70 mL, 66.0 mmol) was added to a solution of 5-tert-
butyl isophthaloic acid (2.52 g, 11.3 mmol) in DCM (40 mL). The mixture 
was heated to reflux and 1 drop of DMF (approx. 0.05 mL) was then 
added. After 2 h under reflux the yellow solution was cooled and the solvents removed 
under vacuum to afford a yellow, oily solid. Unreacted oxalyl chloride was removed under 
high vacuum to afford 2.81 g of a beige solid in quantitative yield, no purification required. 
1H NMR (CDCl3, 300 MHz): δ = 8.72 (s, 1H, Ar), 8.41 (s, 2H, Ar), 1.42 (s, 9H, t-Bu). Analysis is in 
agreement with literature data.1 
(N,N'-bis-(6-aminopyridin-2-yl)-5-tert-butyl isophthalamide), 40  
Isophthaloyl dichloride, 39, was dissolved in dry THF (80 mL) and added dropwise over 2 h 
via syringe pump to a solution of 2,6-diamino pyridine (6.25 g, 57.0 mmol) and NEt3 (1.90 g, 
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19.0 mmol) in THF (40 mL). The solution was stirred for 16 h. The 
volatiles were then removed under vacuum. Water (200 mL) was 
added to the residue and the grey precipitate was filtered and 
washed with water (50 mL) and then ethanol (20% aq. solution). The 
crude product was purified via flash column chromatography on silica (eluent: DCM/THF 
3:1) to give 3.36 g of 40 (8.31 mmol, 75% yield). 1H NMR (300 MHz, CDCl3) δ = 8.36 (s, 2H, 
NH), 8.20 (t, J = 1.6 Hz, 1H, ArH), 8.13 (d, J = 1.6 Hz, 2H, ArH), 7.74 (dd, J = 7.9, 0.5 Hz, 2H, 
pyr), 7.55 (t, J = 8.0 Hz, 2H, pyr), 6.33 (dd, J = 8.0, 0.6 Hz, 2H, pyr), 4.38 (s, 4H, NH2), 1.42 (s, J 
= 8.0 Hz, 9H, tBu). 13C NMR (101 MHz, CDCl3) δ = 164.87 (CO), 157.16 (Cpyr), 149.80 (Cpyr), 
140.21 (CHpyr), 134.95 (C Ar), 128.02 (CH Ar), 122.44 (CH Ar), 104.75 (CH pyr), 103.66 (CH 
pyr), 31.20 (CH tBu), 25.61 (C tBu). Analysis is in agreement with literature data.2 
(5-tert-Butyl- N,N'-bis-(6-undec-10-enoylamino-pyridin-2-yl)-isophthalamide), 41  
40 (0.40 g, 0.98 mmol) was dissolved in dry THF (100 mL). NEt3 
(0.35 mL, 2.5 mmol) was added and the flask cooled to 0o C. A 
solution of 10-undecenoyl chloride (0.50 mL, 2.4 mmol) in THF (40 
mL) was added via syringe and the reaction was stirred overnight. 
The solvent was evaporated and the residue diluted in DCM (100 
mL). The organic phase was washed with sat. NaHCO3 (4 x 50 mL). 
The organic phase was separated and dried using MgSO4, filtered, 
and concentrated under vacuum to afford a yellow oil. Addition of hexane (approx. 10 mL) 
produced a cream solid which was filtered and washed with hexane to afford 0.48 g of 
desired product. (0.65 mmol, 65% yield). 1H NMR (300 MHz, CDCl3) δ = 8.41 (s, 2H, NH), 8.23 
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(s, 1H, ArH), 8.15 (d, J = 1.3 Hz, 2H, ArH), 8.08 (d, J = 8.0 Hz, 2H, CH pyr), 8.00 (d, J = 8.0 Hz, 
2H, CH pyr), 7.80 (t, J = 8.1 Hz, 2H, CH pyr), 7.70 (s, 2H, NH), 5.82 (ddt, J = 16.9, 10.2, 6.7 Hz, 
2H, CHCH2), 5.11 – 4.87 (m, 4H, CHCH2), 2.42 (t, J = 7.5 Hz, 4H, COCH2), 2.11 – 1.99 (m, 4H, 
CH=CH2CH2), 1.74 (dd, J = 14.6, 7.5 Hz, 4H, COCH2CH2), 1.44 (s, 9H, tBu), 1.42 – 1.26 (m, J = 
10.8 Hz, 20H, Alk). 13C NMR (101 MHz, CDCl3) δ = 178.14, 171.75 (CO), 164.90 (CO), 153.38 
(C pyr), 149.73, (Cpyr) 149.36 (C Ar), 141.15 (CH pyr), 139.11 (CH=CH2), 134.51 (C Ar), 128.34 
(CH Ar), 122.70 (CH Ar), 114.17 (CH=CH2), 110.09 (CH pyr), 109.75 (CH pyr), 37.79 (COCH2), 
34.11 (C tBu) 33.76 (CH2=CHCH2), 31.17 (CH3), 29.30 (CH2), 29.19 (CH2), 29.06 (CH2), 28.88 
(CH2), 25.33 (CH2). Mass Spectrum (ES+): calcd for C44H60N6O4Na [M+Na]+ m/z = 759.457, 
found m/z = 759.457. Analysis is in agreement with literature data 3 
(Z)-45-(tert-butyl)-2,6,8,29-tetraaza-1,7(2,6)-dipyridina-4(1,3)-benzenacyclononacosaphan-
18-ene-3,5,9,28-tetraone, 42 
A solution of Grubbs 1st Generation catalyst (27 mg, 0.034 mmol) 
in DCM (17 mL) was added dropwise to a solution of 41 (0.22 g, 
0.28 mmol) in DCM (53 mL). The reaction mixture was heated to 
reflux and stirred for 2 h. The mixture was cooled and any 
volatiles removed under vacuum to afford an oily brown solid 
which was purified using flash column chromatography (eluent: DCM/EtOAc - 0-10%) to 
afford 150 mg of solid (0.21 mmol, 68% yield). 1H NMR (300 MHz, CDCl3) δ = 8.39 (s, 2H, 
NH), 8.32 (s, 1H, ArH), 8.29 (s, 2H, ArH), 8.09 (d, J = 7.9 Hz, 2H, pyr), 7.99 – 7.93 (m, 2H, pyr), 
7.82 (t, J = 8.1 Hz, 2H, pyr), 7.65 (s, 2H, NH), 5.41 – 5.33 (m, 2H CH=CH), 2.41 (t, J = 7.5 Hz, 
4H, COCH2), 2.05 – 1.94 (m, 4H, CH=CHCH2), 1.82 – 1.70 (m, 4H, COCH2CH2), 1.43 (s, 9H, tBu), 
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1.39 – 1.27 (m, 20H, Alk). 13C NMR (101 MHz, CDCl3) δ = 171.87 (CO), 165.44 (CO), 153.87 (C 
pyr), 149.77 (C pyr), 149.57 (C Ar), 140.93 (CH pyr), 134.14 (C Ar), 130.46 (CH=CH trans), 
129.94 (CH=CH cis), 129.72 (CH Ar), 120.67 (CH Ar), 110.03 (CH pyr), 109.79 (CH pyr), 37.83 
(COCH2), 35.21 (C tBu), 32.14 (CH2=CHCH2), 31.02 (CH3), 29.45 (CH2), 29.29 (CH2), 29.14, 
29.05 (CH2), 26.91 (CH2), 25.50 (CH2), 25.34 (CH2). MS (ES+): calcd for C42H56N6O4Na [M+Na]+ 
m/z = 731.9, found m/z = 731.5. Analysis is in agreement with literature data 3 
45-(tert-butyl)-2,6,8,29-tetraaza-1,7(2,6)-dipyridina-4(1,3)-benzenacyclononacosaphane-
3,5,9,28-tetraone, 43  
42 (50 mg, 0.07 mmol) was dissolved in EtOAc (3 mL). Pearlman's 
catalyst (20 mg) was then added followed by NEt3 (6 drops). An 
H2 balloon was then added and the vessel sealed. The mixture 
was heated to 35o C and stirred for 16 h. The suspension was 
filtered through a plug of silica and washed with EtOAc. The 
filtrate was concentrated under reduced pressure to give 47 mg of pure 43 (0.06 mmol, 86% 
yield). 1H NMR (300 MHz, CDCl3) δ = 8.30 – 8.18 (m, 3H, NH and ArH), 8.08 (d, J = 8.1 Hz, 2H, 
pyr), 8.02 (d, J = 7.8 Hz, 2H, pyr), 7.91 (s, 1H, ArH), 7.83 (t, J = 8.1 Hz, 2H, pyr), 7.61 (s, 2H, 
NH), 2.42 (t, J = 7.4 Hz, 4H, COCH2), 1.76 (quint. J = 7.6 Hz, 4H, COCH2CH2), 1.44 (s, 9H, CH3), 
1.25-1.33 (m, 28H, Alk). 13C NMR (101 MHz, CDCl3) δ = 171.69 (CO), 165.19 (CO), 153.94 (C 
pyr), 149.70 (C pyr), 149.41 (C Ar), 141.03 (CH pyr), 134.57 (C Ar), 129.50 (CH Ar), 120.32 (CH 
Ar), 109.99 (CH pyr), 109.77 (CH pyr), 37.87 (COCH2), 35.28 (C tBu), 31.10 (CH3), 29.70 (CH2), 
29.08 (2 x CH2), 29.01 (CH2), 28.96 (2 x CH2), 28.82 (CH2), 25.37 (CH2). Mass Spectrum (ES+): 
cald for C42H58N6O4 [M+Na]+ m/z = 733.4417, found m/z = 733.4446. Elemental Analysis: 
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found: H, 8.43; C, 71.09; N, 11.91; calculated:  H, 8.22; C, 70.95; N, 11.82. mp: 
decomposition at 250o C. IR (neat, cm-1): 3422, 3314 (NH), 2992, 2851 (CH), 1677, 1585 (CO). 
(hexadecane-dioyl chloride), 44  
Hexadecane-dioic acid (0.33 g, 1.1 mmol) was dissolved in DCM (60 mL) and 
1-2 drops of DMF were added. The solution was cooled to 0o C and oxaloyl 
chloride (0.47 mL, 5.5 mmol) was added dropwise. The solution was heated to reflux and 
maintained for 2 h. The volatiles were then removed to afford a yellow oily solid, 44, in 
quantitative yield which was used in the next step without further purification. 
45-(tert-butyl)-2,6,8,25-tetraaza-1,7(2,6)-dipyridina-4(1,3)-benzenacyclopentacosaphane-
3,5,9,24-tetraone, 45  
Two solutions of hexadecane-dioyl chloride (0.74 mmol as obtained), 
in THF (20 mL) and NEt3 (0.53 mL, 3.8 mmol) and 40 (0.30 g, 0.74 
mmol) in THF (20 mL) were added simultaneously, over 2 h, to a 
round bottom flask containing THF (80 mL) and once the addition 
was complete the mixture was stirred for a further 16 h. The volatiles 
were then removed under reduced pressure to produce an oily solid. This was dissolved in 
DCM (100 mL) and washed with 1 M NaOH (50 mL). The separated organic phase was then 
washed with 5% NaHCO3 (3 x 50 mL), dried using MgSO4 and filtered. Concentration under 
vacuum afforded a cream/yellow solid which was purified via flash column chromatography 
(eluent: DCM/EtOAc - 0-10%) to afford 140 mg of solid (0.22 mmol, 30% yield). 1H NMR (300 
MHz, CDCl3) δ = 8.33 (s, 1H, ArH), 8.25 (s, 2H, NH), 8.12 (d, J = 7.5 Hz, 2H, CH pyr), 8.04 (d, J = 
Experimental 
203 
 
7.6 Hz, 2H, CH pyr), 7.88 – 7.80 (m, 3H, ArH and CH pyr), 7.63 (s, 2H, NH), 2.42 (t, J = 7.4 Hz, 
4H, COCH2), 1.83 – 1.73 (m, 4H, COCH2CH2), 1.44 (s, 9H, CH3), 1.40 – 1.24 (m, 20H, Alk). 13C 
NMR (101 MHz, CDCl3) δ = 171.80 (CO), 165.38 (CO), 153.60 (C pyr), 149.76 (C pyr), 149.52 
(C Ar), 141.70 (CH pyr), 133.70 (C Ar), 130.27 (CH Ar), 120.82 (CH Ar), 110.53 (CH pyr), 
110.16 (CH pyr), 37.74 (COCH2), 35.27 (C tBu), 31.12 (CH3), 29.34 (CH2), 29.10 (CH2), 28.67 
(CH2), 28.36 (CH2), 25.19 (CH2), 24.81 (CH2). MS (ES+): calcd for C38H50N6O4Na [M+Na]+ m/z = 
677.3791, found m/z = 677.3784. Analysis is in agreement with literature data 3 
(4-bromo-tert-butyl benzene), 46  
tert-butyl benzene (0.77 ml, 5.0 mmol) was cooled to 0o C. I2 (0.065 g, 5 mol%) 
was added and once dissolved, bromine (0.27 mL, 5.0 mmol) was added and 
stirred for 16 h. The reaction was then washed with sat. Na2S2O3 (40 mL), 
extracted with DCM (60 mL), dried using MgSO4, filtered and concentrated under vacuum to 
afford a clear oil (quantitative yield) which required no further purification. 1H NMR (300 
MHz, CDCl3) δ = 7.46 – 7.41 (m, 2H, ArH), 7.31 – 7.26 (m, 2H, ArH), 1.33 (s, 4H, CH3).  
tris(4-(tert-butyl)phenyl)methanol, 47  
In a 2-neck round bottom flask, Mg turnings (3.00 g, 83.0 mmol) were 
heated under vacuum with a heat gun and then allowed to cool under 
argon. The process was repeated two more times to ensure the 
removal of any moisture. To the flask, a spatula tip of iodine was added followed by dry THF 
(3 mL). A solution of 46 (8.48 g, 40.0 mmol) in THF (18 mL) was made up and 3 mL was 
added to the reaction flask. When the reaction was observed to initiate, the remaining 
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solution was added dropwise over 20 minutes to maintain auto-reflux. Upon full addition 
the solution was stirred for 2 h. Diethyl carbonate (1.56 mL, 13.4 mmol) in THF (2 mL) was 
added slowly over 20 minutes and the solution was left to stir for 16 h. The reaction mixture 
was then acidified to pH 7 with 1 M HCl and water (50 mL) was added. The organic layer was 
removed and the aqueous layer was washed with DCM (60 mL). The organic phases were 
combined, dried with MgSO4, filtered and evaporated to give a blue/white crude solid which 
was purified via crystallisation in hot hexane to give 3.51 g of 47, as a white solid (8.28 
mmol, 62% yield). 1H NMR (300 MHz, CDCl3) δ = 7.37 – 7.30 (m, 6H, ArH), 7.24 – 7.17 (m, 6H, 
ArH), 1.33 (s, 27H, CH3). 13C NMR (101 MHz, CDCl3) δ = 149.81 (C Ar), 144.17 (C Ar), 127.54 
(CH Ar), 124.70 (CH Ar), 34.45 (C tBu), 31.37 (CH3). HRMS (ES+). calcd for C31H40O [M]+ m/z = 
428.3, found m/z = 428.4.  Analysis is in agreement with literature data.4  
4-(tris(4-(tert-butyl)phenyl)methyl)phenol, 48  
47, (1.64 g, 3.84 mmol) was added to a round bottom flask followed 
by phenol (6.20 g, 66.0 mmol). The flask was heated to 80o C and 
once a solution has formed, HCl (1.15 mL, 1.25 M in MeOH) was 
added and the reaction stirred vigorously for 2 h. The reaction 
mixture was partitioned between toluene (50 mL) and 0.5 M NaOH (30 mL). The aqueous 
phase was extracted with Toluene (3 x 50 mL) and the combined organics were dried using 
MgSO4, filtered and concentrated to afford a crude solid which was purified via flash column 
chromatography, (eluent DCM/Hexane 1:1) to give 1.03 g of 48 as a white solid (2.04 mmol, 
53% yield). 1H NMR (300 MHz, CDCl3) δ = 7.27 – 7.19 (m, 6H, ArH), 7.14 – 6.98 (m, 8H, 2 x 
ArH), 6.76 – 6.68 (m, 2H, ArH), 4.61 (s, 1H, OH), 1.32 (s, 27H, CH3). 13C NMR (101 MHz, 
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CDCl3) δ = 153.24 (C Ar), 148.32 (C Ar), 144.10 (C Ar), 139.80 (C Ar), 132.47 (CH Ar), 130.71 
(CH Ar), 124.05 (CH Ar), 113.92 (CH Ar), 34.30 (C tBu), 31.39 (CH3). HRMS (ES+): calcd for 
C37H44O [M]+ m/z = 504.3, found m/z = 504.5. Analysis is in agreement with literature data. 4  
4,4',4''-((4-(2-(2-(2-iodoethoxy)ethoxy)ethoxy)phenyl)methanetriyl)tris(tert-
butylbenzene), 49  
48 (0.20 mg, 0.41 mmol) was dissolved in acetonitrile (30 mL). 1,2-
bis(2-iodoethoxy)ethane (1.54 g, 4.10 mmol) was added, followed by 
K2CO3 (0.25 g, 1.8 mmol) and the suspension was refluxed for 16 h. The 
solvents were removed and the crude mixture was purified via flash 
column chromatography, (eluent: Hexane/EtOAc - 5-10%) to give 0.14 g of 49 as a white 
solid (0.19 mmol, 46% yield). 1H NMR (300 MHz, CDCl3) δ = 7.26 (d, J = 8.6 Hz, 6H, ArH), 7.11 
(d, J = 8.4 Hz, 8H, ArH), 6.81 (d, J = 8.9 Hz, 2H, ArH), 4.18 – 4.11 (m, 2H, AR-OCH2), 3.91 – 
3.87 (m, 2H, Ar-OCH2CH2), 3.82 – 3.71 (m, 6H, OCH2CH2OCH2), 3.28 (t, J = 6.9 Hz, 2H, ICH2), 
1.33 (s, 27H). 13C NMR (101 MHz, CDCl3) δ = 156.55 (C Ar), 148.31 (C Ar), 144.15 (C Ar), 
139.80 (C Ar), 132.25 (CH Ar), 130.74 (CH Ar), 124.07 (CH Ar), 113.08 (CH Ar), 70.83 (CH2 
gly), 70.30 (CH2 gly), 69.90 (CH2 gly), 67.23 (CH2 gly), 61.81 (CH2 gly), 34.31 (C tBu), 31.42 
(CH3), 2.97 (ICH2). HRMS (ES+): calcd for C43H55IO3 [M]+ m/z = 746.3196, found m/z = 
746.3200. Analysis is in agreement with literature data. 5  
(2,2-Bis-dec-9-enyl-malonic acid diethyl ester), 50  
Diethyl malonate (0.24 mL, 1.6 mmol) and 10-bromo-1-decene (0.80 mL, 4.0 mmol) were 
added to a suspension of NaH (160 mg – 60% w/w dispersion in mineral oil, 4.0 mmol) in 
THF (60 mL). The reaction mixture was stirred under reflux for 2 days and then the volatiles 
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were removed. The residue was dissolved in EtOAc (40 mL) and 
washed with brine (50 mL) and water (50 mL). The aqueous phase 
was then extracted with EtOAc (3 x 20mL). The organics were 
combined and dried using MgSO4. The solution was filtered and concentrated under 
reduced pressure to afford a crude yellow oil which was purified via flash column 
chromatography (eluent: Hexane/DCM - 0-10%) to give 0.22 g of 50 as a clear oil (0.50 
mmol, 31% yield). 1H NMR (300 MHz, CDCl3) δ = 5.82 (ddt, J = 16.9, 10.1, 6.7 Hz, 2H, 
CH=CH2), 5.08 – 4.88 (m, 4H, CH=CH2), 4.19 (q, J = 7.1 Hz, 4H, OCH2), 2.05 (dd, J = 14.2, 6.8 
Hz, 4H, CCH2), 1.97 – 1.78 (m, 4H, CH=CH2CH2), 1.45 – 1.11 (m, 30H, OCH2CH3, 12 x CH2). 13C 
NMR (101 MHz, CDCl3) δ = 172.0 (CO), 139.2 (CH=CH2), 114.1 (CH=CH2), 60.9 (OCH2), 52.4 
(C), 38.7 (CH2CH=CH2), 33.8 (CH2), 32.1 (CH2), 29.8 (CH2), 29.3 (CH2), 29.1 (CH2), 28.9 (CH2), 
23.9 (CH2), 14.1 (OCH2CH3). Analysis is in agreement with literature data. 3 
(2,2-Bis-undec-10-enyl-malonic acid diethyl ester), 51  
Diethyl malonate (0.30 mL, 2.0 mmol) and 1-bromo decene (1.2 mL, 
5.5 mmol) were added to a suspension of NaH (0.22 g – 60% w/w 
dispersion in mineral oil, 5.5 mmol) in THF (80 mL). The reaction 
mixture was stirred under reflux for 2 days and then the volatiles were removed. The 
residue was dissolved in EtOAc (50 mL) and washed with brine (50 mL) and water (50 mL). 
The aqueous phase was then extracted with EtOAc (3 x 20 mL). The organics were combined 
and dried using MgSO4. The solution was filtered and concentrated under reduced pressure 
to afford a crude yellow oil which was purified via flash column chromatography (eluent: 
Hexane/DCM - 0-10%) to give 0.57 g of 51 as a clear oil (1.2 mmol, 62% yield). 1H NMR (300 
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MHz, CDCl3) δ = 5.83 (ddt, J = 16.9, 10.1, 6.7 Hz, 2H, CH=CH2), 5.07 – 4.87 (m, 4H, CH=CH2), 
4.19 (q, J = 7.1 Hz, 4H, OCH2), 2.05 (q, J = 7.0 Hz, 4H, CCH2), 1.95 – 1.76 (m, 4H), 1.45 – 1.09 
(m, 34H, OCH2CH3, 14 x CH2). 13C NMR (101 MHz, CDCl3) δ = 172.03 (CO), 139.21 (CH=CH2), 
114.09 (CH=CH2), 60.89 (OCH2), 57.54 (C), 33.80 (CH2), 32.09 (CH2), 29.83 (CH2), 29.45 (CH2), 
29.32 (CH2), 29.12 (CH2), 28.93 (CH2), 23.89 (CH2), 14.12 (OCH2CH3). HRMS (ES+): calcd for 
C29H52O4Na [M+Na]+ m/z = 487.3763, found m/z = 487.3778. IR (neat, cm-1): 2924, 2853 
(CH), 1730 (CO), 1068 (COOC). 
(5,5-Bis-dec-9-enyl-pyrimidine-2,4,6-trione), 52  
50 (0.25 g, 0.60 mmol) was dissolved in dry DMSO (3 mL). NaH (60 mg 
– 60% dispersion, 1.5 mmol) was added to the solution followed by 
urea (76 mg, 1.3 mmol). The mixture was then stirred for 16 h. The 
mixture was then poured into sat. NaHCO3 solution (60 ml) and the 
aqueous phase extracted with EtOAc (2 x 50 mL). The solution was 
dried using MgSO4, concentrated under reduced pressure to afford a yellow oil which 
partially crystallised. The oil was recrystallised from hexane to afford 32 mg of white crystals 
of 52 (0.08 mmol, 13% yield). 1H NMR (300 MHz, CDCl3) δ = 7.91 (s, 2H, NH), 5.82 (ddt, J = 
16.9, 10.1, 6.7 Hz, 2H, CH=CH2), 5.09 – 4.89 (m, 4H, CH=CH2), 2.13 – 1.90 (m, J = 15.5, 6.9 Hz, 
8H, CH=CH2CH2 and CCH2), 1.41 – 1.13 (m, 24H, 12 x CH2). 13C NMR (101 MHz, CDCl3) δ = 
172.32 (CO), 148.17 (CO), 139.12 (CH=CH2), 114.17 (CH=CH2), 56.73 (C), 39.22 (CH2CH=CH2), 
33.75 (CH2), 29.38 (CH2), 29.24 (CH2), 29.08 (CH2), 28.97 (CH2), 28.83 (CH2), 25.06 (CH2). 
HRMS (ES-): m/z = calcd for C24H40N2O3 [M]- m/z = 403.2961, found m/z = 403.2946. Analysis 
is in agreement with literature data. 5 
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(5,5-Bis-undec-10-enyl-pyrimidine-2,4,6-trione), 53  
51 (0.50 g, 1.1 mmol) was dissolved in dry DMSO (5 mL). NaH 
(0.12 g – 60% dispersion, 3.0 mmol) was added to the solution 
followed by urea (0.13 g, 2.2 mmol). The mixture was then 
stirred for 16 h. The mixture was then poured onto sat. NaHCO3 
solution (130 ml) and the aqueous phase extracted with EtOAc (2 
x 100 mL). The solution was dried using MgSO4, concentrated 
under reduced pressure to afford a yellow oil which partially crystallised. The oil was 
recrystallised from hexane to afford 92 mg of 53 as white crystals (0.21 mmol, 20% yield). 1H 
NMR (300 MHz, CDCl3) δ = 7.81 (s, 2H, NH), 6.00 – 5.68 (m, 2H, CH=CH2), 5.10 – 4.82 (m, 4H, 
CH=CH2), 2.14 – 1.87 (m, 8H, CH=CH2CH2 and CCH2), 1.45 – 1.11 (m, 28H, 7 x CH2). 13C NMR 
(101 MHz, CDCl3) δ = 172.40 (CO), 148.31 (CO), 139.18 (CH=CH2), 114.13 (CH=CH2), 56.74 
(C), 39.23 (CH2CH=CH2), 33.78 (CH2), 29.41 (CH2), 29.35 (CH2), 29.13 (CH2), 29.05 (CH2), 28.89 
(CH2), 25.08 (CH2). MS (ES+): calcd for C26H43N2O32Na [M-2H++2Na] m/z = 477.6, found m/z = 
477.4 mp = 82-85o C. Elemental Analysis: found: H, 10.33; C, 72.17; N, 6.52; calculated:  H, 
10.25; C, 72.18; N, 6.48. . IR (neat, cm-1): 3203, 3085 (NH), 2912, 2850 (CH), 1691 (CO). 
1-(allyloxy)-4-bromobenzene, 57  
4-Bromophenol (1.73 g, 10.0 mmol) and K2CO3 (1.80 g, 13.0 mmol) were 
dissolved in DMF (3 mL). Allyl bromide (1.04 mL, 12.0 mmol) was added, and 
the reaction was heated to 60o C for 50 minutes. Once cooled to room 
temperature, water (40 mL) was added and the reaction mixture was extracted with diethyl 
ether (2 x 60 mL). The organic extracts were then combined and washed with brine (60 mL) 
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and dried using MgSO4, filtered and concentrated to afford a crude yellow oil, which was 
purified via flash column chromatography (eluent: Hexane/EtOAc-10%) to afford 2.01 g of 
57 as a clear oil (9.41 mmol, 94% yield). 1H NMR (300 MHz, CDCl3) δ = 7.48 – 7.32 (m, 2H, 
ArH), 6.89 – 6.74 (m, 2H, ArH), 6.05 (ddt, J = 17.2, 10.5, 5.3 Hz, 1H, CH=CH2), 5.48 – 5.24 (m, 
2H, CH=CH2), 4.53 (dt, J = 5.3, 1.5 Hz, 2H, CH2CH=CH2). 13C NMR (101 MHz, CDCl3) δ = 157.68 
(C Ar), 132.86 (CH=CH2), 132.23 (CH Ar), 117.90 (CH=CH2), 116.56 (CH Ar), 112.99 (C Ar), 
69.00 (CH2CH=CH2). HRMS (ES+): calcd for C9H9BrO [M]+ m/z = 211.984, found m/z = 
211.983. Analysis is in agreement with literature data. 6 
1-bromo-4-(undec-10-en-1-yloxy)benzene, 58  
4-Bromophenol (1.11 g, 6.40 mmol) and K2CO3 (1.15 g, 8.30 mmol) were 
dissolved in DMF (3 mL). 10-bromo-undecene (1.50 g, 6.40 mmol) was added, 
and the reaction was heated to 60o C for 16 h. Once cooled to room 
temperature, water (40 mL) was added and the reaction mixture was 
extracted with diethyl ether (2 x 60 mL). The organic extracts were then combined and 
washed with brine (60 mL) and dried (MgSO4), filtered and concentrated to afford a crude 
yellow oil, which was purified via flash column chromatography (eluent: Hexane) to afford 
1.88 g of 58 as a clear oil (5.80 mmol, 91% yield). 1H NMR (300 MHz, CDCl3) δ = 7.46 – 7.32 
(m, 2H, ArH), 6.88 – 6.72 (m, 2H, ArH), 5.84 (ddt, J = 16.9, 10.1, 6.7 Hz, 1H, CH=CH2), 5.12 – 
4.87 (m, 2H, CH=CH2), 3.93 (t, J = 6.6 Hz, 2H, OCH2), 2.07 (dd, J = 14.1, 6.8 Hz, 2H, 
CH2CH=CH2), 1.88 – 1.67 (m, 2H, OCH2CH2), 1.5 – 1.22 (m, 12H, 6 x CH2). 13C NMR (101 MHz, 
CDCl3) δ = 158.25 (C Ar), 139.19 (CH=CH2), 132.17 (CH Ar), 116.30 (CH Ar), 114.13 (CH=CH2), 
112.55 (C Ar), 68.26 (OCH2), 33.80 (CH2CH=CH2), 29.49 (CH2), 29.41 (CH2), 29.35 (CH2), 29.17 
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(CH2), 29.11 (CH2), 28.93 (CH2), 25.99 (CH2). HRMS (ES+): calcd for C17H25BrO [M]+ m/z = 
324.1089, found m/z = 324.1086. Analysis is in agreement with literature data. 7  
(4-(allyloxy)phenyl)boronic acid, 59 
57 (0.57 g, 2.7 mmol) was dissolved in THF (5 mL) and cooled to -78o C. nBuLi 
(1.20 mL – 2.5 M in hexane, 2.99 mmol) was then added dropwise over 5 
minutes and stirring was then continued for 1 h. B(OEt)3 (0.50 mL, 3.1 mmol) 
was then added dropwise over 5 minutes and stirring was continued for 90 minutes. The 
solution was warmed to room temperature and sat. NH4Cl (2.5 mL) was added, followed by 
water (15 mL). Diethyl ether (30 mL) was added, the organic phase separated and washed 
with sat. NaHCO3 (15 mL) and then brine (15 mL). The organic phase was then dried using 
Na2SO4, filtered and evaporated to afford a yellow oil. Recrystallisation from water afforded 
a white solid which was filtered to give 156 mg of 59 as a white solid (1.61 mmol, 59% yield). 
1H NMR (300 MHz, CDCl3) δ = 8.25 – 7.60 (m, 2H, ArH), 7.13 – 6.87 (m, 2H, ArH), 6.10 (ddt, J 
= 16.4, 10.6, 5.3 Hz, 1H, CH=CH2), 5.59 – 5.15 (m, 2H, CH=CH2), 4.69 – 4.59 (m, 2H, OCH2). 
13C NMR (101 MHz, CDCl3) δ = 162.21 (C Ar), 137.48 (CH Ar), 135.25 (CH=CH2), 117.93 
(CH=CH2), 114.24 (CH Ar), 68.63 (CH2CH=CH2). HRMS (ES+): calcd for C9H11BO3 [M]+ m/z = 
178.0801, found m/z = 178.0801.  
(4-(undec-10-en-1-yloxy)phenyl)boronic acid, 60  
58 (0.98 g, 3.0 mmol) was dissolved in THF (3 mL) and cooled to -78o C. nBuLi (1.32 mL - 2.5 
M in hexane, 3.30 mmol) was then added dropwise over 5 minutes and stirring was then 
continued for 1 h. B(OEt)3 (0.58 mL, 3.4 mmol) was added dropwise over 5 minutes and 
stirring was continued for 90 minutes. Repeated warming and cooling was required to 
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prevent gel formation. The solution was then warmed to room 
temperature and sat. NH4Cl (2.5 mL) was added, followed by water (15 
mL). Diethyl ether (30 mL) was added, the organic phase separated and 
washed with sat. NaHCO3 (15 mL) and then brine (15 mL). The organic 
phase was then dried using Na2SO4, filtered and evaporated to afford a crude off-white 
solid. Purification via flash column chromatography (eluent: Hexane-Et2O 1:1) afforded 58 
mg of 60 as a white solid (0.20 mmol, 15% yield).  1H NMR (300 MHz, CDCl3) δ = 8.17 (d, J = 
8.6 Hz, 2H, ArH), 7.02 (d, J = 8.7 Hz, 2H, ArH), 5.85 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H¸ CH=CH2), 
5.14 – 4.87 (m, 2H¸ CH=CH2), 4.06 (t, J = 6.5 Hz, 2H¸ OCH2), 2.07 (dd, J = 14.1, 6.8 Hz, 2H¸ 
CH2CH=CH2), 1.95 – 1.73 (m, 2H¸ OCH2CH2), 1.60 – 1.21 (m, 12H, 6 x CH2). 13C NMR (101 
MHz, CDCl3) δ = 162.79 (C Ar), 139.22 (CH=CH2), 137.46 (CH Ar), 122.01 (C Ar), 114.13 (CH 
Ar), 114.01 (CH=CH2), 67.88 (OCH2) , 33.81 (CH2CH=CH2), 29.52 (CH2), 29.40 (CH2), 29.24 
(CH2), 29.13 (CH2), 28.94 (CH2), 26.06 (CH2). HRMS (ES+): calcd for C17H25O [M-(BOH)2]+ m/z = 
245.3, found m/z = 246.0.  
5,5-bis(4-(allyloxy)phenyl)pyrimidine-2,4,6(1H,3H,5H)-trione, 61  
59 (0.14 g, 0.77 mmol) was added slowly over 15 minutes to a 
solution of Pb(OAc)4 (0.37 g, 0.84 mmol) and Hg(OAc)2 (19 mg, 
0.084 mmol) in CHCl3 (1.5 mL) at 40o C. The mixture was stirred 
for 1 h. Barbituric acid (0.11 g, 0.85 mmol) and pyridine (0.19 mL, 
2.3 mmol) were added and the mixture was stirred for 16 h at room temperature. The 
yellow suspension was then filtered through celite and washed with CHCl3 (10 mL). The 
filtrate was then shaken with 3 M H2SO4 (8 mL) and the aqueous phase extracted with CHCl3 
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(2 x 5 mL). The organics were then combined, dried using Na2SO4, filtered and concentrated 
to afford a crude yellow oil which was purified via flash column chromatography (eluent: 
DCM/EtOAc gradient 10-50%) to afford 73 mg of 61 as an off white solid (0.19 mmol, 24 % 
yield).  1H NMR (300 MHz, CDCl3) δ = 8.84 (s, 2H, NH), 7.19 – 7.05 (m, 4H, ArH), 6.99 – 6.82 
(m, 4H, ArH), 6.05 (ddt, J = 17.2, 10.5, 5.3 Hz, 2H, CH=CH2), 5.53 – 5.21 (m, 4H, CH=CH2), 
4.54 (dt, J = 5.3, 1.3 Hz, 4H¸ CH2CH=CH2). 13C NMR (101 MHz, CDCl3) δ = 170.40 (CO), 158.78 
(C Ar), 148.52 (CO), 132.89 (CH=CH2), 130.17 (CH Ar), 128.81 (C Ar), 117.95 (CH=CH2), 114.90 
(CH Ar), 68.87 (CH2CH=CH2). HRMS (ES-): calcd for C22H19N2O5 [M-H]- m/z = 391.4, found m/z 
= 391.1. mp: 95-98o C. IR (neat, cm-1): 3464, 3230 (NH), 2924, 2855 (CH), 1683 (CO), 1607 
(C=C). 
5,5-bis(4-(undec-10-en-1-yloxy)phenyl)pyrimidine-2,4,6(1H,3H,5H)-trione, 62  
60 (0.68 g, 2.3 mmol) was added slowly over 15 minutes to a 
solution of Pb(OAc)4 (1.12 g, 2.54 mmol) and Hg(OAc)2 (56 mg, 
0.25 mmol) in CHCl3 (4.0 mL) at 40o C. The mixture was stirred for 1 
h. Barbituric acid (0.33 g, 2.6 mmol) and pyridine (0.58 mL, 7.0 
mmol) were added and the mixture was stirred for 16 h at room 
temperature. The yellow suspension was then filtered through celite and washed with CHCl3 
(30 mL). The filtrate was then shaken with 3 M H2SO4 (25 mL) and the aqueous phase 
extracted with CHCl3 (2 x 15 mL). The organics were then combined, dried using Na2SO4, 
filtered and concentrated to afford a crude yellow oil which was purified via flash column 
chromatography (eluent: DCM/EtOAc - 10%) to afford 0.28 g of 62 as a white solid (0.47 
mmol, 20 % yield).  1H NMR (300 MHz, CDCl3) δ = 8.38 (s, 2H, NH), 7.19 – 7.08 (m, 4H, ArH), 
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6.97 – 6.81 (m, 4H, ArH), 5.83 (ddt, J = 16.9, 10.2, 6.7 Hz, 2H, CH=CH2 ), 5.14 – 4.83 (m, 4H, 
CH=CH2), 3.96 (t, J = 6.5 Hz, 4H, OCH2), 2.06 (q, J = 7.2 Hz, 4H, CH2CH=CH2), 1.86 – 1.71 (m, 
4H, OCH2CH2), 1.53 – 1.24 (m, 24H). 13C NMR (101 MHz, CDCl3) δ = 170.19 (CO), 159.36 (C 
Ar), 147.89 (CO), 139.21 (CH=CH2), 130.08 (CH Ar), 128.33 (C Ar), 114.65 (CH Ar), 114.12 
(CH=CH2), 68.07 (OCH2), 33.80 (CH2CH=CH2), 29.50 (CH2), 29.41 (CH2), 29.34 (CH2), 29.18 
(CH2), 29.11 (CH2), 28.92 (CH2), 26.02 (CH2). HRMS (ES+): calcd for C38H52N2O5Na [M+Na]+ 
m/z = 639.3774, found m/z = 639.3769. IR (neat, cm-1): 3221, 3079 (NH), 2924, 2853 (CH), 
1703 (CO), 1609 (C=C). 
 
4,4',4''-((4-(2-(2-(2-(4-bromophenoxy)ethoxy)ethoxy)ethoxy)phenyl)methanetriyl)tris(tert-
butylbenzene), 63  
49 (0.43 g, 0.58 mmol), bromophenol (0.12 g, 0.59 mmol) and 
K2CO3 (0.11 g, 0.77 mmol) were dissolved in DMF (4 mL) and 
heated to 80o C. The reaction was then stirred for 16 h and cooled 
to room temperature. Water (10 mL) was added followed by 
toluene (30 mL) and the organic phase was separated. The 
aqueous phase was extracted with toluene (20 mL) and the 
organics were combined, dried using MgSO4, filtered and concentrated to afford a white 
solid in quantitative yields which was carried through with no further purification. 1H NMR 
(400 MHz, CDCl3) δ = 7.33 – 7.24 (m, 2H, ArH), 7.22 – 7.10 (m, 6H, ArH)), 7.06 – 6.94 (m, 8H, 
ArH), 6.78 – 6.65 (m, 4H, ArH), 4.08 (dd, J = 9.4, 3.9 Hz, 4H, CH2-gly), 3.90 – 3.83 (m, 4H, 
CH2-gly), 3.76 (s, 4H, CH2-gly), 1.23 (s, 27H, CH3). 13C NMR (101 MHz, CDCl3) δ = 156.49 (C 
Ar), 148.32 (C Ar), 144.12 (C Ar), 139.87 (C Ar), 132.25 (CH Ar), 130.72 (CH Ar), 124.05 (CH 
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Ar), 116.48 (CH Ar), 113.08 (CH Ar), ), 70.83 (CH2-gly), 69.84 (CH2-gly), 69.66 (CH2-gly), 67.74 
(CH2-gly), 67.44 (CH2-gly), 67.20 (CH2-gly), 34.30 (C tBu), 31.39 (CH3). HRMS (ES+): calcd for 
C47H55BrO3Na [M+Na]+ m/z = 769.3, found m/z = 769.3. mp: 138-140o C. IR (neat, cm-1):  
2958, 2932, 2865 (CH), 1244 (COC). 
 
2-(2-(2-(4-bromophenoxy)ethoxy)ethoxy)ethan-1-ol, 64  
Bromophenol (1.02 g, 5.90 mmol), and K2CO3 (1.22 g, 8.85 mmol) were suspended 
in DMF (2 mL). 2-(2-(2-iodoethoxy)ethoxy)ethan-1-ol (1.50 g, 5.90 mmol) was 
added to the suspension which was then heated at 60o C for 16 h. Once cooled to 
room temperature, water (50 mL) was added and the organics were extracted 
with diethyl ether (2 x 40 mL). The organics were then combined, dried using MgSO4, 
filtered and concentrated to give a crude, light-brown oil which was purified via flash 
column chromatography (eluent: Hexane/Acetone 4:1) to afford 1.49 g of 64 as a clear oil 
(4.88 mmol, 83 % yield).  1H NMR (300 MHz, CDCl3) δ = 7.49 – 7.33 (m, 2H, ArH), 6.93 – 6.73 
(m, 2H, ArH), 4.12 (dd, J = 5.5, 4.0 Hz, 2H, CH2-gly), 3.87 (dd, J = 5.4, 4.0 Hz, 2H, CH2-gly), 
3.80 – 3.68 (m, 6H, 3 x CH2-gly), 3.68 – 3.59 (m, 2H, CH2-gly). 13C NMR (101 MHz, CDCl3) δ = 
157.84 (C Ar), 132.24 (CH Ar), 116.44 (CH Ar), 113.12 (C Ar), 72.45 (CH2-gly), 70.85 (CH2-gly), 
70.38 (CH2-gly), 69.64 (CH2-gly), 67.62 (CH2-gly), 61.78 (CH2-gly). HRMS (ES+): calcd for 
C12H17O4BrNa [M+Na]+ m/z = 327.0208, found m/z = 327.0206. Analysis is in agreement with 
literature data.8  
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12-(4-bromophenoxy)-2,2-dimethyl-3,3-diphenyl-4,7,10-trioxa-3-siladodecane, 65 
64 (0.53 g, 1.8 mmol) was dissolved in DCM (13 mL). The flask was 
cooled to 0o C and NEt3 (0.75 mL, 5.4 mmol) was added followed by 
tert-butyldiphenylsillyl chloride (1.18 mL, 4.52 mmol) and a spatula tip 
of DMAP. The reaction was left to warm to room temperature and 
stirred for 16 h. Water (20 mL) was added and the phases were 
separated. The aqueous layer was extracted with DCM (2 x 30 mL) and the organics were 
combined, dried using MgSO4 and concentrated to afford a crude, clear oil which was 
purified via flash column chromatography (eluent: Hexane/EtOAc - 5-30%) to afford 0.62 g 
of 65 as a clear oil (1.1 mmol, 62 % yield).  1H NMR (300 MHz, CDCl3) δ = 7.77 – 7.64 (m, 4H, 
ArH), 7.48 – 7.31 (m, 8H, ArH), 6.86 – 6.75 (m, 2H, ArH), 4.15 – 4.03 (m, 2H¸ CH2-gly), 3.91 – 
3.78 (m, 4H, 2 x CH2-gly), 3.75 – 3.67 (m, 4H, 2 x CH2-gly), 3.63 (t, J = 5.3 Hz, 2H, CH2-gly), 
1.08 (s, 9H, CH3). 13C NMR (101 MHz, CDCl3) δ = 157.93 (C Ar), 135.63 (CH Ar), 133.69 (C Ar), 
132.21 (CH Ar), 129.64 (CH Ar), 127.65 (CH Ar), 116.45 (CH Ar), 113.00 (C Ar), 72.51 (CH2-
gly), 70.95 (CH2-gly), 70.84 (CH2-gly), 69.68 (CH2-gly), 67.69 (CH2-gly), 63.46 (CH2-gly), 26.83 
(CH3), 19.22 (C tBu). HRMS (ES+): calcd for C28H36O4SiNa [M-Br+Na]+ m/z = 487.2, found m/z 
= 487.3. IR (neat, cm-1): 3070, 2929, 2857 (CH), 1246, 1111 (COC). 
 
(4-((2,2-dimethyl-3,3-diphenyl-4,7,10-trioxa-3-siladodecan-12-yl)oxy)phenyl)boronic acid, 
66 
65 (0.61 g, 1.1 mmol) was dissolved in THF (1 mL) and cooled to -78o C. nBuLi (2.5 M in 
hexane, 0.50 mL, 1.2 mmol) was added slowly over 5 minutes and stirring was continued for 
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1 h. B(OEt)3 (0.21 mL, 1.2 mmol) was then added and stirring was 
continued for a further 90 minutes. Sat. NH4Cl (2 mL) was then 
added and the reaction was left to warm to room temperature. 
Water (5 mL) was then added and the reaction mixture extracted 
with diethyl ether (20 mL). The organic phase was washed with sat. 
NaHCO3 (10 mL) and then brine (10 mL) and finally dried using Na2SO4, filtered and 
concentrated to afford a yellow viscous oil which was used without further purification, 1H 
NMR yield = 65 %.  1H NMR (300 MHz, CDCl3) δ = 8.17 (d, J = 8.6 Hz, 2H, ArH), 7.78 – 7.65 (m, 
4H, ArH), 7.48 – 7.30 (m, 6H, ArH), 7.03 (d, J = 8.6 Hz, 2H, ArH), 4.26 – 4.18 (m, 2H, CH2-gly), 
3.97 – 3.89 (m, 2H, CH2-gly), 3.85 (t, J = 5.3 Hz, 2H, CH2-gly), 3.74 (qd, J = 5.4, 2.6 Hz, 4H, 2 x 
CH2-gly), 3.70 – 3.61 (m, 2H, CH2-gly), 1.07 (s, 9H, CH3). HRMS (ES+): calcd for C28H37BO6SiNa 
[M+Na]+ m/z = 531.24, found m/z = 531.4.  
1,3-bis(2,4-dimethoxybenzyl)urea, 67  
To a round bottom flask, fitted with a drying tube, 
was added dry DCM (5 mL) followed by benzyl 
isocyanate (1.00 g, 5.18 mmol). The flask was 
cooled to below 5o C and then a solution of benzylamine (0.80 mL, 5.2 mmol) in DCM (1 mL) 
was added slowly over 30 minutes. The precipitate forming hindered stirring so a further 3 
mL of DCM was added. After 30 minutes stirring at 0o C, the flask was warmed to room 
temperature and left stirring for 14 h. The suspension was filtered through a sintered funnel 
and dried to afford 1.68 g of 67, as a white solid (4.67 mmol, 91% yield). 1H NMR (300 MHz, 
CDCl3) δ = 7.10 (d, J = 8.9 Hz, 2H, ArH), 6.39 (dd, J = 5.7, 2.2 Hz, 4H, ArH), 4.18 (s, 4H, 
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NHCH2), 3.79 – 3.73 (m, 6H, OCH3), 3.70 (s, 6H, OCH3). 13C NMR (101 MHz, CDCl3) δ = 160.25 
(CO), 158.85 (C Ar), 158.15 (C Ar), 129.97 (CH Ar), 119.31 (C Ar), 103.96 (CH Ar), 98.36 (CH 
Ar), 55.32 (OCH3), 55.12 (OCH3), 39.44 (NHCH2). HRMS (ES+): calcd for C19H25N2O5 [M]+ m/z = 
361.1763, found m/z = 361.1759. mp: 186-188o C. IR (neat, cm-1):  3295 (NH), 3002, 2918, 
2828 (CH), 1580 (CO). 
1,3-bis(2,4-dimethoxybenzyl)pyrimidine-2,4,6(1H,3H,5H)-trione, 68  
67 (2.99 g, 8.31 mmol) and malonic acid (0.86 g, 8.3 
mmol) were added to acetic anhydride (11.8 mL, 
0.120 mol) to form a slurry. Once heated to 70o C a 
solution formed which was stirred for 16 h. Once cooled to room temperature the acetic 
anhydride was removed under vacuum and the residue obtained partitioned between 2 M 
NaOH (40 mL) and diethyl ether (30 mL).  The aqueous phase was then acidified to pH 2 
with concentrated HCl and the precipitate was dissolved with the addition of CHCl3 (80 mL). 
The organic phase was washed with water (60 mL), dried using Na2SO4, filtered and 
evaporated to give 3.50 g of 68 as a yellow crystalline solid (8.17 mmol, 98% yield). The solid 
can be used as obtained, but to gain further purity, decolourising charcoal can be used to 
obtain a white crystalline solid. 1H NMR (300 MHz, CDCl3) δ = 7.08 (d, J = 8.9 Hz, 2H, ArH), 
6.47 – 6.40 (m, 4H, ArH), 5.04 (s, 4H, NHCH2), 3.85 – 3.68 (m, J = 14.5, 8.4 Hz, 14H, 2 x OCH3, 
COCH2CO). 13C NMR (101 MHz, CDCl3) δ = 164.51 (CO), 160.45 (CO), 158.33 (C Ar), 129.73 
(CH Ar), 116.47 (C Ar), 103.95 (CH Ar), 98.51 (CH Ar), 55.41 (OCH3), 55.38 (OCH3) 40.65, 
(COCH2CO), 39.94 (NCH2). HRMS (ES+): calcd for C22H25N2O7 [M+Na]+ m/z = 429.1662, 
found m/z = 429.1668. mp: 82-83o C. IR (neat, cm-1): 2972, 2984 (CH), 1678 (CO). 
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1,3-bis(4-methoxybenzyl)-5,5-bis(3-methoxyphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione, 69 
3-methoxyphenylboronic acid (0.28 g, 1.9 mmol) was 
added slowly over 15 minutes to a solution of Pb(OAc)4 
(0.82 g, 1.9 mmol) and Hg(OAc)2 (42 mg, 0.19 mmol) in 
CHCl3 (2.8  mL) at 40o C. Stirring was then continued for 
1 h. N-N’-PMB-Barbituric acid (0.62 g, 1.7 mmol) and pyridine (0.45 mL, 5.6 mmol) were 
added and the mixture was stirred for 16 h at room temperature. The yellow suspension 
was then filtered through celite and washed with CHCl3 (20 mL). The filtrate was then 
shaken with 3 M H2SO4 (16 mL) and the aueous phase extracted with CHCl3 (2 x 10 mL). The 
organics were then combined, dried using Na2SO4, filtered and concentrated to afford a 
crude, brown solid which was purified via flash column chromatography (eluent: DCM) to 
afford 0.15 mg of 69 as an off white solid (0.26 mmol, 16 % yield).  1H NMR (300 MHz, CDCl3) 
δ = 7.36 (d, J = 8.7 Hz, 4H, ArH(PG)), 7.17 (t, J = 8.0 Hz, 2H, ArH), 6.94 – 6.72 (m, 6H, ArH, 
ArH(PG)), 6.61 – 6.41 (m, 4H, ArH), 5.06 (s, 4H, NHCH2), 3.82 (d, J = 3.8 Hz, 6H, OCH3), 3.61 
(s, 6H, OCH3). 13C NMR (101 MHz, CDCl3) δ = 169.22 (CO), 159.53 (C Ar), 159.29 (C Ar), 
150.76 (C Ar), 138.17 (C Ar), 130.70 (CH Ar), 129.48 (CH Ar), 128.04 (C Ar), 121.12 (CH Ar), 
114.80 (CH Ar), 114.00 (CH Ar), 113.79 (CH Ar), 67.31 (COCCO), 55.27, 55.07, 45.57 
(NCH2).HRMS (ES+): calcd for C34H33N2O7 [M]+ m/z = 581.2288, found m/z = 581.2292. mp: 
118-120o C. IR (neat, cm-1): 2954, 2837 (CH), 1676 (CO).  
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5,5-bis(3-methoxyphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione, 70 
69 (0.10 g, 0.20 mmol) was suspended in a water/CHC3CN mix (0.5/1.5 
mL). Methanol was added slowly until a solution had formed and the 
reaction was then heated to reflux. CAN (0.51 g, 0.80 mmol) was then 
added and the solution was stirred for 16 h. The solution was then 
diluted with DCM (5 mL) and the organic layer separated, washed with water (5 mL), dried 
using MgSO4, filtered and concentrated to afford a crude yellow solid which was purified via 
flash column chromatography (eluent: DCM/MeOH - 0-5%) to afford 6.5 mg of 70 as a white 
solid (0.019 mmol, 9% yield).  1H NMR (300 MHz, Acetone) δ = 7.37 – 7.22 (m, 2H, ArH), 6.99 
– 6.88 (m, 2H, ArH), 6.88 – 6.79 (m, 4H, ArH), 3.75 (s, 6H, OCH3). MS (ES+): calcd for 
C18H16N2O5Na [M+Na]+ m/z = 363.0957, found m/z = 363.0956.  
(4-bromophenoxy)(tert-butyl)dimethylsilane, 71 
Bromophenol (7.42 g, 42.9 mmol), Imidazole (8.70 g, 127 mmol) and tert-
butyldimethylsilyl chloride (9.00 g, 59.0 mmol) were dissolved in DMF (100 
mL). The reaction was stirred for 16 h. The solution was then poured into 
water (500 mL) and extracted with ethyl acetate (2 x 200 mL). The organic 
phase was then washed with water (180 mL) and then brine (180 mL). The organic phase 
was then dried using Na2SO4, filtered and evaporated. The oil was used as obtained with no 
further purification required. Yield: quantitative. 1H NMR (300 MHz, CDCl3) δ = 7.39 – 7.29 
(m, 2H, ArH), 6.82 – 6.66 (m, 2H, ArH), 0.99 (s, 9H, CCH3), 0.20 (s, 6H, SiCH3). 13C NMR (101 
MHz, CDCl3) δ = 154.83 (C Ar), 132.29, (CH Ar), 121.91 (CH Ar), 113.60, (C Ar), 25.63 (CH3), 
18.20 (C tBu), -4.49 (SiCH3).  
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(4-((tert-butyldimethylsilyl)oxy)phenyl)boronic acid, 72  
71 (5.44 g, 18.9 mmol) was dissolved in THF (25 mL). The flask was cooled 
to -78o C and then a solution of n-BuLi (10.4 mL, 2 M in hexane, 20.8 mmol) 
was added dropwise over 30 minutes. Once addition was complete, the 
reaction was stirred for a further 30 minutes at -78o C, followed by the 
dropwise addition of B(OEt)3 (13.1 mL, 56.7 mmol) over 5 minutes. After 30 minutes stirring 
at -78 oC, the reaction was warmed to room temperature and acidified with 5% HCl solution. 
The organic phase was separated, washed with brine (30 mL), dried using Na2SO4, filtered 
and evaporated to form a yellow/white solid. The crude solid was purified via flash column 
chromatography (eluent: Hexane/EtOAc 1:1) to give 2.66 g of 72 (10.6 mmol, 56% yield). 1H 
NMR (300 MHz, MeOD) δ = 7.73 – 7.49 (m, 2H, ArH), 6.95 – 6.70 (m, 2H, ArH), 1.01 (s, 9H, 
CH3), 0.22 (s, 6H, SiCH3). 13C NMR (101 MHz, CDCl3) δ = 159.75 (C Ar), 137.45 (CH Ar), 122.96 
(C Ar), 119.78 (CH Ar), 25.69 (CH3), 18.31 (C tBu), -4.31 (SiCH3). Analysis is in agreement with 
literature data 9  
5,5-bis(4-((tert-butyldimethylsilyl)oxy)phenyl)-1,3-bis(2,4-dimethoxybenzyl)pyrimidine-
2,4,6(1H,3H,5H)-trione, 73  
Pb(OAc)4 (2.12 g, 4.78 mmol) and Hg(OAc)2 (0.12 g, 0.38 
mmol) were dissolved in dry CH3Cl (7 mL). Once heated 
to 40o C, 72 (1.13 g, 4.48 mmol) was added over 15 
minutes. After stirring for 30 minutes pyridine (6.4 mL) 
and 68 (0.71 g, 1.7 mmol) were added and the 
suspension was stirred for 16 h at room temperature. The suspension was then filtered 
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through celite and rinsed with CH3Cl (10 mL). The filtrate was washed with 3 M H2SO4 (15 
mL) and the organic phase separated, dried with Na2SO4, filtered and evaporated to afford a 
crude red solid which was purified via flash column chromatography, eluent (DCM) to give 
0.63 g of 73 as a white crystalline solid (0.75 mmol, 45% yield). 1H NMR (300 MHz, CDCl3) δ = 
6.96 (d, J = 8.3 Hz, 2H, ArH (PG)), 6.87 – 6.76 (m, 4H, ArH), 6.74 – 6.64 (m, 4H, ArH), 6.45 – 
6.26 (m, 4H, ArH (PG)), 5.12 (s, 4H, NHCH2), 3.80 (s, 6H, OCH3), 3.61 (s, 6H¸ OCH3), 1.03 – 
0.93 (m, 18H, CH3), 0.28 – 0.14 (m, 12H, SiCH3). 13C NMR (101 MHz, CDCl3) δ = 169.83 (CO), 
160.38 (CO), 158.39 (C Ar), 155.48 (C Ar), 150.35 (C Ar), 130.54 (C Ar), 130.13 (CH Ar), 
130.07 (CH Ar), 119.74 (CH Ar), 116.48 (C Ar), 103.74 (CH Ar), 98.31 (CH Ar), 66.31 (COCCO), 
55.35 (OCH3), 55.19 (OCH3), 41.33 (NCH2), 25.65 (CH3), 18.18 (C tBu), -4.36 (SiCH3). HRMS 
(ES+): calcd for C46H61N2O9Si2 [M]+ m/z = 841.3916, found m/z = 841.3917. mp: 58-59 oC. IR 
(neat, cm-1):  2975, 2930, 2855 (CH), 1689 (CO), 1257 (COC). 
1,3-bis(2,4-dimethoxybenzyl)-5,5-bis(4-hydroxyphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione, 
74  
73 (0.10 mg, 0.12 mmol) was dissolved in THF (4 mL). 
TBAF (0.70 mL, 1 M in THF, 0.70 mmol) was added 
dropwise. The solution was stirred at room 
temperature for 2.5 h. The solvent was then removed 
and the residue taken up in DCM (30 mL). The organic phase was washed with water (20 
mL), then brine (20 mL) and dried using Na2SO4, filtered and evaporated to afford a crude 
brown oil which was purified by flash column chromatography (eluent: DCM/MeOH - 4%) to 
give 72 mg of pure 74 as a white crystalline solid (0.17 mmol, 98% yield). 1H NMR (300 MHz, 
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CDCl3) δ = 6.99 (d, J = 8.2 Hz, 2H, ArH (PG)), 6.87 – 6.76 (m, 4H, ArH), 6.73 – 6.63 (m, 4H, 
ArH), 6.42 – 6.31 (m, 4H, ArH (PG)), 5.12 (s, 4H, NCH2), 4.87 (s, 2H, OH), 3.81 (s, 6H, OCH3), 
3.60 (s, 6H, OCH3). 13C NMR (101 MHz, CDCl3) δ = 170.13 (CO), 160.25 (CO), 158.35 (C Ar), 
156.50 (C Ar), 150.30 (C Ar), 130.19 (CH Ar), 130.08 (CH Ar), 128.72 (C Ar), 116.34 (C Ar), 
115.20 (CH Ar), 103.76 (CH Ar), 98.20 (CH Ar), 66.43 (COCCO) 55.39 (OCH3), 55.11 (OCH3), 
41.36 (NCH2). HRMS (ES+): calcd for C34H32N2O9Na [M+Na]+ m/z = 635.2009, found m/z = 
635.1990. mp: 201-203o C. IR (neat, cm-1): 3301 (OH), 3011, 2947, 2839 (CH), 1674 (CO). 
1,3-bis(2,4-dimethoxybenzyl)-5,5-bis(4-(2-(2-(2-(4-(tris(4-(tert-
butyl)phenyl)methyl)phenoxy)ethoxy)ethoxy)ethoxy)phenyl)pyrimidine-2,4,6(1H,3H,5H)-
trione, 75  
74 (0.23 g, 0.38 mmol), Cs2CO3 (0.83 g, 
2.6 mmol) and 49 (0.73g, 0.98 mmol) 
were dissolved in DMF (4 mL) and 
refluxed for 2 h. The solvent was 
removed and the residue taken up in 
DCM (60 mL). The organic phase was 
then washed with water (40 mL) and 
then brine (40 mL), dried using Na2SO4, filtered and evaporated to afford a crude solid 
which was purified via flash column chromatography (eluent: DCM) to give 0.52 g of 75 as a 
white solid (0.28 mmol, 78% yield). 1H NMR (300 MHz, CDCl3) δ = 7.28 – 7.22 (m, 12H, ArH 
(stopper)), 7.14 – 7.07 (m, 16H, ArH (stopper)), 6.98 (d, J = 8.2 Hz, 2H, ArH (barbiturate), 
6.91 – 6.72 (m, 12H, ArH (4H-stopper, 8H-barbiturate)), 6.42 – 6.33 (m, 4H, ArH 
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(barbiturate)), 5.12 (s, 4H, NCH2), 4.17 – 4.08 (m, 8H, CH2-gly), 3.91 – 3.83 (m, 8H, CH2-gly), 
3.79 (s, 6H, OCH3), 3.77 (s, 6H, OCH3), 3.60 (s, 8H, CH2-gly), 1.32 (s, 54H, CH3). 13C NMR (101 
MHz, CDCl3) δ = 169.76 (CO), 160.43 (CO), 158.41 (C Ar), 156.53 (C Ar), 156.43 (C Ar), 151.75 
(CH Ar), 148.31 (C Ar), 146.01 (C Ar), 144.61 (C Ar), 144.18 (C Ar), 139.86 (C Ar), 132.25 (CH 
Ar), 131.02 (CH Ar), 130.75 (CH Ar), 130.14 (CH Ar), 125.23 (CH Ar), 124.09 (CH Ar), 116.41 
(C Ar), 114.40 (CH Ar), 113.11 (CH Ar), 72.57 (CH2-gly), 70.89 (CH2-gly), 69.92 (CH2-gly), 69.81 
(CH2-gly), 69.76 (CH2-gly), 67.25 (CH2-gly), 64.10 (COCCO), 63.16 (C Ar) 55.40 (OCH3),  55.21 
(OCH3), 41.43 (NCH2), 34.32 (C tBu), 31.42 (CH3). HRMS (ES+): calcd for C120H140N2O15Na 
[M+Na]+ m/z = 1872.0151, found m/z = 1872.0134. mp: 154-156o C. IR (neat, cm-1): 2958, 
2928, 2867 (CH), 1608 (CO). 
5,5-bis(4-(2-(2-(2-(4-(tris(4-(tert-
butyl)phenyl)methyl)phenoxy)ethoxy)ethoxy)ethoxy)phenyl)pyrimidine-2,4,6(1H,3H,5H)-
trione, 76  
75 (0.47 g, 0.25 mmol) was dissolved in 
the minimum amount of DCM. Water 
(1.8 mL) was then added followed by 
acetone (2 mL). The solution was then 
heated to 65o C, followed by the 
addition of CAN (0.85 g, 1.6 mmol). 
After stirring for 15 minutes, the 
solvents were removed and the residue taken up in DCM (10 mL). The organic phase was 
washed with water (6 mL) and then brine (6 mL). The organic phase was separated , dried 
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using Na2SO4, filtered and evaporated to afford a crude solid which was purified via flash 
column chromatography, eluent (Hexane/EtOAc 1:1) to give 81 mg of 76 (52 µmol, 21% 
yield). 1H NMR (300 MHz, CDCl3) δ = 7.27 – 7.20 (m, 12H, ArH-stopper), 7.15 – 7.03 (m, 20H, 
ArH (16H-stopper, 4H-barbiturate), 6.93 – 6.85 (m, 4H, ArH-barbiturate), 6.79 (d, J = 8.9 Hz, 
4H, ArH-stopper), 4.12 (dd, J = 9.4, 3.9 Hz, 8H, CH2-gly), 3.91 – 3.83 (m, 8H, CH2-gly), 3.76 (s, 
8H, CH2-gly), 1.31 (s, 54H, CH3). 13C NMR (101 MHz, CDCl3) δ = 170.14 (CO), 158.92 (CO), 
156.52 (C Ar), 148.29 (C Ar), 147.92 (C Ar), 144.13 (C Ar), 139.77 (C Ar), 132.23 (CH Ar), 
130.72 (CH Ar), 130.13 (CH Ar), 128.90 (C Ar), 124.04 (CH Ar), 114.76 (CH Ar), 113.07 (CH 
Ar), 70.83 (2 x CH2-gly), 69.84 (CH2-gly), 69.66 (CH2-gly), 67.44 (CH2-gly), 67.20 (CH2-gly), 
63.05 (COCCO), 34.30 (C tBu), 31.40 (CH3). HRMS (ES+): calcd for C102H120N2O11Na [M+Na]+ /z 
= 1571.8790, found m/z = 1571.8761. mp: 167-169 oC. IR (neat, cm-1): 2973, 2942 (CH), 
1740, 1703 (CO). 
diethyl 2,2-bis(4-methoxyphenyl)malonate, 77  
Anisole (4.40 mL, 40.4 mmol) was dissolved in acetic acid (20 mL, 
0.21 mol). Diethyl ketomalonate (3.10 mL, 20.2 mmol) was added 
and the solution heated to 50o C. H2SO4 (2.3 mL, 42 mmol) was 
added and the reaction was stirred at 80o C for 2 h and then at room 
temperature for 16 h. Water (40 mL) was added to the reaction and the diluted reaction 
solution was poured into 4.75 M NaOH solution (100 mL). The solution was neutralised to 
pH 7 with acetic acid and then extracted with ethyl acetate (3 x 60 mL), dried using MgSO4, 
filtered and concentrated to afford a crude viscous oil which was purified via flash column 
chromatography (eluent: Hexane/EtOAc - 10%) to give 0.73 g of 77 (2.0 mmol, 10% yield). 1H 
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NMR (300 MHz, CDCl3) δ = 7.39 – 7.28 (m, 4H, ArH), 6.98 – 6.79 (m, 4H, ArH), 4.27 (q, J = 7.1 
Hz, 4H, OCH2), 3.81 (d, J = 4.9 Hz, 6H, OCH3), 1.25 (t, J = 7.1 Hz, 6H, OCH2CH3). 13C NMR (101 
MHz, CDCl3) δ = 170.24 (CO), 158.78 (C Ar), 130.88 (C Ar), 130.71 (CH Ar), 113.25 (CH Ar), 
67.08, (COCCO), 61.73 (OCH2), 55.21 (OCH3), 13.94 OCH2CH3). HRMS (ES+): calcd for 
C21H25O6Na [M+Na]+ m/z = 373.1651, found m/z = 373.1645. mp: 60-62o C. IR (neat, cm-1): 
3003, 2985, 2937, 2838 (C-H), 1718 (CO). 
2,2-bis(4-methoxyphenyl)malonic acid, 78  
77 (0.30 g, 0.80 mmol) was dissolved in a water/EtOH mix (4 mL, 1:1 v:v). 
KOH (0.56 g, 10 mmol) was added and the reaction was refluxed for 4 h 
and then stirred at room temperature for 16 h. The solvents were 
removed and the residue dissolved in water (20 mL). This was extracted 
with diethyl ether (2 x 15 mL). The aqueous phase was then acidified to pH 0 with conc. HCl. 
This was then extracted with diethyl ether (2 x 20 mL), dried with MgSO4, filtered and 
concentrated to afford 0.32 g of 78 (1.06 mmol, 80% yield). 1H NMR (300 MHz, CDCl3) δ = 
7.36 – 7.18 (m, 4H, ArH), 6.97 – 6.80 (m, 4H, ArH), 3.81 (s, 6H, OCH3). 13C NMR (101 MHz, 
CDCl3) δ = 178.98 (CO), 158.85 (C Ar), 130.37 (C Ar), 129.67 (CH Ar), 114.04 (CH Ar), 55.29 
(OCH3). MS (ES+): calcd for C17H17O6 [M+H]+ m/z = 317.3, found m/z = 317.1. mp: 104-106o C. 
IR (neat, cm-1): 3596 (OH), 3005, 2984, 2939 (C-H), 1701 (CO), 1506 (COC).  
3-azidopropyl 4-methylbenzenesulfonate, 80 
3-bromo-propanol (7.69 g, 56.0 mmol) was dissolved in water (120 mL). NaN3 (9.86 g, 150 
mmol) was then added and the suspension was stirred at 80o C for 16 h. The reaction 
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mixture was cooled and then extracted with EtOAc (5 x 90 mL) 
and the organics were combined and washed with brine (100 
mL).  The organic layer was then dried using MgSO4, filtered 
and concentrated to afford 3.66 g of 79 (36.2 mmol, 71% yield) which was used as obtained. 
79 (1.09 g, 10.8 mmol) and Et3N (3.04 mL, 21.6 mmol) were dissolved in DCM (100 mL) and 
cooled to 0o C. 4-Toluenesulfonyl chloride (2.17 g, 11.4 mmol) was then added and the 
solution was allowed to warm to room temperature and stirred for 16 h. The reaction was 
quenched with water (50 mL) and the organic layer was separated and dried using MgSO4, 
filtered and evaporated to afford an oily solid which was purified via flash column 
chromatography (eluent: DCM/Pet. Ether 1:9) to give 1.27 g of 80 as a slightly yellow oil 
(5.00 mmol, 46% yield). 1H NMR (300 MHz, CDCl3) δ 7.82 (d, J = 8.3 Hz, 2H, ArH), 7.39 (d, J = 
8.0 Hz, 2H, ArH), 4.12 (t, J = 5.9 Hz, 2H, OCH2), 3.40 (t, J = 6.5 Hz, 2H, N3CH2), 2.48 (s, J = 12.8 
Hz, 3H, CH3), 1.98 – 1.79 (m, 2H, OCH2CH2). Analysis is in agreement with literature data.10  
1-azido-3-iodopropane, 81 
80 (2.00 g, 7.84 mmol), was then dissolved in acetone (20 mL) and NaI (1.77 g, 
11.8 mmol) was added. The suspension was refluxed for 16 h. The white 
suspension was filtered off and washed with acetone (20 mL). Ether was added to the 
filtrate (60 mL) and this was then washed with water (2 x 20 mL). The organic layer was 
separated and dried using MgSO4, filtered and concentrated to afford 1.50 g (7.14 mmol, 
95% yield) of 81 which was used as obtained with no further purification necessary. 1H NMR 
(300 MHz, CDCl3) δ 3.46 (t, J = 6.3 Hz, 2H), 3.27 (t, J = 6.6 Hz, 2H), 2.06 (p, J = 6.5 Hz, 2H). 
Analysis is in agreement with literature data.11 
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diethyl 2,2-bis(3-azidopropyl)malonate, 82  
Diethyl malonate (1.44 mL, 9.48 mmol) was dissolved in THF (130 
mL).  NaH (0.60 g, 23.7 mmol) was added and the solution was 
refluxed for 1 h. 81 (5.00 g, 23.7 mmol) was then added and the 
reaction was held at reflux for 16 h. The solvents were then removed and the crude residue 
purified via flash column chromatography (eluent: Pet. Ether/EtOAc 9:1) to give 2.10 g of 82 
(6.40 mmol, 68 % yield). 1H NMR (300 MHz, CDCl3) δ = 4.22 (q, J = 7.1 Hz, 4H, COCH2), 3.32 
(t, J = 6.6 Hz, 4H, N3CH2), 2.02 – 1.91 (m, 4H, CCH2), 1.58 – 1.44 (m, 4H, N3CH2CH2), 1.28 (t, J 
= 7.1 Hz, 6H, OCH2CH3). 13C NMR (101 MHz, CDCl3) δ = 171.05 (CO), 61.45 (OCH2), 56.77 (C), 
51.29 (N3CH2), 29.90 (CCH2), 23.78 (N3CH2CH2), 14.06 (OCH2CH3).  HRMS (ES+): calcd for 
C13H22N6O4Na [M+Na]+ m/z = 349.2, found m/z = 349.2. Analysis is in agreement with 
literature data.12 
5,5-bis(3-azidopropyl)pyrimidine-2,4,6(1H,3H,5H)-trione, 83  
82 (1.80 g, 5.50 mmol) and urea (1.65 g, 27.5 mmol) were dissolved in DMSO 
(80 mL). NaH (0.66 g, 27 mmol) was added to the solution which was then 
stirred for 16 h. Sat. NaHCO3 (160 mL) was then added and the mixture was 
extracted with EtOAc (2 x 200 mL). The combined organic extracts were 
dried using MgSO4, filtered and concentrated to afford a clear oil. Addition of water 
precipitates the product, which was filtered, redissolved in EtOAc, dried using MgSO4, 
filtered and concentrated to afford 0.52 g of  83 as a yellow solid (1.8 mmol, 32% yield). 1H 
NMR (300 MHz, CDCl3) δ = 8.19 (s, 2H, NH), 3.31 (t, J = 6.6 Hz, 4H, N3CH2), 2.13 – 2.02 (m, 
4H, CCH2), 1.59 – 1.47 (m, 4H, N3CH2CH2). 13C NMR (101 MHz, CDCl3) δ = 172.37 (CO), 149.58 
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(CO), 55.24 (C), 50.76 (N3CH2), 35.51 (CCH2), 24.43 (N3CH2CH2). HRMS (ES+): calcd for 
C10H14N8O3Na [M+Na]+ m/z = 317.1087, found m/z = 317.1077. Analysis is in agreement with 
literature data.12 
4,4',4''-((4-(prop-2-yn-1-yloxy)phenyl)methanetriyl)tris(tert-butylbenzene), 84  
48 (0.40g, 0.79 mmol) was dissolved in DMF (8 mL). K2CO3 (0.52 g, 
3.8 mmol) was added and the mixture was stirred at 80o C for 30 
minutes. Propargyl bromide (0.12 mL, 80% in toluene, 1.3 mmol) 
was added and stirring continued at 80o C for 16 h. The solvent was 
removed and the residue taken up in water (20 mL) and EtOAc (30 
mL). The aqueous phase was separated, extracted with EtOAc (2 x 30 mL) and the combined 
organics were dried using MgSO4, filtered and concentrated to afford a white crude solid 
which was purified via flash column chromatography (eluent: Hexane/DCM 8:2) to give 0.40 
g of 84 as a white solid (0.73 mmol, 92% yield). 1H NMR (400 MHz, CDCl3) δ = 7.28 – 7.23 (m, 
6H, ArH), 7.15 – 7.08 (m, 8H, ArH), 6.89 – 6.85 (m, 2H, ArH), 4.69 (d, J = 2.4 Hz, 2H, OCH2), 
2.54 (t, J = 2.4 Hz, 1H, CCH), 1.33 (s, 27H, CH3). 13C NMR (101 MHz, CDCl3) δ = 155.47 (C Ar), 
148.35 (C Ar), 144.02 (C Ar), 140.49 (C Ar), 132.28 (CH Ar), 130.73 (CH Ar), 124.06 (CH Ar), 
113.30 (CH Ar), 78.81 (OCH2C), 75.38 (CCH) 55.77 (OCH2), 34.31 (C tBu), 31.39 (CH3). HRMS 
(ES+): calcd for C40H46O [M]+ m/z = 542.8, found m/z = 542.3. Analysis is in agreement with 
literature data.12  
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5,5-bis(3-(4-((4-(tris(4-(tert-butyl)phenyl)methyl)phenoxy)methyl)-1H-1,2,3-triazol-1-
yl)propyl)pyrimidine-2,4,6(1H,3H,5H)-trione, 85  
83 (16 mg, 0.054 mmol,), and 
84 (62 mg, 0.114 mmol,) were 
dissolved in dry, degassed 
chloroform (1 mL). A catalytic 
amount of Cu(MeCN)4PF6 and 
TBTA were added, and the reaction mixture was stirred at room temperature, under argon 
for 3 days. After solvent removal, the crude product was purified by flash column 
chromatography (eluent: cyclohexane/EtOAc 7:3) to give 31 mg of 85 as a white solid (22 
µmol, 26 % yield).  1H NMR (300 MHz, CDCl3) δ = 8.37 (s, 2H, NH), 7.62 (d, J = 6.6 Hz, 2H, 
CHtria), 7.26 – 7.20 (m, 12H, ArH), 7.14 – 7.04 (m, 16H, ArH), 6.83 (d, J = 8.8 Hz, 4H, ArH), 
5.18 (s, 4H, OCH2), 4.39 – 4.24 (m, 4H, NCH2), 2.06 – 1.97 (m, 4H, CCH2), 1.97 – 1.83 (m, 4H, 
NCH2CH2), 1.31 (s, 54H, CH3). 13C NMR (101 MHz, CD2Cl2) δ = 171.70 (CO), 156.02 (C Ar), 
148.39 (C Ar), 144.39 (C Ar), 140.36 (C Ar), 131.95 (CH Ar), 130.37 (CH Ar), 124.32 (CH Ar), 
113.27 (CH Ar), 63.10 (C), 61.48 (OCH2), 55.05 (COCCO), 49.73 (NCH2), 34.80 (CCH2), 34.18 (C 
tBu), 31.11 (CH3), 25.35 (NCH2CH2). HRMS (ES+): calcd for C90H106N8O5Na [M+Na]+ m/z = 
1401.8, found m/z = 1401.6. Analysis is in agreement with literature data.12  
 
4,4',4''-((4-(3-azidopropoxy)phenyl)methanetriyl)tris(tert-butylbenzene), 86  
48 (1.04 g, 2.06 mmol) and 80 (0.53 g, 2.1 mmol) were suspended in butanone. Once heated 
to 50o C a solution forms. K2CO3 (1.42 g, 10.3 mmol) is then added and the mixture is heated 
Experimental 
230 
 
at 70o C for 16 h. The suspension was then filtered through a 
sintered funnel and washed with acetone. The filtrate was 
concentrated to give a crude white solid which was purified via 
flash column chromatography (eluent: Pet. Ether/DCM 7:3) to give 
0.75 g of 86 (1.3 mmol, 62 % yield). 1H NMR (300 MHz, CDCl3) δ = 7.28 – 7.21 (m, 6H, ArH), 
7.15 – 7.05 (m, 8H, ArH), 6.83 – 6.74 (m, 2H, ArH), 4.04 (t, J = 5.9 Hz, 2H, N3CH2), 3.54 (t, J = 
6.7 Hz, 2H, OCH2), 2.06 (p, J = 6.3 Hz, 2H, N3CH2CH2), 1.32 (s, 27H, CH3). 13C NMR (101 MHz, 
CDCl3) δ = 156.44 (C Ar), 148.31 (C Ar), 144.10 (C Ar), 139.86 (C Ar), 132.29 (CH Ar), 130.71 
(CH Ar), 124.05 (CH Ar), 112.93 (CH Ar), 64.29 (N3CH2), 61.45 (C), 48.31, OCH2), 34.30 (C tBu), 
31.39 (CH3), 28.85 (N3CH2CH2). Analysis is in agreement with literature data.10  
4-((4-(tris(4-(tert-butyl)phenyl)methyl)phenoxy)methyl)-1-(3-(4-(tris(4-(tert-
butyl)phenyl)methyl)phenoxy)propyl)-1H-1,2,3-triazole, 87  
84 (81 mg, 0.15 mmol) and 86 (88 mg, 0.15 
mmol) were dissolved in degassed CHCl3 (6.5 
mL). A catalytic amount of Cu(MeCN)4PF6  was 
then added and the reaction was left to stir for 
16 h. The solvents were removed and the 
residue dissolved in DCM (15 mL) and washed 
with water (10 mL). The organic phase was then dried using MgSO4, filtered and 
concentrated to afford a crude white solid which was purified via flash column 
chromatography (eluent: Hexane/EtOAc 8:2) to give 0.13 g of 87 (0.14 mmol, 76 % yield). 1H 
NMR (300 MHz, CDCl3) δ = 7.64 (s, J = 3.9 Hz, 1H, CHtria), 7.24 (d, J = 8.6 Hz, 12H, ArH), 7.13 – 
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7.05 (m, 14H, ArH), 6.84 (d, J = 9.0 Hz, 2H, ArH), 6.74 (d, J = 8.9 Hz, 2H, ArH), 5.19 (s, 2H, 
OCH2C), 4.61 (t, J = 6.9 Hz, 2H, NCH2), 3.96 (t, J = 5.6 Hz, 2H, OCH2CH2), 2.48 – 2.36 (m, 2H, 
OCH2CH2), 1.29 (d, J = 8.4 Hz, 54H). 13C NMR (101 MHz, CDCl3) δ = 156.2 (C Ar), 148.3 (C Ar), 
144.1 (C Ar), 132.3 (CH Ar), 130.6 (CH Ar), 124.3 and 124.1 (CH Ar), 119.5 (CHtria), 113.3 and 
113.0 (CH Ar), 63.9 (OCH2C=C), 47.5 (NCH2), 34.3 (C tBu), 31.3 (CH3) HRMS (ES+): calcd for 
C80H96N3O2 [M]+ m/z = 1130.7503, found m/z = 1130.7496. mp: 330-334o C. IR (neat, cm-1): 
2957, 2942, 2853 (C-H), 1503 (COC). 
5-(tert-butyl)-N1-(6-dodecanamidopyridin-2-yl)-N3-(6-propionamidopyridin-2-
yl)isophthalamide compound with 5-(3-(1H-1,2,3-triazol-1-yl)propyl)-5-(3-(4-((4-(tris(4-
(tert-butyl)phenyl)methyl)phenoxy)methyl)-1H-1,2,3-triazol-1-yl)propyl)pyrimidine-
2,4,6(1H,3H,5H)-trione and 4,4',4''-((4-ethoxyphenyl)methanetriyl)tris(tert-butylbenzene) 
(1:1), 88  
45 (37 mg, 0.056 
mmol), 83 (16 mg, 
0.054 mmol) and 84 
(62 mg, 0.11 mmol) 
were dissolved in 
CHCl3 (1 mL). The 
solution was stirred 
for 1 h and catalytic amounts of Cu(MeCN)4PF6 and TBTA were then added. The suspension 
was stirred for 16 h. The solvents were then removed and the residue purified via flash 
column chromatography (eluent: DCM/MeOH - 2-4%) to afford 6 mg of 88 (2.95 µmol, 5% 
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yield). 1H NMR (300 MHz, CDCl3) δ 12.72 (s, 2H, NH), 9.84 (s, 2H, NH), 9.34 (s, 2H, NH), 8.32 
(s, 1H, 6), 8.22 (s, 2H, 4), 8.09 (d, J = 1.4 Hz, 2H, 11), 8.00 (d, J = 8.0 Hz, 2H, 9), 7.73 (t, J = 7.7 
Hz, 2H, 10), 7.52 (s, 2H, 14’), 7.22 (m, 12 H, 5’), 7.08 - 7.06 (m, 12H, 9’ and 4’), 6.75 (d, J = 8.9 
Hz, 4H, 10’), 5.04 (s, 4H, 12’), 4.34 (t, J = 6.0Hz, 4H, 15’), 2.44 (m, 4H, 14), 2.21 (m, 4H, 17’), 
2.05 (m, 4H, 16’), 1.71 (m, 4H, 15), 1.36 (s, 9H, 1), 1.29 (s, 54H, 1’), 1.24 (m, 20H, alk). 13C 
NMR (101 MHz, CDCl3) δ 173.951 (CO), 172.72 (CO), 167.28 (CO), 156.17 (C Ar), 152.84 (C 
Ar), 152.15 (CH Ar), 150.93 (C pyr), 150.29 (C pyr), 148.44 (C Ar), 145.48 (C tria), 144.28 (C 
Ar), 141.52 (CH pyr), 140.65 (C Ar), 134.37 (CO), 132.54 (CH Ar), 130.85 (CH Ar), 130.15 (CH 
Ar), 124.49 (CH Ar), 124.26 (CH tria), 122.73 (CH Ar), 113.21 (CH Ar), 112.34 (CH pyr), 111.42 
(CH pyr), 63.23 (C Ar), 62.06 (OCH2), 55.38 (COCCO), 49.65 (NCH2), 37.77 (COCH2), 35.94 
(NCH2CH2CH2), 35.46 (C tBu), 34.55 (C tBu), 31.58 (CH3), 31.37 (CH3), 30.14 (alk), 29.98 (alk), 
29.87 (alk), 26.05 (alk), 25.46 (NCH2CH2). HRMS (ES+): calcd for C128H155N14O9Na [M+Na]+ 
m/z = 2055.9, found m/z = 2055.2. Analysis is in agreement with literature data.12 
45-(tert-butyl)-2,6,8,25-tetraaza-1,7(2,6)-dipyridina-4(1,3)-benzenacyclopentacosaphane-
3,5,9,24-tetraone compound with 4-((4-(tris(4-(tert-
butyl)phenyl)methyl)phenoxy)methyl)-1-(3-(4-(tris(4-(tert-
butyl)phenyl)methyl)phenoxy)propyl)-1H-1,2,3-triazole (1:1:1), 89 
45 (73 mg, 0.11 mmol) was dissolved in CHCl3. Cu(MeCN)4PF6 (42 mg, 0.11 mmol) was added 
and the reaction was stirred for 1 h. 84 (71 mg, 0.13 mmol) and 86 (77 mg, 0.13 mmol) were 
then added and the reaction was stirred for 16 h. A solution of KCN (70 mg) in MeOH (10 
mL) was added and the white suspension was stirred for 1 h. The solvents were then 
removed and the residue dissolved in DCM (15 mL) and washed with water (10 mL). The 
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organic phase was then dried using 
MgSO4, filtered and concentrated to 
afford a crude white solid which was 
purified via flash column 
chromatography (eluent: Hexane/EtOAc 
8:2) to give 45 mg of 89 (25 µmol, 19% 
yield).  1H NMR (300 MHz, CDCl3) δ 9.35 
(s, 2H, NH), 8.52 (s, 1H, 6), 8.38 (s, J = 12.0 Hz, 2H, 4), 8.07 (d, J = 8.0 Hz, 2H, 9), 7.90 (d, J = 
8.0 Hz, 2H, 11), 7.78 (s, 1H, 15’), 7.67 (t, J = 8.1 Hz, 2H, 10), 7.59 (s, 2H, NH), 7.28 – 7.13 (m, 
14H, 5’, 10’ [nearest triazole]), 7.13 – 6.95 (m, 16H, 4’, 9’), 6.64 (d, J = 8.9 Hz, 2H, 10’), 5.48 
(s, 2H, 12’), 4.48 (t, J = 6.7 Hz, 2H, 17’), 3.77 (t, J = 5.4 Hz, 2H, 15’), 2.17 – 2.02 (m, 6H, 16’, 
14), 1.70 – 1.50 (m, 4H, 15), 1.42 (s, J = 3.7 Hz, 9H, 1), 1.30 (d, J = 5.4 Hz, 54H, 1’), 1.26 (d, J = 
5.6 Hz, 20H, alk). 13C NMR (126 MHz, CDCl3) δ 171.64 (CO), 165.24 (CO), 155.93 (C Ar), 
155.84 (C Ar), 153.41 (C Ar), 149.94 (C pyr), 149.38 (CH Ar), 148.50 (C Ar), 148.35, 144.79 (C 
tria), 143.98 (C Ar), 143.69 (C pyr), 141.68 (CH pyr), 140.68 (C Ar), 140.40, 133.83 (CH Ar), 
132.69, (CH Ar) 132.37 (CH Ar), 130.66 (CH Ar), 130.57 (CH Ar), 124.16 (CH tria), 124.08 (CH 
Ar), 118.20, 113.65, 110.00 (CH pyr), 109.62 (CH pyr), 47.70 (NCH2), 37.57 (COCH2), 35.29 
(NCH2CH2CH2), 34.29 (C tBu), 31.39 (CH3), 30.04 (CH3), 29.70 (alk), 29.36 (alk), 28.51 (alk), 
28.29 (alk), 28.06 (alk), 25.03 (NCH2CH2). HRMS (ES+): calcd for C118H146N9O6 [M+H]+ m/z = 
1785.1396, found m/z = 1785.1267. mp: 143-146o C. IR (neat, cm-1): 3587 (NH), 2963, 2927, 
2858 (C-H), 1704 (CO), 1506 (COC). 
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5.3 Synthesis of Anthracene terminated compounds 
General Procedure A for the Synthesis of Ethyl-9-anthryloxyenoate Derivatives: 
Acetone (200 mL) was added to a round bottom flask and degassed for 30 minutes. To this 
was added anthrone and K2CO3. After stirring for 10 minutes the flask was heated to reflux 
at which point the appropriate bromo-ester was added. The solution was left at reflux for 24 
h. The contents were then filtered and the solvent removed. The residue was dissolved in 
DCM (100 mL) and washed with water (50 mL). The organic phase was then dried using 
MgSO4, filtered and evaporated. The resulting orange oil was purified via flash column 
chromatography, to give a yellow solid.  
ethyl 4-(anthracen-9-yloxy)butanoate, 95 
 General Procedure A using anthrone (4.00g, 20.1 mmol), K2CO3 
(2.78 g, 20.1 mmol) and ethyl 4-bromobutyrate (2.90 mL, 20.1 
mmol) in acetone (200 mL) gave 95 (1.48 g, 20% yield). 
Chromatography on silica (eluent: DCM/Hexane 9:1). 1H NMR (300 MHz, CDCl3) δ = 8.36 – 
8.16 (m, 3H, Ar), 8.11 – 7.91 (m, 2H, ArH), 7.58 – 7.39 (m, 4H, ArH), 4.31 – 4.18 (m, 4H, 
OCH2CH2 and COOCH2CH3), 2.82 (t, J = 7.4 Hz, 2H, OCH2CH2CH2), 2.49 – 2.35 (m, 2H, 
OCH2CH2), 1.33 (t, J = 7.1 Hz, 3H¸ COOCH2CH3). 13C NMR (101 MHz, CDCl3) δ = 173.28 (CO), 
151.03 (C Ar), 132.41 (C Ar), 128.46 (CH Ar), 125.47 (CH Ar), 125.20 (CH Ar), 124.64 (C Ar), 
122.24 (CH Ar), 74.55 (OCH2), 60.56 (COOCH2CH3), 31.19 (OCH2CH2CH2), 26.05 (OCH2CH2), 
14.31 (COOCH2CH3). MS (ES+): calcd for C20H20O3 [M++MeO-] m/z = 338.15, found m/z = 
338.3. Analysis is in agreement with literature data.13  
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ethyl 7-(anthracen-9-yloxy)heptanoate, 96 
General Procedure A using anthrone (4.00g, 20.1 mmol), K2CO3 (2.78 g, 
20.1 mmol) and ethyl 7-bromoheptanoate (3.64 mL, 20.1 mmol) in 
acetone (200 mL) gave 96 (3.59 g, 51% yield). Chromatography on silica 
(eluent: DCM/Hexane 9:1). 1H NMR (300 MHz, CDCl3) δ = 8.38 – 8.18 (m, 
3H, ArH), 8.09 – 7.95 (m, 2H, ArH), 7.56 – 7.41 (m, 4H, ArH), 4.28 – 4.12 (m, 4H, OCH2CH2 
and COOCH2CH3), 2.39 (t, J = 7.5 Hz, 2H, COCH2), 2.15 – 2.00 (m, 2H, OCH2CH2), 1.84 – 1.69 
(m, 4H, Alk), 1.58 – 1.47 (m, 2H, Alk), 1.32 – 1.27 (m, 3H, COOCH2CH3). 13C NMR (101 MHz, 
CDCl3) δ = 173.79 (CO), 151.44 (C Ar), 132.44 (C Ar), 128.43 (CH Ar), 125.45 (CH Ar), 125.07 
(CH Ar), 124.72 (C Ar), 122.42 (CH Ar), 121.99 (CH Ar), 75.99 (OCH2), 60.25 (COOCH2CH3), 
34.35 (COCH2CH2), 30.54 (OCH2CH2), 29.15 (C Alk), 26.00 (C Alk), 24.98 (C Alk), 14.29 
(COOCH2CH3). HRMS (ES+): calcd for C23H26O3 [M]+ m/z = 350.2, found m/z = 350.3. Analysis 
is in agreement with literature data.13 
ethyl 10-(anthracen-9-yloxy)decanoate, 97 
 General Procedure A using anthrone (2.79 g, 14.4 mmol), K2CO3 
(1.99 g, 14.4 mmol) and ethyl 7-bromodecanoate (4.00 mL, 14.4 
mmol) in acetone (200 mL) gave 97 (3.54 g, 62% yield). 
Chromatography on silica (eluent: DCM/Hexane 7:3). 1H NMR (300 
MHz, CDCl3) δ = 8.30 – 8.15 (m, 2H, ArH), 8.14 (s, 1H, ArH), 8.01 – 7.83 (m, 2H, ArH), 7.53 – 
7.25 (m, 4H, ArH), 4.31 – 3.85 (m, 4H, COOCH2 and OCH2), 2.23 (t, J = 7.5 Hz, 2H, COCH2), 
1.98 (dd, J = 8.4, 6.8 Hz, 2H, OCH2CH2), 1.68 – 1.48 (m, 4H, OCH2CH2CH2 and COCH2CH2), 1.43 
– 1.21 (m, 8H, Alk), 1.18 (t, J = 7.1 Hz, 3H, COOCH2CH3). 13C NMR (101 MHz, CDCl3) δ = 
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173.92 (CO), 151.52 (C Ar), 132.44 (C Ar), 128.41 (CH Ar), 125.43 (CH Ar), 125.02 (CH Ar), 
124.74 (C Ar), 122.45 (CH Ar), 121.93 (CH Ar), 76.17 (OCH2), 60.18 (COOCH2CH3), 34.41 
(COCH2CH2), 30.69 (OCH2CH2), 29.55 (alk), 29.46 (alk), 29.27 (alk), 29.16 (alk), 26.24 (alk), 
25.00 (alk), 14.28 (COOCH2CH3). HRMS (ES+): calcd for C12H24O3Na (loss of anthracene) m/z = 
239.16, found m/z = 239.2.  IR (neat): 3077 (CH) 2928 (CH) 2855 (CH) 1678 (CO). 
General Procedure B for the Synthesis of Carboxylic Derivatives:  
The ester compound was dissolved in a round bottom flask containing degassed ethanol 
(100 mL). 10% NaOH solution (100 mL) was then added and the mixture was heated under 
reflux for 14 h. Once cooled to room temperature, the ethanol was removed under vacuum 
to afford a solid which was then dissolved in water (400 mL). To this solution, conc. HCl was 
added dropwise with stirring until pH 6 at which point a cream precipitate forms. The 
precipitate was filtered, and dried to give a cream precipitate.  
4-(anthracen-9-yloxy)butanoic acid, 98 
 General procedure B using ester 95 (3.45 mmol) gave 98 (0.86 
g, 89%). 1H NMR (300 MHz, CDCl3) δ = 8.32 – 8.20 (m, 3H, ArH), 
8.07 – 7.96 (m, 2H, ArH), 7.58 – 7.40 (m, 4H, ArH), 4.27 (t, J = 
6.2 Hz, 2H, OCH2), 2.90 (t, J = 7.4 Hz, 2H, COCH2), 2.41 (dd, J = 13.6, 6.9 Hz, 2H, OCH2CH2). 13C 
NMR (101 MHz, CDCl3) δ = 176.38 (CO), 150.93 (C Ar), 134.18 (CH Ar), 132.37 (C Ar), 128.42 
(CH Ar), 125.44 (CH Ar), 125.20 (CH Ar), 124.59 (C Ar), 122.17 (CH Ar), 74.63 (OCH2), 30.93 
(COCH2), 25.93 (OCH2CH2). HRMS (ES+): calcd for C18H16O3Na [M+Na]+ m/z = 303.0997, found 
m/z = 303.1003. Analysis is in agreement with literature data.13   
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7-(anthracen-9-yloxy)heptanoic acid, 99 
General procedure B using ester 95 (1.03 mmol) gave 99 (2.79 g, 84%). 
1H NMR (300 MHz, CDCl3) δ 8.37 – 8.18 (m, 3H, ArH), 8.07 – 7.95 (m, 2H, 
ArH), 7.55 – 7.41 (m, 4H, ArH), 4.21 (t, J = 6.6 Hz, 2H, OCH2CH2), 2.45 (t, J 
= 7.4 Hz, 2H¸ COCH2), 2.16 – 2.02 (m, 2H, OCH2CH2), 1.84 – 1.67 (m, 4H, 
OCH2CH2CH2 and COCH2CH2), 1.61 – 1.49 (m, 2H, COCH2CH2CH2). 13C NMR (101 MHz, CDCl3) 
δ = 179.1 (CO), 151.4 (C Ar), 132.4 (CH Ar), 128.4 (CH Ar), 125.5 (CH Ar), 125.1 (CH Ar), 124.7 
(C Ar), 122.4 (CH Ar), 122.0 (CH Ar), 76.0 (OCH2), 33.8 (COCH2), 30.6 (OCH2CH2), 29.1 
(COCH2CH2CH2), 26.1 (OCH2CH2CH2), 24.7 (COCH2CH2). HRMS (ES+): calcd for C21H21O3 [M-H]- 
m/z = 321.1 found m/z = 321.3. Analysis is in agreement with literature data.13 
10-(anthracen-9-yloxy)decanoic acid, 100  
General procedure B using ester 97 (8.90 mmol) gave 100 (2.19 g, 
67%). 1H NMR (300 MHz, CDCl3) δ 8.27 – 8.14 (m, 2H, ArH), 8.12 (s, 
1H, ArH), 7.90 (m, 2H, ArH), 7.49 – 7.25 (m, 4H, ArH), 4.10 (t, J = 6.6 
Hz, 2H, OCH2CH2), 2.28 (t, J = 7.4 Hz, 2H, COCH2), 1.95 (dt, J = 12.8, 5.4 Hz, 2H, OCH2CH2), 
1.68 – 1.44 (m, 4H, OCH2CH2CH2 and COCH2CH2), 1.46 – 1.21 (m, 8H, Alk). 13C NMR (101 
MHz, CDCl3) δ = 179.64 (CO), 151.50 (C Ar), 132.44 (C Ar), 128.41 (CH Ar), 125.44 (CH Ar), 
125.03 (CH Ar), 124.74 (C Ar), 122.46 (CH Ar), 121.95 (CH Ar), 76.17 (OCH2), 34.18 
(COCH2CH2), 30.68 30.69 (OCH2CH2), 29.55 (alk), 29.45 (alk), 29.26 (alk), 29.10 (alk), 26.23 
(alk), 24.76 (alk). HRMS (ES+): calcd for C24H29O3 [M]+ m/z = 365.2117, found m/z = 
365.2179. mp: 208-210o C. IR (neat): 3243 (OH) 2913 (CH) 2849 (CH) 1675 (CO). 
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General Procedure C for the Synthesis of Activated Ester Derivatives:  
The carboxylic acid and N-Hydroxysuccinimide were dissolved in dry EtOAc in a round 
bottom flask. A solution of N,N'-Dicyclohexylcarbodiimide in EtOAc was then added 
dropwise via syringe over 15 minutes and the resulting solution was stirred at room 
temperature for 48 h. The suspension formed was filtered through a sintered funnel and the 
filtrate was then concentrated under reduced pressure to form an orange oil. The flask was 
then cooled on ice for 4 h to form the pure compound as a yellow crystalline solid. Crude 
103 was purified via flash column chromatography. 
2,5-dioxopyrrolidin-1-yl 4-(anthracen-9-yloxy)butanoate, 101 
 General Procedure C using carboxylic acid 98 (0.82 g, 2.9 
mmol), N-Hydroxysuccinimide (0.34 g, 2.9 mmol) in EtOAc (30 
mL) and N,N'-Dicyclohexylcarbodiimide (0.66 g, 2.9 mmol) in 
EtOAc (15 mL) gave 101 (1.08 g, 98%). 1H NMR (300 MHz, CDCl3) 
δ 8.29 – 8.22 (m, 3H, ArH), 8.01 (dt, J = 7.5, 3.7 Hz, 2H, ArH), 7.58 – 7.42 (m, 4H, ArH), 4.30 
(t, J = 6.1 Hz, 2H, OCH2), 3.20 (t, J = 7.4 Hz, 2H, COCH2), 2.90 (s, J = 2.1 Hz, 4H, CH2-NHS), 2.59 
– 2.44 (m, 2H, OCH2CH2). 13C NMR (101 MHz, CDCl3) δ 169.09 (CO), 168.43 (CO), 150.66 (C 
Ar), 132.38 (C Ar), 128.48 (CH Ar), 125.52 (CH Ar), 125.42 (CH Ar), 124.56 (C Ar), 122.41 (CH 
Ar), 122.09 (CH Ar), 73.44 (OCH2), 49.30 (CH2-NHS) 33.82 (COCH2), 27.88 (OCH2CH2). HRMS 
(ES+): calcd for C22H19O5Na [M+Na]+ m/z = 400.1161, found m/z = 400.1171. Analysis is in 
agreement with literature data.13    
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2,5-dioxopyrrolidin-1-yl 7-(anthracen-9-yloxy)heptanoate, 102 
 General Procedure C using carboxylic acid 99 (2.60 g, 8.07 mmol), N-
Hydroxysuccinimide (1.02 g, 8.88 mmol) in EtOAc (80 mL) and N,N'-
Dicyclohexylcarbodiimide (1.83 g, 8.88 mmol) in EtOAc (40 mL) gave 102 
(3.21 g, 96%).1H NMR (300 MHz, CDCl3) δ = 8.34 – 8.15 (m, 3H, ArH), 
8.07 – 7.93 (m, 2H, ArH), 7.59 – 7.39 (m, 4H, ArH), 4.22 (t, J = 6.6 Hz, 2H, OCH2CH2) 2.85 (s, J 
= 4.7 Hz, 4H, CH2-NHS), 2.70 (t, J = 7.4 Hz, 2H, COCH2), 2.16 – 2.00 (m, 2H, OCH2CH2), 1.89 
(dt, J = 15.1, 7.4 Hz, 2H, OCH2CH2CH2), 1.83 – 1.69 (m, 2H, COCH2CH2), 1.70 – 1.54 (m, 2H, 
COCH2CH2CH2. Analysis is in agreement with literature data.13 
2,5-dioxopyrrolidin-1-yl 10-(anthracen-9-yloxy)decanoate, 103 
General Procedure C using carboxylic acid 100 (0.99 g, 2.7 mmol), 
N-Hydroxysuccinimide (0.31 g, 2.7 mmol) in EtOAc (25 mL) and 
N,N'-Dicyclohexylcarbodiimide (0.61 g, 2.7 mmol) in EtOAc (15 mL) 
gave 103 (1.21 g, 97%). Chromatography on silica (eluent: 
DCM/EtOAc 8:2). 1H NMR (300 MHz, CDCl3) δ = 8.27 – 8.17 (m, 2H, ArH), 8.13 (s, 1H, ArH), 
7.97 – 7.85 (m, 2H, ArH), 7.45 – 7.34 (m, 4H, ArH), 4.11 (t, J = 6.6 Hz, 2H, OCH2CH2), 2.81 – 
2.63 (m, 4H, CH2-NHS), 2.54 (t, J = 7.5 Hz, 2H, COCH2), 2.05 – 1.89 (quin, J = 8.0 Hz, 2H, 
OCH2CH2), 1.69 (quin, J = 7.9 Hz, 2H¸ COCH2CH2), 1.64 – 1.51 (quin, J = 6.8 Hz, 2H¸ 
OCH2CH2CH2), 1.44 – 1.22 (m, 8H, Alk). 13C NMR (101 MHz, CDCl3) δ = 169.19 (CO), 168.70 
(CO), 151.53 (C Ar), 132.44 (C Ar), 128.41 (CH Ar), 125.45 (CH Ar), 125.04 (CH Ar), 124.75 (C 
Ar), 122.48 (CH Ar), 121.93 (CH Ar), 76.18 (OCH2), 30.97 (COCH2), 30.68 (OCH2CH2), 29.48 
Experimental 
240 
 
(alk), 29.34 (alk), 29.07 (alk), 28.77 (alk), 26.21 (OCH2CH2CH2), 25.59 (CH2-NHS), 24.60 
(COCH2CH2). HRMS (ES+): calcd for C28H32N2O5 [M]+ m/z = 462.2280, found m/z = 462.2276. 
mp: 88-90o C. IR (neat): 2924 (CH) 2849 (CH) 1778 (CO) 1731 (CO). 
General Procedure D for the Synthesis of Diaminopyridine Derivatives: 
Diisopropylethylamine and an excess of 2,6-diaminopyridine were suspended in dry DCM 
(180 mL). A solution of the activated-(NHS) ester in DCM (50 mL) was then added dropwise 
over 10 minutes with stirring. The mixture was then heated to reflux and maintained for 5 
days. Once cooled to room temperature, the suspension was filtered and the filtrate 
washed with water (3 x 300 mL). The organic phase was then dried using MgSO4, filtered 
and evaporated. The crude oil obtained was then purified via flash column chromatography 
to give an amber solid. 
N-(6-aminopyridin-2-yl)-4-(anthracen-9-yloxy)butanamide, 104 
 General Procedure D using Diisopropylamine (0.70 mL, 4.0 mmol) 
and 2,6-diaminopyridine (2.89 g, 26.5 mmol) in DCM (55 mL) and 
101 (1.00 g, 2.65 mmol) in DCM (18 mL) gave 104 (0.90 g, 91 %). 
Chromatography on silica (eluent: DCM/EtOAc 8:2). 1H NMR (300 
MHz, CDCl3) δ = 8.30 – 8.21 (m, 3H, ArH), 8.17 (s, 1H, NH), 8.05 – 7.95 (m, 2H, ArH), 7.62 (d, J 
= 7.7 Hz, 1H, pyr), 7.53 – 7.42 (m, 5H, ArH (1H-pyr and 4H-Aranth), 6.26 (d, J = 7.9 Hz, 1H, 
pyr), 4.37 (s, J = 37.7 Hz, 2H, NH2), 4.26 (t, J = 6.2 Hz, 2H, OCH2), 2.84 (t, J = 7.4 Hz, 2H, 
COCH2), 2.52 – 2.39 (m, 2H, OCH2CH2). 13C NMR (101 MHz, CDCl3) δ = 170.84 (CO), 157.03 (C 
pyr), 150.98 (C Ar), 149.75 (C pyr), 140.29 (CH pyr), 132.39 (C Ar), 128.47 (CH Ar), 125.49 (CH 
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Ar), 125.28 (CH Ar), 124.61 (C Ar), 122.22 (CH Ar), 104.34 (CH pyr), 103.36 (CH pyr), 74.55 
(OCH2), 34.13 (COCH2), 26.22 (OCH2CH2). HRMS (ES+): calcd for C23H22N3O2 [M]+ m/z = 
372.1712, found m/z = 372.1721. Analysis is in agreement with literature data.13     
N-(6-aminopyridin-2-yl)-7-(anthracen-9-yloxy)heptanamide, 105 
General Procedure D using Diisopropylamine (2.29 mL, 13.2 
mmol) and 2,6-diaminopyridine (9.60 g, 88 mmol) in DCM (180 
mL) and 102 (3.69 g, 8.80 mmol) in DCM (50 mL) gave 105 (2.21 
g, 62 %). Chromatography on silica (eluent: DCM/EtOAc 8:2). 1H 
NMR (300 MHz, CDCl3) δ = 8.36 – 8.18 (m, 3H, ArH), 8.08 – 7.95 (m, 2H, ArH), 7.78 – 7.65 (m, 
1H, NH), 7.61 – 7.54 (m, 1H, pyr), 7.52 – 7.40 (m, 5H ArH (4H-anth and 1H-pyr)), 6.33 – 6.25 
(d, J = 7.9 Hz, 1H, pyr), 4.42 – 4.26 (m, 2H, NH2), 4.21 (t, J = 6.6 Hz, 2H, OCH2CH2), 2.46 – 2.37 
(m, 2H, COCH2), 2.14 – 2.02 (m, 2H, OCH2CH2), 1.90 – 1.80 (m, 2H, COCH2CH2), 1.78 – 1.66 
(m, 2H¸ OCH2CH2CH2), 1.62 – 1.50 (m, 2H, COCH2CH2CH2). Analysis is in agreement with 
literature data.13 
N-(6-aminopyridin-2-yl)-10-(anthracen-9-yloxy)decanamide, 106 
General Procedure D using Diisopropylamine (0.70 mL, 4.0 
mmol) and 2,6-diaminopyridine (2.89 g, 26.5 mmol) in 
DCM (55 mL) and 103 (1.22 g, 2.65 mmol) in DCM (18 mL) 
gave 106 (0.48 g, 40 %). Chromatography on silica (eluent: DCM/EtOAc 9:1). 1H NMR (300 
MHz, CDCl3) δ = 8.27 – 8.16 (m, 2H, ArH), 8.12 (s, 1H, ArH), 7.95 – 7.84 (m, 2H, ArH), 7.68 (s, 
1H, NH), 7.47 (d, J = 7.9 Hz, 1H, pyr), 7.43 – 7.31 (m, 5H, ArH (4H-ArHanth and 1H-pyr), 6.14 
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(d, J = 8.7 Hz, 1H, pyr), 4.29 – 4.17 (m, 2H, NH2), 4.10 (t, J = 6.6 Hz, 2H, OCH2), 2.25 (t, J = 7.5 
Hz, 2H, COCH2), 2.02 – 1.89 (m, 2H, OCH2CH2), 1.72 – 1.48 (m, 4H, OCH2CH2CH2 and 
COCH2CH2), 1.38 – 1.23 (m, 8H, Alk). 13C NMR (101 MHz, CDCl3) δ = 171.59 (CO), 156.87 (C 
pyr), 151.52 (C Ar), 149.69 (C pyr), 140.33 (CH pyr), 132.44 (C Ar), 128.41 (CH Ar), 125.44 (CH 
Ar), 125.03 (CH Ar), 124.75 (C Ar), 122.48 (CH Ar), 121.93 (CH Ar), 104.17 (CH pyr), 103.25 
(CH pyr), 76.19 (OCH2), 37.86 COCH2), 30.69 (OCH2CH2), 29.55 (alk), 29.45 (alk), 29.34 (alk), 
29.20 (alk), 26.23 (OCH2CH2CH2), 25.41 (COCH2CH2). HRMS (ES+): calcd for C29H34N3O2 [M]+ 
m/z = 456.2651, found m/z = 456.2643. mp: 63-65o C. IR (neat): 3336 (N-H) 2926 (C-H) 2853 
(C-H) 1676 (CO) 1617 (CO). 
General Procedure E for the synthesis of Acyclic Receptors 107-109 
In a round bottom flask, the amine terminated compound and NEt3 were dissolved in THF. A 
solution of 39 in THF was added dropwise at room temperature. The reaction mixture was 
left stirring for 48 h. When using compound 109 catalytic DMAP was added. Once complete, 
the suspension was filtered, and the solvent removed under reduced pressure. The crude 
product was then purified via flash column chromatography to afford a yellow crystalline 
solid. 
N1,N3-bis(6-(4-(anthracen-9-yloxy)butanamido)pyridin-2-yl)-5-(tert-butyl)isophthalamide, 
107 
 General Procedure E using 39 (0.08 g, 0.30 mmol) in THF (20 mL) and 104 (0.25 g, 0.67 
mmol), NEt3 (0.10 mL, 0.72 mmol) in THF (40 mL) gave 107 (0.14 g, 51 %). Chromatography 
on silica (eluent: DCM/EtOAc - 15%). 1H NMR (300 MHz, CDCl3) δ = 8.48 (s, 2H, NH), 8.28 – 
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7.89 (m, 19H, (2H-NH, 4H-pyr, 3H Ar, 10H Aranth)), 7.78 (t, J 
= 8.0 Hz, 2H, pyr), 7.47 – 7.35 (m, 8H, Aranth), 4.24 (t, J = 
6.0 Hz, 4H, OCH2), 2.85 (t, J = 7.1 Hz, 4H COCH2), 2.50 – 
2.36 (m, 4H, COCH2CH2), 1.39 (s, 9H, CH3). 13C NMR (101 
MHz, CDCl3) δ = 171.20 (CO), 165.03 (CO), 153.35 (C pyr), 
150.77 (C Aranth), 149.68 (C pyr), 149.49 (C Ar), 140.93 (CH 
pyr), 134.28 (C Ar), 132.31 (C Aranth), 128.60 (CH Aranth), 
128.49 (CH Ar), 125.43 (CH Aranth), 125.25 (CH Aranth), 124.50 (C Aranth), 122.35 (CH Aranth), 
122.02 (CH Aranth), 110.14 (CH pyr), 109.88 (CH pyr), 74.38 (OCH2), 35.16 (C tBu), 34.02 
(COCH2), 31.07 (CH3), 26.04 (OCH2CH2). HRMS (ES+): calcd for C58H53N6O6 [M]+ m/z = 
929.4027, found m/z = 929.4016. Analysis is in agreement with literature data.13     
N1,N3-bis(6-(7-(anthracen-9-yloxy)heptanamido)pyridin-2-yl)-5-(tert-
butyl)isophthalamide, 108 
General Procedure E using 39 (0.28 g, 1.1 mmol) in THF (70 
mL) and 105 (1.00 g, 2.42 mmol), NEt3 (0.36 mL, 2.59 mmol) 
in THF (140 mL) gave 108 (0.37 g, 33 %). Chromatography 
on silica (eluent: DCM/ EtOAc - 5%). 1H NMR (300 MHz, 
CDCl3) δ = 8.41 (s, 2H, NH), 8.31 – 8.24 (m, 4H, ArHanth), 8.21 
(s, 2H, ArHanth), 8.19 (s, 1H, ArH), 8.14 (s, J = 1.5 Hz, 2H, 
ArH), 8.07 (d, J = 8.0 Hz, 2H, pyr), 8.04 – 7.94 (m, 6H, ArH 
(4H-anth and 2H pyr), 7.85 – 7.72 (m, 4H, NH and pyr), 7.52 
– 7.40 (m, 8H, ArHanth) 4.17 (t, J = 6.5 Hz, 4H, OCH2CH2), 2.43 (t, J = 7.4 Hz, 4H, COCH2), 2.09 
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– 1.99 (m, 4H, OCH2CH2), 1.88 – 1.77 (m, 4H, COCH2CH2), 1.71 (dt, J = 15.3, 7.6 Hz, 4H, 
OCH2CH2CH2), 1.58 – 1.48 (m, 4H, COCH2CH2CH2), 1.37 (s, 9H, CH3). 13C NMR (101 MHz, 
CDCl3) δ = 171.83 (CO), 165.09 (CO), 153.33 (C pyr), 151.34 (C Aranth), 149.80 (C pyr), 149.39 
(C Ar), 140.95 (CH pyr), 134.38 (C Ar), 132.41 (C Aranth), 128.45 (CH Aranth), 125.44 (CH Aranth), 
125.09 (CH Aranth), 124.68 (C Aranth), 122.76 (CH Ar), 122.34 (CH Aranth), 122.04 (CH Aranth), 
110.11 (CH pyr), 109.71 (CH pyr), 75.91 (OCH2), 37.55 (COCH2), 35.22 (C tBu), 31.14 (CH3), 
30.50 (OCH2CH2), 29.16 (COCH2CH2CH2), 26.07 (OCH2CH2CH2), 24.93 (COCH2CH2). HRMS 
(ES+): calcd for C66H68N4O6Na [M+2H+Na]+ m/z = 1035.5, found m/z = 1035.6. Analysis is in 
agreement with literature data.13 
N1,N3-bis(6-(10-(anthracen-9-yloxy)decanamido)pyridin-2-yl)-5-(tert-
butyl)isophthalamide, 109 
General Procedure E using 39 (0.10 g, 0.39 mmol) in THF 
(25 mL) and 106 (0.39 g, 0.86 mmol), NEt3 (0.13 mL, 0.93 
mmol) in THF (50 mL) gave 109 (0.23 g, 53 %). 
Chromatography on silica (eluent: DCM/ EtOAc - 15%). 1H 
NMR (300 MHz, CDCl3) δ = 8.54 (s, NH), 8.22 – 8.14 (m, 4H, 
ArHanth), 8.09 (m, 3H, ArH (2H-anth and 1H-Ar), 8.01 (s, 2H, 
ArH), 7.95 – 7.82 (m, 10H, (8H-pyr, 4H-anth, 2NH)), 7.62 (t, 
J = 8.1 Hz, 2H, pyr), 7.41 – 7.28 (m, 8H, ArHanth), 4.07 (t, J = 
6.7 Hz, 4H, OCH2), 2.28 (t, J = 7.5 Hz, 4H, COCH2), 1.93 (p, J 
= 6.8 Hz, 4H, OCH2CH2), 1.57 (dq, J = 29.4, 7.2 Hz, 8H, OCH2CH2CH2 and COCH2CH2CH2), 1.31 
– 1.26 (m, 16H, Alk), 1.25 (s, 9H, CH3). 13C NMR (101 MHz, CDCl3) δ = 172.04 (CO), 165.00 
Experimental 
245 
 
(CO), 153.31 (C pyr), 151.45 (C ArAnth), 149.86 (C pyr), 149.47 (C Ar), 140.86 (CH pyr), 134.31 
(C Ar), 132.42 (C Aranth), 128.53 (CH Ar), 128.42 (CH Aranth), 125.44 (CH Aranth), 125.04 (CH 
Aranth), 124.71 (C Aranth), 122.65 (CH Ar), 122.42(CH Aranth), 121.95 (CH Aranth), 110.07 (CH 
pyr), 109.69 (CH pyr), 76.14 (OCH2), 37.68 (COCH2), 35.20 (C tBu), 31.14 (CH3), 30.68 
(OCH2CH2), 29.56 (alk), 29.47 (alk), 29.38 (alk), 29.24 (alk), 26.23 (COCH2CH2CH2), 25.36 
(COCH2CH2). HRMS (ES+): calcd for C70H77N6O6 [M]+ m/z = 1097.5905, found m/z = 
1097.5913. mp: 99-101o C. IR (neat): 3283 (N-H) 3054 (N-H) 2926 (C-H) 2854 (C-H) 1678 (CO) 
1584 (CO). 
General Procedure F for the synthesis of Cyclic Receptors 110-112 
A solution of acyclic receptor in degassed DCM (25 mL) at c = 5x10-4 M was irradiated with a 
UV lamp using a bandpass filter at 365 nm. The dimerization was monitored using UV-Vis 
absorption to observe the decrease in anthracene signal and once complete the solvent was 
removed and the obtained crude product was purified via flash column chromatography to 
afford a yellow solid. 
(145S,146R,1411R,1412S)-45-(tert-butyl)-145,146,1411,1412-tetrahydro-13,15-dioxa-2,6,8,20-
tetraaza-1,7(2,6)-dipyridina-14(5,11)-5,12:6,11-bis([1,2]benzeno)dibenzo[a,e][8]annulena-
4(1,3)-benzenacycloicosaphane-3,5,9,19-tetraone, 110 
Chromatography on silica (eluent: DCM/EtOAc - 10%). Yield: quantitative. 1H NMR (300 
MHz, CDCl3) δ 8.54 (s, 2H, NH), 8.18 (s, 2H, ArH), 8.14 – 8.01 (m, 4H, (2H-pyr and 2H-NH)), 
7.95 – 7.80 (m, 5H, (1H-ArH, 4H-pyr)), 7.08 (d, J = 7.3 Hz, 4H, ArH-xyl), 6.87 (d, J = 7.0 Hz, 4H, 
ArH-xyl), 6.71 (dt, J = 22.0, 7.0 Hz, 8H, ArH-xyl), 4.42 (s, 2H, CHbridgehead), 3.75 (t, J = 6.0 Hz, 
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4H, OCH2), 2.82 – 2.60 (m, 4H, COCH2), 2.34 – 2.19 (m, 4H, 
COCH2CH2), 1.42 (s, 9H, CH3). Analysis is in agreement with 
literature data.13 
 
 
 
(175S,176R,1711R,1712S)-45-(tert-butyl)-175,176,1711,1712-tetrahydro-16,18-dioxa-2,6,8,26-
tetraaza-1,7(2,6)-dipyridina-17(5,11)-5,12:6,11-bis([1,2]benzeno)dibenzo[a,e][8]annulena-
4(1,3)-benzenacyclohexacosaphane-3,5,9,25-tetraone, 111 
 Chromatography on silica (eluent: DCM/EtOAc - 15%). Yield: 
quantitative. 1H NMR (300 MHz, CDCl3) δ 8.22 (s, 2H, NH), 8.08 
(s, 3H, ArH), 8.03 (d, J = 2.8 Hz, 2H, pyr), 8.00 (d, J = 2.9 Hz, 2H, 
pyr), 7.81 (t, J = 8.1 Hz, 2H, pyr), 7.65 (s, 2H, NH), 7.01 – 6.88 (m, 
8H, ArH), 6.78 – 6.64 (m, 8H, ArH), 4.36 (s, 2H, CHbridgehead), 3.47 
(t, J = 6.9 Hz, 4H, OCH2), 2.41 (t, J = 7.1 Hz, 4H, COCH2), 1.89 – 
1.77 (m, 12H, Alk), 1.53 (dd, J = 14.0, 6.6 Hz, 4H, COCH2CH2CH2), 
1.41 (s, 9H, CH3). MS (ES+): calcd for C64H64N6O6 [M+H]+ 1013.3, found m/z = 1013.5. Analysis 
is in agreement with literature data.13 
(205S,206R,2011R,2012S)-45-(tert-butyl)-205,206,2011,2012-tetrahydro-19,21-dioxa-2,6,8,32-
tetraaza-1,7(2,6)-dipyridina-20(5,11)-5,12:6,11-bis([1,2]benzeno)dibenzo[a,e][8]annulena-
4(1,3)-benzenacyclodotriacontaphane-3,5,9,31-tetraone, 112: 
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 Chromatography on silica (eluent: DCM/EtOAc - 10%). Yield: 
quantitative. 1H NMR (300 MHz, CDCl3) δ 8.31 (s, 2H, NH), 8.21 
(s, 1H, ArH), 8.11 (s, 2H, ArH), 8.07 – 7.94 (m, 4H, pyr), 7.75 (t, J 
= 8.0 Hz, 2H, pyr), 7.64 (s, 2H, NH), 7.10 – 6.88 (m, 8H, ArH), 
6.88 – 6.69 (m, 8H, ArH), 4.42 (s, 2H, CHbridgehead), 3.50 (t, J = 6.7 
Hz, 4H, OCH2), 2.48 – 2.32 (m, 4H, COCH2), 1.94 – 1.70 (m, 8H, 
OCH2CH2 and OCH2CH2CH2), 1.44 (s, J = 8.2 Hz, 9H, CH3), 1.38 (s, 
J = 23.4 Hz, 16H, Alk). HRMS (ES+): calcd for C70H77N6O6 [M]+ m/z = 1097.5905, found m/z = 
1097.5957. mp: 125-128o C. 
45-(tert-butyl)-179,1710-dihydro-16,18-dioxa-2,6,8,26-tetraaza-1,7(2,6)-dipyridina-17(9,)-
anthracena-4(1,3)-benzenacyclohexacosaphane-3,5,9,25-tetraone compound with 5,5-
bis(3-(4-((4-(tris(4-(tert-butyl)phenyl)methyl)phenoxy)methyl)-1H-1,2,3-triazol-1-
yl)propyl)pyrimidine-2,4,6(1H,3H,5H)-trione (1:1), 113 
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A solution of 108 in degassed DCM (25 mL) at c = 5x10-4 M, containing 85 (3 equivalents) 
was irradiated with a UV lamp using a band pass filter at 365 nm. The dimerization was 
monitored using UV-Vis absorption to observe the decrease in anthracene signal and once 
complete, the solvent was removed and the white solid obtained was purified via flash 
column chromatography, eluent (DCM/EtOAc – 10%) to give the 20 mg of 113 (8.4 µmol, 
58% yield). 1H NMR (300 MHz, Acetone) δ 9.46 (d, J = 8.9 Hz, 2H, NH), 8.29 (s, 1H, 6), 8.20 (s, 
J = 1.5 Hz, 2H, 4), 8.04 (d, J = 8.0 Hz, 2H, 9), 7.95 (d, J = 8.1 Hz, 2H, 11), 7.83 (t, J = 8.1 Hz, 2H, 
10), 7.69 (s, 2H, 7’), 7.32 (d, J = 8.7 Hz, 12H, 16’), 7.19 – 7.01 (m, 20H, 12’, 17’, 24a), 6.94 
(dd, J = 6.9, 1.3 Hz, 4H, 24b), 6.83 (d, J = 8.9 Hz, 4H, 11’), 6.78 – 6.64 (m, 8H, 23), 5.09 (s, 4H, 
9’), 4.54 (s, 2H, 21), 3.94 – 3.71 (m, 8H, 19, 6’), 2.56 – 2.41 (m, 4H, 14), 2.13 – 2.04 (m, 8H, 
18, 5’), 1.86 – 1.71 (m, 4H, 15), 1.66 – 1.40 (m, 12H, 4’, 16, 17), 1.36 (s, J = 6.2 Hz, 9H, 2), 
1.31 (s, 54H, 20’). 13C NMR (126 MHz, Acetone-d6) δ 174.22 (CO), 172.50 (CO’), 166.37 (CO), 
157.26 (C Ar’), 153.26 (C pyr), 151.82 (C Ar), 151.65 (C pyr), 151.12 (C Ar), 151.04 (C Ar’), 
149.16 (C Ar’), 145.15, 144.38 (C Ar’), 144.23(Ctria), 141.44 (CH pyr), 140.67 (C Ar’), 135.46 
(CH Ar’), 132.79 (C Ar), 131.42 (CH Ar’), 129.78 (CH Ar’), 128.04 (CH Ar), 126.86 (CHtria), 
126.17 (CH Ar), 125.76 (CH Ar), 125.04 (C Ar), 124.27 (CH Ar’), 123.61 (CH Ar), 114.19, 
111.30 (CH pyr), 110.55 (CH pyr), 66.28 (OCH2), 63.89 (C’), 62.62 (C’), 62.40 (OCH2’), 55.59 
(COCCO’), 49.79 (NCH2’), 37.65 (COCH2), 35.98 (C tBu), 34.86 (CCH2’), 34.32 (C tBu), 31.38 
(CH3), 31.08 (CH3’), 30.04 (OCH2CH2), 29.94 (alk), 29.46 (alk), 27.05 (alk), 25.76 (NCH2CH2’). 
HRMS (ESI+) cald for C154H172N14O11 [M + 2H]2+ m/z = 1197.2, found m/z = 1197.3.  Melting 
Point: 156-158 oC. 
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